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This graph shows how some sutures lose most of their strength
before the slow-healing fascia (healing rate shown by pink area) can
stand on its own. p d s suture holds its strength while the tissue
regains its strength.'
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QUILL ON SCALPEL
This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

Perspectives on Malignant Biliary Obstruction:
Does the Surgeon Have a Role in Management?
Concepts of intervention for malignant
biliary obstruction have altered substan
tially since the first reports of successful
percutaneous drainage in 19781 and
endoscopic drainage in 1979.2 Manage
ment previously had been entirely opera
tive with most treatment decisions being
made by surgeons, who carried out pal
liative bypass in the majority of cases.
However, current imaging techniques for
obstructive jaundice often involve radi
ologists and gastroenterologists before the
surgeon is consulted. In fact, the imag
ing requests may be followed directly by
an interventional procedure that is con
sidered definitive treatment by the
operator.
This may be appropriate if all biliary
strictures were considered to be incura
ble malignant lesions. However, most
authorities accept that certain ampullary
and bile-duct carcinomas are curable.
Whether the same is considered true for

pancreatic carcinoma is debatable. None
the less, not all lesions obstructing the bile
duct will prove to be of pancreatic origin,
so consideration of surgical cure should
not be withheld from patients when even
slight hope of resectability exists.
The combination of cholangiography
and sophisticated abdominal scanning
techniques should allow biliary disease to
be categorized, so that the surgeon, radi
ologist and gastroenterologist together
could select the appropriate therapeutic
technique. Advanced metastatic obstruc
tion of the bile duct or prim ary
hepatobiliary-pancreatic carcinoma with
proven unresectable spread should be
considered for nonoperative palliation.
But a distal bile-duct stricture without any
definition of the mass by scanning
demands that resectability be verified by
operation. Even hilar bile-duct lesions
without a large mass effect or intrahepatic
spread may be resectable, although not
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always curable.3 I propose that, before
any intervention, the mode of treatment
should be decided upon jointly by staff
from all disciplines involved, using the
experience and expertise o f all available
specialists.
Discussion of the management of
unresectable disease frequently compares
the results of various forms of palliative
intervention with those of operative
bypass. Often the surgical statistics
quoted are outdated and describe small
numbers of cases; universally, the results
from the surgical series selected are
inferior to those of the palliative tech
nique under consideration. Sarr and
Cameron4 reported the results o f surgi
cal palliation for pancreatic carcinoma
collected between 1965 and 1982. Over
10 000 patients were treated by biliaryenteric bypass, with a mean survival of
5.5 months. Patients who did not undergo
bypass survived 3.4 m onths after
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laparotomy alone — a result similar to
those from many reports of nonoperative
biliary drainage.4 This historical baseline
must be considered whenever results of
intervention are debated.
The results of prospective randomized
trials may be valuable to compare the
quality and duration of palliation for
unresectable disease. Such analysis offers
an improvement over retrospective anal
ysis of interventional palliation describ
ing success in terms of radiologic illustra
tions or biochemical changes. Any trial
must indicate success or failure in terms
of restoration of normality, the severity
and frequency of disabling morbidity,
recurrence of presenting problems and
length of survival. For comparative
results to be meaningful, they must be
categorized. Cholangiography and scan
ning will be valuable in this respect.
However, pathologic features of the
tumour may not be obtainable in all
cases, and the biologic behavioural differ
ences between bile-duct carcinoma and
pancreatic carcinoma are enough to affect
the evaluation of data from any sample
size.
N onoperative biliary drainage is
associated with a lower morbidity and
mortality than surgery in most reports
from experienced units. This is particu
larly true for the procedure alone, con
sidering the complexities associated with
operation and anesthesia in patients with
decompensated liver function and sup
pressed immune response. However, the
30-day death rate may be equal to or
greater than that for operation when
short-term complications of percutaneous
and endoscopic stenting are included in
the analysis.5

As Olak and associates report in
this issue (pages 243 to 246, sepsis is
extremely important whenever palliative
bypass is not wholly internal. External
cannulas are considered important for
changing stents in the presence of infec
tion. Indeed, the results justify the need.
Similar requirements exist for endoscopic
stenting due to infection and occlusion of
the prosthesis. Surgically placed U tubes
suffer a similar fate and require frequent
changes. Surgically placed endopros
theses, free of external conduits, are
rarely complicated by infection or occlu
sion.6,7 This may also correlate with the
increased luminal diameter of the stent
sustaining improved bile flow.
No area has so long been the sacred
ground of general surgery as has the
biliary tract. Surgical competence in this
region is rarely questioned of qualified
specialists. Our results are so uniformly
outstanding that we almost never audit
our work and rarely publish the results
of other-than-unusual cases or collected
series from referral centres. However, be
aware of intrusion from non-surgeons,
who are capable of treating our diseases.
They have little more than scopes, nee
dles and catheters. They understand
imaging as well or better than we do.
They communicate with patients and
referring colleagues as well or better than
we do. Indeed, they may be as aggressive
as we think we are! And they do audit
their results and publish even small ser
ies of cases, creating awareness of the
frontiers that have been opened in our
field by non-surgeons.
We cannot all become endoscopists
capable of interventional techniques, nor
radiologists skilled in percutaneous ther

apy; however, we can evaluate our role
in current-day management of disorders
of the biliary tract, determine our place
on the team that will be involved in inves
tigation and treatment, upgrade our sur
gical skills and techniques, take part or
direct audits of the therapies applied, and
report results in print or presentation. The
alternative does not bode well for general
surgery.
R oger G. K eith ,

md , frcs , frcsc , facs

Member,
Editorial Board.
Associate professor of surgery,
University of Toronto,
Ste. 407,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
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Modern Management of the
Unruptured Tubal Pregnancy

Between 1970 and 1980 there was a
threefold increase in the occurrence of
ectopic pregnancy.1 In 1883 Lawson Tait
performed the first salpingectomy for this
condition. After excision of the affected
oviduct, the standard gynecologic prac
tice for ectopic pregnancy, patients can
be expected to conceive in 50% of cases,
have a live birth in 34% and a repeat
ectopic pregnancy in 16% of cases.2 This
traditional form of surgical management,
while undoubtedly life-saving, does little
to enhance the future fertility of women
226

wishing to preserve their reproductive
potential. During the past decade alter
native, more conservative, methods of
management have been explored with
considerable success. Since little other
than partial salpingectomy can be offered
to the woman who has suffered catas
trophic rupture of a tubal pregnancy,
earlier diagnosis before rupture is the
keystone o f a more conservative
approach.
The combination of acute clinical
awareness of the condition, measurement

of the circulating levels of the beta subu
nit of human chorionic gonadotropin3
and ultrasonographic assessment of the
pelvic organs in most cases will allow
early diagnosis to be made. The woman
with a short period of amenorrhea, pel
vic pain and vaginal spotting, in whom
an elevated level of beta human chorio
nic gonadotropin is detected may indeed
suffer from this condition. By the 25th
day after conception a gestational sac can
be detected by ultrasonography within the
uterine cavity. If no such sac is detected,
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the patient should be considered to have
an ectopic pregnancy until proven other
wise. The next logical investigation is
laparoscopy. Of 165 patients examined
laparoscopically by Samuelsson and
Sjovall4 and believed to have an ectopic
pregnancy 164 did so and of 312 thought
not to have ectopic pregnancy the diagno
sis was correct in all but 6. Laparoscopy
provides the opportunity to make a con
crete diagnosis, to assess the status of the
contralateral oviduct and, in many cases,
to perform definitive conservative sur
gery. The use of laparoscopic electrosurgical methods will allow performance of
linear salpingostomy or minimal segmen
tal resection of the gestational sac.5
For the surgeon unfamiliar with
laparoscopic surgical techniques, a sim
ple alternative is to combine laparoscopy
with mini-laparotomy. Such a procedure
is feasible only in the slim patient in
whom the uterus and affected oviduct are
freely mobile. When a uterine cannula is
placed in the cervix it is possible to
manipulate the uterine fundus immedi
ately beneath the anterior abdominal
wall. A 1- to 2-cm suprapubic incision is
all that is required to deliver the tube to
the exterior where a conservative surgi
cal approach can be undertaken.6
If formal laparotomy is undertaken the
pregnancy can be milked from the tube
if it is in the ampullary portion. The
results have been less than satisfactory,
with a repeat incidence of ectopic preg
nancy of 21.4%.7 The optimal approach
would appear to be linear salpingostomy.
Women whose incisions were permitted
to heal by secondary intention have been
shown by DeCherney and colleagues8 to
do better than those in whom primary
closure was undertaken. Langer and
colleagues9 studied 54 patients in whom
linear salpingostomy was performed 44
times and milking 13 times. Of 49 patients
who wished to become pregnant, 71%
experienced a live birth and there was an
ectopic pregnancy rate of only 12%.
Perhaps more impressive than the intrau
terine pregnancy rate of 90% in patients
with a healthy contralateral tube was the
intrauterine pregnancy rate of 62.5% in
patients in whom the contralateral tube
was absent or damaged.
U ndoubtedly these conservative
approaches are more effective when
microsurgical techniques are used. Such
a statement may intimidate the practising
surgeon who has not had special training
in microsurgery, but there is nothing mys
tical about these procedures, relying as
they do on the principles of magnifica
tion, pinpoint electrocautery and delicacy
in tissue handling. Magnification for the
conservative management of the tubal
pregnancy is provided very adequately by
opthalmologists’ loupes which give a
magnification of 4 x or 6 x . Any solidstate electrocautery machine can be used

in conjunction with a pinpoint electrocau
tery needle. Irrigation can be provided by
a 20-ml syringe and an Angiocath. When
salpingostomy is performed, a few fine,
preferably 8-0, sutures at the angles of the
incision will usually be all that is needed
to secure hemostasis. Perhaps in the
future ectopic pregnancy diagnosed early
will no longer be treated surgically. A
recent report10 demonstrated that when
six patients with unruptured ectopic preg
nancies were treated with methotrexate
and folic acid, all responded to one course
of treatment and none required surgery.
Hysterosalpingography performed 3
months after treatment revealed patent
tubes and normal uterine anatomy. While
such reports are preliminary and do not
provide information about subsequent
pregnancy and ectopic pregnancy rates,
they do hold promise for noninvasive
management.
Although in-vitro fertilization techni
ques may provide future hope for women
who suffer from ectopic pregnancy,
attempts at primary conservation add
little to the operating time, do not involve
expensive high-technology methods and
appear to have a gratifying success rate
with respect to live births. It should now
be incumbent upon any surgeon involved
with the gynecologic care of women to
consider early diagnosis and conservation
of the affected fallopian tube.
P a t r ic k

J.

T aylo r,

m d , fr c sc , f r c o g

Director, Endocrine/Infertility Clinic,
University of Calgary,
Health Sciences Centre,
3330 Hospital Drive NW,
Calgary, Alta.
T2N 4N1
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CORRESPONDENCE

Contributions to the Correspondence section are welcomed.
They should be typewritten and double spaced.

Campylobacter jejuni Associated
With a Perirectal Abscess

To the editors.—Campylobacter jejuni is
a slender, curved, S-shaped or spiral,
motile, microaerophilic, gram-negative
bacillus, positive for sodium hippurate
hydrolysis.1 Acute enteritis is the com
monest clinical manifestation of infection
due to this bacterium,2 which may cause
a variety of other intestinal disorders—
toxic megacolon and colitis,3 massive
gastrointestinal hemorrhage,4 chole
cystitis5 and pancreatitis.6
We report a case of C. jejuni isolated
directly from a perirectal abscess, which
we believe is the first such report.

usually represent mixed infections involv
ing anaerobes, particularly Bacteroides
fragilis and gram-negative enteric
bacilli.7 Our patient is the first in whom
C. jejuni has been isolated from an
abscess at this site. One may speculate
that the episode of self-limited enteritis
was caused by C. jejuni and was subse
quently complicated by an abscess due to
this organism in proximity to the gastroin
testinal tract. Similar manifestations
(perineal, perirectal abscesses) are wellknown in relationship to Salmonella
infections.8
It is recommended that any patient with
a perirectal abscess who has suffered ente
ritis in the preceding few weeks and
requires incision and drainage should
have samples of pus sent to the microbi
ology laboratory. The laboratory should
be asked to culture not only aerobes and
anaerobes, but also Campylobacter which
requires specific media and culture con
ditions for isolation.1
Sigmund Krajden, md, frcpc
Department of Microbiology
Claude J. Burul, md, frcsc
Department of Surgery
M ilan Fuksa, d sc
Department of Microbiology

6. G allagher P, C hadwick p , J ones DM, et at: Acute
pancreatitis associated with Campylobacter infection Br
J Surg 1981; 68: 383
7. Mitchell AA: Incidence and isolation of Bacteroides
species from clinical material and their sensitivity to antibi
otics. J Clin Pathol 1973; 26: 738-741
8. Saphra I, W inter JW: Clinical manifestations of
salmonellosis in man: an evaluation of 7779 human infec
tions identified at the New York Salmonella Center. NEngl
J Med 1957; 256: 1128-1134

Tube Cecostomy

To the editors.—To evaluate the role of
tube cecostomy, one must consider the
purpose of the procedure, its effectiveness
and its morbidity.
The purpose of tube cecostomy is to
Three weeks before being seen in the clinic,
decompress
the colon. Decompression
a 64-year-old woman experienced an episode
involves the release of gas, liquid and
of diarrhea (5 to 10 movements daily),
solid material. Rosenberg and Gordon in
associated with abdominal pain. The attack
the January 1986 issue of this journal
resolved spontaneously within a week. There
(pages 38 to 40) showed that tube
was no fever, nausea, vomiting or hematochececostomy is not reliably effective in
zia. There had been no recent exotic travel or
consumption of unpasteurized dairy products
achieving that goal. Frequent and
or inadequately cooked meat.
unavoidable tube obstruction is the limit
Two weeks later, a gradually increasing pain
ing factor in this procedure. A mucosaful mass developed in the right perianal area,
to-skin cecostomy without a tube may
unassociated with fever or chills. A right
reduce
the incidence of obstruction.
perirectal abscess was found and drained
However, the stoma may be small, diver
through an incision placed in the squamous
sion incomplete and a second operation
epithelium of the right buttock after appropri
required for closure.
ate disinfection. Pus was sent to the microbi
Rosenberg and Gordon outlined the
ology laboratory. However, owing to a cleri
morbidity associated with tube ceco
cal error the specimen was labelled as “ rectal
swab” rather than “ perirectal abscess” , and University of Toronto and
stomy, further emphasizing the dis
was handled as a stool sample rather than an
St. Joseph’s Health Centre,
advantages of this procedure.
abscess. As such, cultures for anaerobes were 30 The Queensway,
Are there any indications for this
not done. Campylobacter jejuni and Citrobac- Toronto, Ont.
procedure, which is, at best, partially
ter freundii were isolated from the specimen. M6R 1B5
decompressing? The intraluminal stapler
References
has made it possible to create more secure
Most perirectal abscesses are thought
anastomoses in the pelvis and has reduced
Morris GK, P atton CM: Campylobacter. In Lennette the need for proximal diversion of the
to arise in the 6 to 10 anal glands that 1. EH,
B
alows A, H ausler WJ JR, et at (eds): Manual
empty into the anal canal at the dentate
o f Clinical Microbiology, 4th ed, American Society for
fecal stream. If such diversion is deemed
Washington, 1985
margin. The infection begins in the plane 2. FMicrobiology,
necessary,
a loop transverse colostomy or
inch MJ, R iley LW: Campylobacter infections in the
between the internal (visceral) and the
a
loop
ileostomy
will more completely
United States. Results of an 11-state surveillance. Arch
Med 1984; 144: 1610-1612
external (somatic) sphincters. From there 3. MIntern
divert
gas,
liquid
and
solid material than
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the infection progresses caudally to form
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of
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in
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the mucosa was sutured to the skin was
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used once with good anastomotic healing;
however, the cecostomy continued to
drain small amounts of stool and was still
not closed 2 years after surgery.
Cecal volvulus requires a procedure
that will release gas from the cecum
and prevent recurrent volvulus. Tube
cecostomy is better suited to this role, but
again the incidence of tube obstruction
limits the value of this procedure. Ileoce
cal resection is a safe and more reliable
alternative.
Pseudo-obstruction of the colon
requires temporary gas decompression of
the cecum. If colonoscopic decompres
sion has failed, a tube cecostomy may be
considered. However, a mucosa-to-skin
cecostomy is more reliable.
In summary, tube cecostomy is not a
reliable means of diversion or decompres
sion for protecting distal anastomoses.
Cecal volvulus is best managed by resec
tion and primary anastomosis. Tube
cecostomy or a mucosa-to-skin cecostomy
may still have a role in the management
of pseudo-obstruction of the colon
unresponsive to colonoscopic decompres
sion. Currently there are no other indi
cations for the use of tube cecostomy.

Management of Breast
Fibroadenoma in Women
Under 25 Years of Age

S t a n ley M . G o l d b e r g , m d , facs
D av id L. M e e s e , md

To the editors.—Deschenes and associates
(Can JSurg 1985; 28: 372-374) advocate
delayed excision of breast fibroadenomas
for women under 25 years of age with a
cytologically confirmed tumour on the
grounds that the risk of breast cancer is
small and spontaneous regression may
occur. In a retrospective study1 of 134
patients with a clinical diagnosis of
fibroadenoma, cancer was found in 8.
One of these patients was only 26 years
old. Fine-needle aspiration biopsy has a
sensitivity of over 95% in the diagnosis
of suspected malignant breast masses,2
but a negative result is of no value. In two
out of eight patients with a clinical diag
nosis of fibroadenoma who later were
found to have cancer, fine-needle aspi
ration cytology gave negative results.1
The extent to which fibroadenomas
may show spontaneous regression is
uncertain. In one report3 only 2 of 17
fibroadenomas observed for varying
periods regressed. The standard treatment
of fibroadenoma should, therefore,
remain surgical excision1 since it is both
diagnostic and therapeutic.

Department of Surgery,
Division of Colon and Rectal Surgery,
University of Minnesota Medical School,
516 Delaware St. SE,
Minneapolis, MN 55455
USA

V .K . K a p o o r , m b , b s , ms
Formerly senior resident
Research officer
L.K. SHARMA, MB, MS, FICS
Professor

Organization of Trauma Care
To the editors.—Although you are to be
commended for an excellent overview of
traum a care systems in Canada (vol. 28,
no. 6, November 1985), I would like to
update you on progress being made in
Ontario. Presently, we have one central
air ambulance dispatch for the entire
province and central land ambulance dis
patch for all the major urban and regional
centres.
With respect to the air ambulance, in
Ontario, Bandage 1 helicopter which
operates out of Toronto and covers cen
tral Ontario has had paramedical staff for
7 years. In addition, advanced life sup
port is being introduced in the near future
to the two helicopters and two small jets
that operate as dedicated air ambulances
in Northern Ontario.
J.W . C ro sby ,

m d , fr c pc

Medical consultant,
Emergency Care Programs,
Ministry of Health,
Government of Ontario,
7 Overlea Blvd.,
Toronto, Ont.
M4H 1A8

Department of Surgery,
All India Institute of Medical Sciences,
New Delhi — 110029,
India

and in our series of 1564 cases, there was
no woman in her teens and there were,
respectively, 9 (0.15%) and 3 (0.19%)
patients aged 20 to 24 years. In these 12
young patients with breast cancer, clini
cal findings were not suggestive of a
fibroadenoma.
Prom pt surgery is justified for young
women with a presumptive diagnosis of
fibroadenoma who mention a rapidly
growing lump, have a tumour measuring
more than 15 to 20 mm in diameter or
seem anxious. Otherwise, we recommend
an excisional biopsy in the next few
months at the patient’s convenience.
Occasionally, at re-examination, the
tumour has vanished. If a biopsy is not
performed, it is practically impossible to
know whether the lump was in fact a
fibroadenoma, a small cyst depleted by
the fine needle of the aspiration biopsy
or a nodule associated with premenstrual
changes in the breast.2
L u c D e s c h £ n e s , m d , fr csc
J a c q u e l in e F a b ia , m d , sc d
S im o n J a c o b , m d , f r c p c
Hopital du Saint-Sacrement,
1050, chemin Ste-Foy,
Quebec, PQ,
G1S 4L8
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To the editors.— We fully agree with
Kapoor and Sharma that excisional
biopsy is the standard management of
women with a presumptive clinical and
cytologic diagnosis of fibroadenoma.
Like Haagensen,1 however, we see no
point in rushing patients under 25 years
of age to the operating room. The risk of
a malignant condition is, indeed, minimal
at that age. Among our 762 patients with
histologically confirmed fibroadenoma,
studied in the last 8 years, 158 (20.7%)
were in the 20- to 24-year age group and
85 (11.2%) were under 20 years of age,
the youngest being 15 years old. On the
other hand, in Haagensen’s series of 6000
patients with carcinoma of the breast1

This list is an acknowledgement of
books received. It does not preclude
review at a later date.
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New York, Inc., New York, 1985. $38.50
(US). ISBN 0-387-81874-X.
Atlas of Skeletal Dysplasias. Ruth WynneDavies, Christine M. Hall and A. Graham
Apley. 646 pp. Must. Churchill Living
stone, Edinburgh; Academic Press Canada,
Don Mills, Ont., 1985. $230.95. ISBN
0-443-03047-2.
Colorectal Tumors. Edited by Oliver H.
Beahrs, George A. Higgins and Jacob J.
Weinstein. 334 pp. Must. J.B. Lippincott
Company, Philadelphia, 1986. $57.50 (US).
ISBN 0-397-50677-5.
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After Trauma. Edited by G. Hierholzer and
K.B. Muller. 407 pp. Must. Springer-Verlag
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Heart Transplants Likely to Quadruple in Canada
by 1990
“ Between ages 10 and 55 years, about
1500 to 2000 people in Canada each year
could benefit from heart transplantation;
if you extend the age limit to 65, the num
ber is probably doubled,” says the man
heading the newest heart-transplant pro
gram in the country.
Dennis Modry, FRCSC, who spent 3
years at Stanford and was chief of the
transplant service in his last year there,
received approval from the Alberta
government on May 1 this year for a pro
gram at the University of Alberta Hospi
tal in Edmonton, giving the western
provinces their first centre for heart and
heart-lung transplants. The approval fol
lows a pilot program in which Modry’s
team performed three heart transplants —
the first one on July 28, 1985 — and then
analysed the costs and results of the care
both in and outside the hospital.
Within 4 years, Modry expects his and
other Canadian centres each to be per
forming about 50 heart transplants annu
ally. “ The goal for 1990 is to do about
500 transplants across the country in 10
or so centres; the centres performing
heart-lung transplants may each do
another 5 or 10 of those. That’s a realis
tic number to aim for given the status of
available donors. If legislation is enacted
to make it incumbent upon physicians to
approach donor families, then the trans
plant teams could conceivably handle
about two-thirds of the people who can
benefit from the procedure.
“ In Edmonton, we have now accepted
seven individuals as recipients for heart
transplants but there are hundreds that
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.
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have been referred from British Colum
bia, Alberta and Saskatchewan. There is
talk of another two western centres — one
in Vancouver — that should come on
stream in a couple of years and one in
Winnipeg. Most centres begin with heart
transplantation and move into the more
difficult heart-lung procedure. For our
program, the next transplant could be a
heart-lung operation as far as Em con
cerned since Eve done several at Stanford
and a great number in the lab.
“ Since we are just getting started in
transplantation we haven’t assessed the
wait list. In future, we will probably have
actively selected 12 to 15 people at any
one time, although there may be any
where from 50 to 75 who are waiting to
get on the active list.”
At present, like Modry’s group, most
of the other centres are just gearing up,
averaging fewer than 10 each in the past
year. Besides the group in Edmonton,
teams at four hospitals in Montreal, two
in Toronto, one in London and one in
Ottawa are performing heart or heartlung transplants.
As the procedures are performed only
on individuals with “ end-stage” disease,
the operation’s ability to extend life has
not been debated since survivors
undoubtedly live longer than they would
have without the transplant and success
rates approach 90% in most centres.

Ottawa Team Opts for
Artificial Heart
At the success rates typical of heart trans
plant programs, the risk of imminent
death for recipients is much greater before

than after transplantation — a reality that
has prompted cardiac transplant teams
not only to step up the numbers of ope
rations but to seek reliable means of tem
porary support until a human heart
becomes available. So it was that in May,
the University of Ottawa Heart Institute
— or rather team leader Wilbert Keon,
FRCSC, coordinator Arvind Koshal,
FRCSC, Alan Menkis, clinical and
research fellow, and resident Ed Farrell
— became the first in Canada to test an
artificial heart as a means to bridge the
time between heart failure and receipt of
a suitable donor heart.
Menkis has submitted for publication
a report of the events leading up to and
following the use of the Jarvik 7-70 in
Noella Leclair but briefly reviewed the
event: “ The patient was a 41-year-old
mother of one who was asymptomatic
before the initial infarct. During the next
week the infarct extended to cover most
of her left ventricle, and despite all of the
usual and dramatic things that cardiolo
gists and cardiac surgeons do, including
the use of streptokinin, intra-aortic bal
loon pumping and subsequent double
bypass, she couldn’t come off bypass. By
the time we put in the artificial heart she
was effectively dead.” The decision
proved timely and, despite some bleeding,
she was “ in good shape when a donor
became available” . Thus, the first reci
pient of an artificial heart in Canada
became the 12th to receive a human heart
at the institute, which began its program
2 years ago. (True to the statistics else
where, one patient in the series died, 5
weeks after transplantation.)
As might be expected, the technique for
inserting the air-driven pump made of
plastic and metal differs substantially
from that for a human heart, so last year
the team spent time learning the proce
dure with the heart’s developer in Salt
Lake City.
The Jarvik heart has now been used at
least 12 times to maintain individuals
awaiting human hearts, and only two
patients have reportedly died while it was
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inserted. It has not been compared with
other means of temporary support but
was the method with which the Ottawa
team felt most comfortable.
Methods of bridging will be used
increasingly often, not only for patients
like Leclair who deteriorate rapidly, but
also for those who become victims of the
competition for organs. At present, only
about 15% of organs that could be used
for transplantation are being donated,
and the frustrating part, says Menkis, is
“ Every institution in Canada is capable
of contributing donors. Whether it is
capable of retrieving the organs is irrele
vant, since the MORE (Multiple Organ
Retrieval, Toronto) system will arrange
for someone to come to the institution.
A very small hospital can contribute
organs if it has the intensive care facili
ties to keep someone who is brain dead
physiologically going.
“ When you have a recipient or donor,
you call MORE or NATCO (North
American Transplant Coordinating
Agency), and the staff there make a
preliminary match by blood type, size and
age of the individuals. An urgency or
status-nine list is reserved for patients in
imminent danger of dying.”
Leclair was put on the list. The heart
that she eventually received was from a
44-year-old Montreal man killed in a car
accident near London, Ont.
At one time, a heart older than 35 years
wouldn’t have been considered because of
the prevalence of heart disease in North
America, but, says Menkis, “ Generally
all the programs are relaxing their criteria
somewhat, using chronologically older
donors and recipients. We do an angio
gram to confirm there is no coronary
artery disease in older donors...the
healthy heart of a 40-year-old is better
than the near-dead heart of the
recipient.”

London Multiorgan Service to
Perform 200 Transplants

Calvin Stiller, FRCPC, chief of the multiorgan transplant service at University
Hospital, London, Ont., reports that the
cardiac transplant team there performed
19 heart transplants in the first quarter
of this year and by the end of May had
done more than 70.
“ Although, like most transplant pro
grams, we initially were quite restrictive
about recipients, we are now taking
patients on the basis of their need. We
have performed heart transplants in 15
older than 50 years and 10 older than 55
years. The current success rate is over
80% for the entire program.”
Stiller prefers to discuss the complete

multiorgan service. The statistics are
impressive, with similar success rates
across the board for kidney, liver and
heart.
The teams in the service expect to per
form transplants at the rate of about two
kidneys, one heart and one liver each
week this year.
Says Stiller, “ About four of every five
transplant recipients will regain their pre
illness health at a cost to society of about
$40 000 to $50 000 for every heart and
liver transplant and something in the
region of $25 000 for every kidney. Each
of the clinical programs is preceded by
intensive work in the laboratory. For
instance, right now transplant programs
for intestines, limbs and islets are in the
preparatory period, with clinical applica
tions expected in the next 2 to 3 years. A
facility is now under construction to
house the whole program; a 12-bed unit
is being built and will open in December,
the focus being detection and manage
ment of rejection.”

Montreal MD Recalls Events
Leading to His Heart
Transplant a Year Ago
“ I had everything to contraindicate
transplantation,” says Samir Chebeir,
FRCSC, who at 49 years was still within
the criteria for age, but was suffering
from pulmonary infection, renal insuffi
ciency and hypotension, as well as hav
ing numerous rib fractures and a swollen
foot from misguided medical care he had
received days before in the Azores
Islands.
Albert Guerraty, FRCSC, head of the
heart-transplant team at the Royal Vic
toria Hospital in Montreal, had to be
pushed to perform the operation accord
ing to Chebeir: “ I was in very bad shape;
he told everyone I was going to die, but
he operated on me April 29, 1985. After
the transplant I was in a coma for 3 days,
I had to have dialysis and I had a gastric
hemorrhage.”
When it had all begun 1 month earlier,
Chebeir and his wife were en route to Por
tugal for a holiday. As the plane stopped
to refuel in the Azores Islands, Chebeir,
who had no history of heart disease and
was a hard-working obstetriciangynecologist, experienced a sharp,
unmistakable stab.
He called for oxygen, and when no one
responded he fumbled to find the plane’s
canister. It was empty, but a flight atten
dant noticed the commotion and began
to chastise him before realizing his dis
tress. A fellow traveller — a doctor from
Toronto — took his pulse, confirmed
arrhythmia and administered lidocaine
hydrochloride and called an ambulance.

The first hospital sent him to a second
where he was admitted. As he entered, he
moved backward in time — to the days
when defibrillators caused every muscle
in the body to contract, when anesthetics
were not offered and no equipment except
an electrocardiograph was used for inves
tigations. He watched his electrocardio
gram charting a series of arrhythmias; he
was given a pacemaker. He continually
asked to be allowed to return to Canada
for treatment.
He had no phone in his room, and the
receptionists at the hospital spoke only
Portuguese so relayed no messages to
him. His request for assistance in reach
ing specialists in Montreal was denied.
His wife succeeded in arranging for col
leagues at Hotel-Dieu — a cardiologist
and cardiac surgeon — to obtain
whatever they needed in the way of equip
ment and medications and to rent a jet
from New Jersey. They arrived in the
Azores to oversee his flight home.
Back in Montreal, the investigations
began. Besides the ischemic cardiomyopa
thy, he had pulm onary infection,
hypotension, renal insufficiency, an
inflamed foot, and every day he required
either cardiac massage or defibrillation,
the cardiac arrests numbering more than
100 before he underwent transplantation.
Chebeir has had no episodes of rejec
tion; he takes cyclosporine (150 mg twice
a day) and cortisone (10 mg daily). Peri
odically he has also needed captopril for
renal hypertension related to the long
term use of cyclosporine. His serum
creatinine levels are elevated (between 159
and 194 /unol/L) and although he is pre
pared to decrease his intake of cyclospo
rine, he refuses to consider a regimen
without the drug. “ If I switch now to
Imuran (azathioprine), the chances of
rejection, I think, are high, and it’s
impossible to know beforehand. I prefer
to diminish the dosage of cyclosporine.”
By radioimmunoassay, the levels of
cyclosporine in his blood are within the
range considered suitable for maintenance
— between 90 ng and 150 ng/ml.
Chebeir is one of 19 who have received
new hearts at the Royal Victoria Hospi
tal. All but one are still alive and have
Guerraty and his team to thank. To show
his gratitude, Chebeir has been
instrumental in obtaining support from
the private sector for the program. Lloyd
MacLean, FRCSC, surgeon-in-chief,
noted that Chebeir has been able to put
the services of a Lear jet at the disposal
of the transplantation unit when a donor
heart needs to be picked up, even from
as far away as South Carolina.
Says Chebeir, “ The cardiac team at the
Royal Victoria is very capable and could
do even more than they are doing now if
they had some help. The government has
not provided funds and the conditions at
the hospital are not what one would
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expect for sophisticated surgery. The
hospital doesn’t have anything — I had
to bring a chair from my home for my
room.
“ Competition with other hospitals for
funds has been detrimental, and my aim
is to help establish a foundation for heart
transplantation so that everyone who
needs a transplant can have one.”
In the meantime, Chebeir has done
much to facilitate organ procurement and
he would like to see the government do
more. “ At least three or four are await
ing heart-lung transplants at the Royal
Victoria and another six are waiting for
hearts. In April, the shortage was serious
for many centres. What we need to do is
to persuade the government to pass a law
similar to the one in France, number
761181 du Conseil d ’etat.” This law
assumes that a person is willing to donate
organs unless he or she officially opts out.
Few surgeons would disagree with Che
beir that the pool of donors has to be
extended, but the methods for doing so
are widely debated.

condition in which one needs to take out
both lungs, such as cystic fibrosis or
emphysema. At the moment, the only
way we can replace both lungs is to
include the heart, although we are work
ing on an operation for just the lungs.
“ We have performed five heart-lung
transplants, with four survivors. One of
the survivors has now — a year later —
died, probably as a result of chronic rejec
tion. All the others are doing well. One
was a gal from Chicago; another muchpublicized case was a woman from Que
bec — Diane Hebert. She had been down
to Stanford for a couple of years and had
come here to die. One was a chap from
Calgary who had a congenital immune
deficiency — agammaglobulinemia.
“ At first I thought it was insane to con
sider a transplant for him. His defect
meant he wasn’t making B-cell antibod
ies to protect him against bacterial infec
tion. To take someone like that and fur
ther suppress the immune system — do

Heart-Lung Transplants
in Toronto Began as Treatment
for End-Stage Lung Disease

The Toronto team performing heart-lung
transplants, unlike the others in Canada,
began the operation as an extension of
their program to deal with end-stage lung
disease.
Joel Cooper, FRCSC, who heads the
program as part of the division of
thoracic surgery at the University of
Toronto, explains: “ There are two com
ponents of the program — single-lung
and heart-lung transplantations. The
former is unique in that we have the only
successes in the world after about 45
unsuccessful tries over the past 20 years.
We’ve done single-lung transplants in five
patients with pulmonary fibrosis, with
four long-term successes. The first was in
November 1983, and that recipient is now
61 years old, leading a normal life. The
second was a woman who’s now touring
Germany; she was confined to a wheel
chair before the operation. All the sur
vivors returned to work within 3 months.
“ However, the heart-lung operation or
— as we refer to it — the lung-heart oper
ation is used in most places in the world
for an individual whose heart has failed
in association with some narrowing of the
blood vessels of the lung. We started
using the operation because there are
some people with lung failure for whom
a single-lung operation is not suitable, for
example, when the heart fails because of
lung disease or when the patient has a
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a T-cell immunosuppression to protect
against rejection — I thought would
render him hopelessly vulnerable. What
I found out was that gammaglobulin can
now be injected intravenously once a
month to keep this type of individual
immune competent. That treatment
wasn’t available before and the repeated
infections destroyed his lungs.
“ It’s only one case so all I can tell you
is that he probably had fewer problems
with rejection than did anyone else,
although some of the other recipients had
only minimal rejection.
“ For all our heart-lung transplant
recipients, we use primarily cyclosporine
for immunosuppression; after the first 3
weeks we also use prednisone — not
before, because we feel it interferes with
wound healing. We use azathioprine, and
in the early days we sometimes use
antilymphocyte globulin.”
Amy C houinard

SESAP V Question

Item 44
Which of the following statements about operative management of pa
tients with unresectable carcinoma of the pancreas is TRUE?
(A)

Gastrojejunostomy should be performed only if duodenal obstruc
tion is already present

(B)

Cholecystojejunostomy will reliably decompress the biliary tree if
the gallbladder is distended

(C)

Choledochoenteric anastomosis should be performed if the tumor
encroaches on the cystic duct

(D)

Placement of a hepatic U tube can provide excellent palliation if
this procedure can technically be performed

(E)

Routine drainage of the obstructed pancreatic duct is usually recom
mended

For the critique of Item 44 see page 286.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and
Self-Assessment Program No. 5. For enrolment in the Surgical Education and
Self-Assessment Program No. 5, please apply to the American College of Sur
geons, 55 East Erie St., Chicago, IL 60611.)
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Surgical Management of Gastric Ulcer

The charts of 139 patients operated on
for benign gastric ulcer between 1976
and 1980 were reviewed. Indications for
surgery included failure of medical
management, bleeding, perforation and
inability to differentiate benign from
malignant disease. Surgical management
included hemigastrectomy 2 9 % , vagot
omy with antrectomy 2 7 % , vagotomy
with pyloroplasty 1 3 % , wedge resection
7 % and highly selective vagotomy 4 % .
Eighty-four patients (6 0 % ) were available
for a minimum 4-year follow-up. Recur
rence rates were highest in those treated
by highly selective vagotomy (3 3 % ) and
wedge resection (3 0 % ). The overall
death rate was 4 .3 % , and 7 0 % of the
patients were classified as Visick grades
I or II (no or minimal symptoms).
Of the 30 patients with acute perfora
tion, 21 were treated by omental patching;
1 died and 3 had recurrent ulcer. Of six
patients treated by vagotomy with antrec
tomy, there were no deaths and no
recurrences.
The authors conclude that lesser
procedures are associated with an unac
ceptable recurrence rate and that gastric
resection is the procedure of choice for
both elective and emergency manage
ment of gastric ulcer.
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On a etudie les dossiers medicaux de
139 patients qui ont ete operes pour un
ulcere gastrique benin entre 1976 et
1980. Parmi les indications chirurgicales,
on notait I'echec du traitement medical,
des saignements, une perforation et
I'impossibilite de differencier I'ulcere
benin d'un cancer. Les techniques chirur
gicales comprenaient 2 9 % d'hemigastrectomies, 2 7 % de vagotomies avec
antrectomies, 1 3 % de vagotomies avec
pyloroplasties, 7 % de resections cun6iformes et 4 % de vagotomies hyperselectives. Quatre-vingt-quatre patients (6 0 % )
ont pu se preter pendant un minimum de
4 ans a des examens de surveillance.
Les plus hauts taux de rechute ont 6te
observes chez les patients traites par
vagotomie hypers6lective (3 3 % ) et par
resection cun6iforme (3 0 % ). La mortality
a 6te de 4 .3 % , et 7 0 % des patients ont
ete cotes I ou ll a la classification de
Visick (absence de symptomes ou
symptomes minimes).
Des 30 patients en perforation aigue,
21 ont ete traites par pose d'une plaque
d'epiploon; 1 est decede et 3 ont eu une
rechute ulcereuse. II n'y a eu ni deces ni
recidive chez les six patients traites par
vagotomie et antrectomie.
Les auteurs concluent que les interven
tions limitees sont entachees d'un taux
de rechute inacceptable et que la resec
tion gastrique represente ('intervention
de premier choix dans le traitement
d'urgence ou d iffe r de I'ulcere gas
trique.

Peptic ulceration of the stomach has a
number of characteristics in common
with duodenal ulcer, especially when the
distal antrum and pyloric region are
involved.1 However, ulceration of the
body of the stomach remains distinct in
its pathogenesis, the population at risk

and potential for complications. Unlike
duodenal ulcer, a major priority in the
management of gastric ulcer is the early
detection of a possible malignant lesion.
Despite these differences, the surgical
management of gastric ulcer is often
based on the principles underlying duo
denal ulcer, resulting in an inappropri
ately high incidence of recurrence and
morbidity.2-4 In an effort to define the
features of gastric ulcer that demand
separate consideration in surgical
management, we undertook to review a
series of patients treated at our insti
tution.

Patients and Methods
The charts of all patients operated on
for gastric ulcer at the major Dalhousie
University teaching hospitals between
1974 and 1980 were reviewed. Ulceration
was confirmed radiologically, endoscopically or by pathological study. Patients
with coexisting duodenal ulcer were
excluded, as were those with superficial
erosions, gastritis or malignant gastric
ulceration.
Follow-up information was obtained
by questionnaire and by a review of
hospital admissions after the ulcer sur
gery. Particular attention was paid to
ulcer recurrence and postoperative syn
dromes.
A modified Visick classification was
used to grade postoperative results, as fol
lows: Visick I — no symptoms, Visick II
— minimal symptoms, Visick III —
severe symptoms controlled by medica
tion and Visick IV — uncontrolled
symptoms.

Findings
There were 139 patients (82 men, 57
women), with a mean age of 57 years. A
minimum 4-year follow-up was possible
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in 84 (60%). With respect to the surgical
procedures performed, patient availabil
ity for re-evaluation was as follows: gas
tric resection 49%, vagotomy and antrec
tomy 58%, vagotomy and pyloroplasty
100%, wedge resection 56% and highly
selective vagotomy 100%. Within the ser
ies, seven (5%) patients had previously
undergone a Nissen fundoplication for
gastroesophageal reflux.
Diagnosis
Endoscopy, the most common means
of diagnosis, was used in 81 (58%)
patients and correctly localized the ulcer
in 73. As expected, those presenting with
acute perforation were not subjected to
endoscopy preoperatively. In 8 of the 81
patients the ulcer was not visualized
endoscopically but was found at laparo
tomy. Biopsy and cytologic specimens
were obtained through the endoscope in
only 29 patients. Despite this, only 2 of
the 139 patients were subsequently found
to have underlying malignant disease.
Upper gastrointestinal series was used
to identify the ulcer in 74 (53%) patients;
the remainder were located at laparo
tomy. Acid secretory studies were carried
out preoperatively in six patients, and, of
these, acid secretion was normal in five
patients and below normal in one.
The ulcer was located in the body of
the stomach, along its lesser curvature, in
64 patients (46%). Of these, eight had
ulcers in close proximity to the cardia.
Fifty ulcers (36%) were in the prepyloric
area and 17 (12%) arose from the gastric
antrum.
Operative Procedures
The indications for operation and the
surgical procedures performed are set
forth in Tables I and II. The lowest recur
rence rates followed gastric resection with
or without truncal vagotomy.
Acute upper gastrointestinal bleeding
was the indication for surgery in 32 (23%)
patients. In three the bleeding point was
simply oversewn because other risk fac
tors were present, and in two of these the
bleeding recurred immediately after oper
ation, necessitating reoperation that
resulted in the death of one patient. Six
patients underw ent vagotom y and
pyloroplasty, two with concurrent wedge
resection of the ulcer. Three patients
underwent wedge resection alone. One
patient, subjected to vagotomy and
pyloroplasty, had recurrent bleeding
postoperatively and required reoperation.
No episodes of bleeding postoperatively
were documented in 11 patients who had
gastric resection or in 9 subjected to
resection with truncal vagotomy. Surgery
for bleeding gastric ulcer was followed by
substantial morbidity. Wound complica
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tions occurred in 13 (41%) patients and
7 (22%) patients had respiratory compli
cations. Overall, the postoperative death
rate was 13%.
Thirty patients required surgery for
acutely perforated gastric ulcer. Only 11
(37%) of them had a history of ulcer dis
ease and 13 (43%) were poor surgical
risks, because of advanced age, concur
rent medical illness and delay before sur
gery. Free air was visible on abdominal
films in only 52% of those in whom the
study was carried out. The perforation
was in the distal stomach and prepyloric
area in 20 (67%) patients. Of 14 patients
in whom specimens of peritoneal fluid
were submitted for bacteriologic culture
at the time of surgery, only 3 demon
strated substantial growth, consisting
mainly of enteric organisms. A patch of
omentum was used to seal the perforation
in 21 patients, most of whom were poor
surgical risks or had extensive peritoneal
contamination. Biopsies of the ulcer were
done in 12 of these and 3 suffered recur
rent ulceration. One patient died shortly
after operation. Truncal vagotomy and
distal gastric resection to include the per
foration was carried out in six patients,
with no deaths and no recurrences.
Postoperative morbidity following sur
gery for perforation was again mainly in
the form of respiratory (20%) and wound
complications (13%). The overall death
rate was 3%.
Overall Mortality and Morbidity
In the early postoperative period, six
(4.3%) patients died. Acute bleeding was
the indication for surgery in four of these,
and in another acute perforation.
Wound complications were the most
common source of morbidity postopera
tively, occurring in 23 (17%) patients.
These were followed by respiratory tract
complications, with significant atelecta
sis and pneumonia occurring in 20 (14%)
patients. Cardiovascular complications
occurred in two patients and two
experienced delayed gastric emptying in
the early postoperative period.
O f the 84 patients available for follow
up, long-term morbidity was minimal,
with 57% rated as Visick I and 13% as
Visick II. Symptoms suggestive of the
dumping syndrome occurred in five
patients (6%), diarrhea in four (5%) and
alkaline reflux gastritis in two (2%). Of
these 11 patients with post-gastrectomy
syndromes, truncal vagotomy had been
carried out in 9 (82%).

and pepsin. Davenport5 and Du Plessis6
suggested that ulceration results from
duodenal alkaline reflux, with destruction
of the gastric mucosal barrier and cellu
lar destruction mediated by back diffu
sion of luminal acid. Thus, one would
expect ulcer recurrence to be a common
phenomenon following gastric resection.
However, as in our series, recurrence rates
have consistently been less than 5% when
gastric ulcer is managed by resection.7’8
Oi and colleagues9 suggested that the
tendency for gastric ulcer to involve the
lesser curvature near the incisura
angularis can be explained by the presence
of a congenital point of least resistance
where parietal cell mucosa borders on
antral mucosa. The failure of wedge
resection of the ulcer to prevent recur
rence, as in our series, suggests that other
factors are involved. Of interest in our
series, was the association between gas
tric ulcer and previous Nissen fundo
p lication, an association already
described.10’11 Alkaline reflux into the
stomach and esophagus and altered gas
tric emptying with hypergastrinemia have
been proposed as possible contributory
factors but are unproven.
Unlike duodenal ulcer in which the risk
of underlying malignant disease is
minimal, as many as 10% of gastric ulcers
are ulcerating carcinomas.12 This empha
sizes the importance of endoscopic exami
nation with tissue sampling in all patients
whose gastric ulcer fails to heal rapidly
with medical management or who demon
strate clinical features suggestive of malig
nant disease.
If endoscopy cannot be carried out
preoperatively, as in acute perforation,
gastric resection allows sampling of ade
quate tissue to exclude the presence of a
malignant lesion. When resection is con
traindicated, full-thickness biopsy speci
mens of the ulcer margins should be
obtained before resorting to a lesser
procedure, such as omental patching. The
Table I—Indications for Operation
Indication
Intractability
Bleeding
Perforation
Possible malignant disease
Obstruction
Penetration

% of
patients
37
23
22
14
3
1

Table II—Procedures Performed and
________ Postoperative Recurrences________
%

Discussion
While the pathogenesis of gastric ulcer
remains unknown, some accept that the
basic defect is a deficiency in mucosal
protective factors to the secretion of acid

Procedure
Vagotomy and antrectomy
Resection
Vagotomy and pyloroplasty
Wedge resection
Highly selective vagotomy

recurrence
0
5
11
30
33
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failure of endoscopy to detect the ulcer
preoperatively in 10% of our cases is pos
sibly related to those emergency situations
with bleeding. It also suggests the
presence of a blind spot in the stomach,
especially on the lesser curvature, that
should be carefully evaluated during
endoscopic examination.
The high incidence of wound compli
cations in our series underscores the need
for perioperative antibiotic prophylaxis
and peritoneal lavage in the management
of gastric ulcer, especially in bleeding gas
tric ulcers in which the protective action
of luminal acid is negated by the buffer
ing effects of blood. During the period
of our study, antibiotic prophylaxis and
irrigation were not in widespread use.
Gastric resection, including the ulcer
crater, appears to be the procedure of
choice in the elective management of
uncomplicated gastric ulcer. Recurrence
rates of less than 5% have consistently
been reported with acceptable postoper
ative morbidity and death rates.7-8 Addi
tion of a truncal vagotomy is indicated
by the presence of a coexisting duodenal
ulcer, the location of the ulcer in the
prepyloric antrum or by preoperative acid
studies suggesting hypersecretion. Vagot
omy is not required for the treatment of
proximal gastric ulcers or in patients with
hyposecretion, as it can itself cause addi
tional operative and postoperative
problems.
Truncal vagotomy and pyloroplasty,
when used to treat gastric ulcer is
associated with recurrence rates higher
than those seen when the procedure is
used for duodenal disease.4,13,14 Also, the
incidence of late postoperative problems
is similar to that observed following trun
cal vagotomy with antrectomy. It is,
however, indicated for a potentially
difficult duodenal stump or in the surgi
cal management of a bleeding or perfo
rated prepyloric ulcer in an unstable
patient, after adequate biopsy samples
have been obtained. The addition of ulcer
excision did not improve the recurrence
rate in our series, as one of the nine
patients so treated had recurrent ulcer.
Highly selective vagotomy has gained
a place in the management of uncompli
cated duodenal ulcer,15,16 but recur
rence rates following this procedure for
gastric ulcer are unacceptable.2,3,15,16
Although Reid and colleagues,17 in a
randomized clinical trial, found no differ
ence in recurrence rates between Billroth
I resection and resection of the ulcer with
highly selective vagotomy, the recurrence
rate in the gastrectomy group was
unusually high compared with those of
most other series. Prepyloric and pyloric
canal ulcers appear to be especially resis
tant to resolution by highly selective
vagotomy.2,3 Our series corroborates
these data, with a 33% recurrence rate

following the use of highly selective
vagotomy for gastric ulcer.
Although wedge resection of the ulcer
provides enough tissue to exclude malig
nant disease, the recurrence rate in our
series was far greater than that following
gastric resection, with the same potential
for postoperative suture-line leakage and
infection. Damage to the adjacent nerves
of Latarjet is not unexpected and could
account for the two cases of delayed gas
tric emptying following wedge resection
in our series.
Acutely perforated gastric or duodenal
ulcers present a similar clinical picture,
but in addition to the potential for malig
nancy in gastric ulcer, the often-advanced
age of the patient, with associated medi
cal disease, may contraindicate aggressive
surgical management. Always a consider
ation in the management of visceral per
foration is the degree o f intraperitoneal
contamination with the potential for
intra-abdominal sepsis and suture-line
breakdown. Of interest in our series was
the high incidence of negative cultures
from intraperitoneal fluid, even in
patients with a history indicative of per
foration 12 hours or more before surgery.
A similar incidence of negative cultures
has been noted by Boey and colleagues,18
suggesting that extensive or long-standing
peritoneal contamination does not con
traindicate a definitive procedure for per
forated peptic ulcer.
Because of the high recurrence rate
after omental patching, gastric resection
is clearly the operation o f choice for gas
tric perforation. However, when resection
is contraindicated as in the unstable
elderly patient with underlying medical ill
ness, patching may be the only alterna
tive.19 Intraoperative biopsy and then
long-term therapy with histam ine2
blockers are suggested before more defini
tive surgery is considered in the event of
recurrence.
A substantial number of perforated
gastric ulcers are located in the antrum
and prepyloric area where they share the
physiologic characteristics of duodenal
ulcer. In these circumstances the addition
of a truncal vagotomy is appropriate,
despite the risk of complications postoperatively.
When surgery is required for bleeding
gastric ulcer, our series suggests that any
thing less than resection of the ulcer, as
a gastrectomy, results in a high incidence
of recurrent bleeding in the early post
operative period. This must be kept in
mind when choosing a lesser procedure
in high risk, unstable or elderly patients
in whom the operative death rate of a
second procedure can be extremely high.
As in duodenal ulcer, optimal manage
ment of bleeding gastric ulcer depends on
prompt recognition and the timing of
surgery.

Conclusions
When considering operative treatm ent
for gastric ulcer in either elective or emer
gency situations, the surgeon must recog
nize the possibility of malignant disease
and rule it out by tissue sampling endoscopically or at laparotomy. Gastric
resection is the procedure of choice in
both emergency and elective situations,
with the addition of truncal vagotomy,
when indicated by location of the ulcer
or the results of preoperative acid secre
tory studies. In the emergency setting,
when the patient is unstable or a poor
risk, a less-definitive procedure may be
undertaken providing the increased inci
dence of ulcer recurrence is anticipated.
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Recent in-vitro research has shown that clindamycin concentrates within
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rates of chemotaxis, phagocytosis and killing of bacteria by PMNs are also
enhanced by the presence of this antibiotic.2^3 These characteristics may
help explain clindamycin’s outstanding record of clinical efficacy in both
anaerobic and gram-positive aerobic infections.
Since host defense factors may be crucial in determining the outcome of
an infection, selection of antibiotics based on host defense parameters
may become a trend in infectious disease therapy.
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Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species and microaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when
the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has
not been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have
demonstrated lincomycin sensitivity.
U ntil further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn
(infants below 30 days of age), or in pregnant women.
Mtarnings: Some cases of severe and persistent diarrhea have been reported during or after therapy with
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tion as indicated. Corticoid retention enemas and systemic corticoids may be of help in persistent
cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes of colitis
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Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco
mycin were administered orally four times a day for 5 -1 0 or more days, there was a rapid observed
disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
Is should be noted that serious relapses have occurred up to one month after apparently successful
treatm ent. A relatively prolonged period of continuing observation is therefore recommended
Precnitlons: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with
caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate measures should be taken as indicated by the
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As w ith all antibiotics, perform culture and sensitivity studies in conjunction w ith drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic
liver function tests should be performed during prolonged therapy. Blood counts should also be
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effective means of removing the compound from the blood. Periodic serum levels should be determined
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Adverse Reactions: Local.
(a) Intramuscular Injections: 01404 patients treated w ith Dalacin C Phosphate (clindamycin phos
phate) intramuscularly (w ith a solution containing 150 m g/m L), six (1.5%) demonstrated local
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at the
injection site and two developed sterile abscesses.
(b) Intravenous Infusions: Of 192 patients treated w ith Dalacin C Phosphate by intravenous infusion,
14 (7.3% ) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and
one patient developed both superficial and deep thrombophlebitis. The majority of these cases
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the drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated w ith Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as
follows:
Number o f Patients
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Shortness of Breath .................................................................................................................................... 1
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Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
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Colonoscopic Assessment of Radiologic Strictures
of the Colon
The authors studied 47 patients with
radiologic evidence of stricture to deter
mine whether colonoscopy in this situa
tion increased the accuracy of diagnosis
and how this procedure might influence
patient management. Colonoscopy
increased to 81% the diagnostic
accuracy, which was established at 38%
with the single-contrast enema. Failure
of both techniques to establish a precise
diagnosis was 19%.
From the clinical and radiologic data,
surgical exploration for the 47 strictures
would have been necessary in 28, not
indicated in 9, and indicated solely for
diagnostic purposes in 10. The addition
of colonoscopy prevented unnecessary
laparotomy in 5 (18%) of the first group
and in 8 (80%) of the last. The authors
conclude that colonoscopy should be
complementary to the standard radiologic
examination for colonic strictures, espe
cially when carcinoma is suspected or if
roentgenography does not provide a
definitive diagnosis.

Devaluation par coloscopie de 47
stenoses radiologiques du colon a ete
faite pour etablir une correlation entre les
diagnostics radiologiques, endoscopiques
et finaux et pour determiner si la conduite therapeutique a pu etre influencee
par I'addition de la coloscopie. Le diag
nostic radiologique a ete exact et precis
dans 18 cas (38%). L'addition de la
coloscopie a permi d'accroitre ce taux
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d'exactitude a 81% (20 cas additionnels).
L'indication chirurgicale qui avait ete
posee 28 fois sur des criteres ciiniques
et radiologiques a ete infirmee par la
coloscopie chez cinq et differee chez
neuf autres. De plus, une intervention
chirurgicale a pu etre evitee a raison huit
fois mais a tort une fois chez 10 patients
ou l’indication chirurgicale ne reposait
que sur un doute diagnostique radiolo
gique.
A cause d'un taux residuel de 19% de
diagnostic inexact ou imprecis, on doit
considerer la coloscopie comme compiementaire a la radiologie dans les
stenoses et I'eiement clinique ne doit pas
etre ignore.

Strictures of the large bowel seen radiologically may or may not represent a seri
ous pathologic condition. Spasm, muscu
lar thickening, fibrosis, inflammation and
carcinoma can all be manifested by nar
rowing of the colonic lumen. Although
there may be typical radiologic features
for each lesion, in many cases a diagnos
tic dilemma persists,1,2 especially when
carcinoma cannot be ruled out. Before
the advent of colonoscopy, the only
approaches to these strictures were to
observe the patient by repeated barium
enema roentgenography or to operate,
both of which had obvious disadvantages.
Even with the more widespread use of aircontrast enemas, the tortuous sigmoid
colon, the commonest site of strictures,1
is not easily completely demonstrated.3
The purpose of this paper is to deter
mine the extent to which colonoscopy can
add to the diagnostic accuracy and
influence subsequent surgical manage
ment of the patient.
Patients and Methods
Between 1980 and 1984, we attempted
colonoscopy in every patient under our
care who had radiologic evidence of
colonic stricture. We excluded those with
the typical symptomatic annular, “ applecore” lesion, because there is no doubt
as to the diagnosis of carcinoma, and the
typical filiform narrowing in patients who

had recurrent Crohn’s disease. There were
47 patients (20 men, 27 women) whose
mean age was 59 years.
Single-contrast radiologic examinations
were performed initially with barium, or
water-soluble material in acute cases. The
opinions were those of the radiologist’s
written report. Colonoscopy was subse
quently performed with an Olympus CFLB3R instrument (Olympus Corp. of
America, New Hyde Park, NY) with xray films on display during the procedure.
Fluoroscopy was not used. The diagno
sis was established in all but one patient,
either by surgical exploration and patho
logical examination of the resected bowel,
endoscopic biopsy or, in non-operated
cases, through a combination of history,
endoscopic findings and follow-up (e.g.,
asymptomatic normal bowel).
Before colonoscopy an indication for
surgery was made from the clinical fea
tures (persistent or disabling symptoms,
presence of a mass, signs of bowel
obstruction) or the radiologic diagnosis
or a suspicion of carcinoma; the indica
tion in each case was considered to be
either present, absent or doubtful (when
no diagnosis could be made). After
colonoscopy we reassessed our findings
to determine if surgery was indeed neces
sary, not necessary, necessary but could
be delayed, or whether the colonoscopic
findings were inconclusive.
Findings
As expected the sigmoid colon was the
most common site of stricture in 33 (7097o)
patients (Table I). A summary of all
cases, with radiologic diagnoses, colonos
copic findings, final diagnosis and indiTable 1-Site of Stricture in 47 Patients
No. of
patients (%)
Site
33 (70.2)
Sigmoid colon
7(14.9)
Descending colon
2 (4.3)
Splenic flexure
1 (2.1)
Transverse colon
1 (2.1)
Ascending colon
1 (2.1)
Cecum
2 (4.3)
Ileocolonic anastomosis
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cation for surgery before and after
colonoscopy are shown in Table II. A
definitive diagnosis of diverticulitis was
made radiologically in 11, and of carci
noma in 9, but in most other cases the
radiologic findings were equivocal and
offered a wide variety of diagnoses.
Figures 1 to 6 illustrate the varying radi
ologic findings in these patients. The dis
tribution of final diagnoses established by

laparotomy, endoscopic biopsy or a com
bination of history, endoscopy and
follow-up are shown in Table III.
The radiologic diagnosis correlated
with the final diagnosis in 18 cases (38%).
The endoscopist was right in 14 of these
cases, uncertain in 2 (cases 12 and 41) and
could not reach the stricture in 2 cases of
carcinoma (cases 15 and 16). The radiol
ogist’s opinion did not correlate in 13

cases. The colonoscopist made the correct
diagnosis in nine of these, erred in two
(cases 24 and 39), one of which was a
patient with carcinoma, remained doubt
ful in one (case 40) and could not reach
the stenosis in one (case 17, normal bowel
on barium follow-through). Finally, bar
ium enema examination was not diagnos
tic in 16 (34%) (cases 25 to 34 and 42 to
47). Of these, colonoscopy resulted in the

Table 11-Summary of Diagnostic Investigations in 47 Cases of Colonic Stricture
Case
no.

Age,
Sex
M
F

yr

10

F
F
F
F
M
F
F

63
61
68
76
42
57
70
69
63
61

11
12
13
14
15
16
17

F
F
M
F
M
M
F

56
73
63
67
75
63
78

18
19

F
F

67
47
77
63
61
61
70
48
78
67
62

i
2

3
4
5
6
7
8
9

M

20

M

21
22
23
24
25
26
27
28

F
M
F
M
M
F
F
M

29
30
31
32
33
34
35

M
M
F
M
F
M

29
55
47
37
65
37

36
37
38

F
F
F

39

F
F

40

M

41
42

M

43
44
45

F
F
M

M

Site of stenosis
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Transverse colon
Descending colon
lleotransverse
anastomosis
Splenic flexure
Descending colon
Sigmoid
Sigmoid
Descending colon
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid
Sigmoid

Radiologic
diagnosis
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
CA
CA
CA
CA
CA
CA

Colonoscopic
impression
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
Anastomotic
stenosis
N
? not diagnostic
CA
CA
Not reached
Not reached
Not reached

CA
CA
CA
DIV and CA
Lymphoma
DIV and polyp
DIV and polyp
DIV or CA
DIV or CA
DIV or CA
DIV or CA

N
N
DIV
DIV and CA
DIV
DIV
DIV and polyp
DIV
DIV
DIV
DIV

DIV or CA
Inflammation or CA
Inflammation or CA
Crohn's disease or CA
Inflammation or ischemia
Inflammation or fibrosis
Anastomotic stenosis

N
Crohn's disease
Ischemic colitis
Crohn's disease
Inflammation
Radiation stenosis
Crohn's disease

71
61
44

Sigmoid
Descending colon
Descending colon
Sigmoid
Descending colon
Sigmoid
lleotransverse
anastomosis
Sigmoid
Descending colon
Sigmoid

Postop changes
Ulcerative colitis
Spasm

Anastomotic band
Ulcerative colitis
Fibrosis

72
39
19
56

Sigmoid
Sigmoid
Ascending colon
Sigmoid

Extracolonic origin
Extracolonic origin
Extracolonic origin
? not diagnostic

Extracolonic
Extracolonic
Extracolonic
CA

38
48
75

Sigmoid
Cecum
Sigmoid

? not diagnostic
? not diagnostic
? not diagnostic

60

Surgical indication
Before
After
Final diagnosis
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
DIV
Anastomotic
stenosis
N
CA
CA
CA
CA
CA
N
N
N
DIV
DIV and CA
DIV
DIV
DIV
DIV
DIV
CA
Foreign-body
perforation
N
Crohn's disease
Ischemic colitis
Crohn's disease
Pancreatitis
Radiation stenosis
Crohn's disease
Anastomotic band
Ulcerative colitis
Fibrosis after seat
belt injury
CA
Endometriosis
Unknown*
Extracolonic
(carcinomatosis)
Endometriosis
Crohn's disease
Anastomotic
stenosis
N
N

DIV
Crohn's disease
Anastomotic
stenosis
46
F
58
Splenic flexure
? not diagnostic
N
47
M
62
Sigmoid
? not diagnostic
N
DIV - diverticulitis, CA = carcinoma, A - anastomosis, N - normal bowel.
'Congenital bands suspected because of age, location, no intraluminal disease, no symptoms; surgery not indicated,
t + - present, - - absent, ? = doubtful, indicated for diagnostic purpose only.
1+ “ still present, - - still absent, 0 - no longer present, +0 - still present but delayed.
§Final diagnosis established by barium follow-through examination.
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correct diagnosis in 11, but was incorrect
in 4 (cases 27, 28, 42 and 43) and was
equivocal in 1 (case 33).
Barium enema examination alone re
sulted in the correct diagnosis in 18 out
of 47 patients. When the 20 correct diag
noses obtained at colonoscopy in the
remaining 29 are added, the combined
accuracy of both techniques totals (81 Wo)
(38 of 47).
As to management of the patients, the
indication for surgery was present before
colonoscopy in 28 patients, absent in 9
and doubtful or indicated for diagnosis

FIG. 1—Case 31. Radiologic appearance
suggests inflammatory condition but carci
noma could not be ruled out. Endoscopic and
histologic features were consistent with
ischemic colitis and stricture.

FIG. 2—Case 33. Inflammation or ischemia
was suggested radiologic diagnosis. Endoscopic
findings were o f inflammation of unknown
cause. Subsequent exploration revealed pan
creatitis and extrinsic compression.

only in 10. In the 28 patients for whom
surgery was initially indicated, that indi
cation was still present after colonoscopy
in 14, it was still present, but could be
delayed to a more appropriate time in 9,
and was no longer present in 5 (normal
bowel 3, cases 17, 18, 19; diverticulitis,
case 20; ischemic colitis, case 31). In the
nine patients presenting no indication for
surgery before colonoscopy, none was
established later. Finally in the other 10
patients in whom the indication for sur
gery was doubtful, it was considered not
indicated in 8, indicated in 1 (case 42) and
remained doubtful in 1 (case 33) follow
ing colonoscopy. Further investigation of
the last patient led to a diagnosis of
chronic pancreatitis and surgical explora
tion was carried out.

FIG. 3—Case 41. Radiologic and endoscopic
diagnosis was extracolonic disease. There was
no known final diagnosis, but congenital bands
were suspected because of patient’s young age
(19 years), location of stricture and because
there were no symptoms and no intraluminal
disease. Patient was not operated on.

FIG. 4—Case 19. Findings are suggestive of
carcinoma but bowel appeared normal at
endoscopy.

Discussion
Most important in the diagnosis and
treatment of stenotic lesions o f the large
bowel is to establish the presence or
absence of a malignant condition. Both
diverticular disease and carcinoma occur
most commonly in the sigmoid colon
where they may coexist and be very
difficult to differentiate. In our study,
roentgenography established a diagnosis
of diverticulitis in 12 cases, later con
firmed in 10. Colonoscopy suggested the
correct diagnosis in all 12 but was defini
tive in only 2, neither being a carcinoma.
This is contrary to the experience of
Boulos and associates4 who reported
coexistent neoplasia, benign or malig
nant, in 31% of radiologically demon
strated diverticular disease. Carcinoma

FIG. 5—Case 27. Roentgenography could
not differentiate diverticulitis from carcinoma
and endoscopic examination suggested a diag
nosis of diverticulitis. Final diagnosis was car
cinoma.

FIG. 6—Case 25. Radiologic appearance
suggested either diverticulitis or carcinoma.
Endoscopy ruled out carcinoma.
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(or lymphoma) was thought to be present
on 11 contrast enema examinations: 5
were subsequently proven incorrect, 4 by
colonoscopy (cases 18, 19, 20 and 22).
The suspicious area in the fifth could not
be reached by colonoscopy. These find
ings are comparable to the experience of
Hunt and colleagues1 who disproved the
presence of carcinoma in 30 (57%) of 53
“ m alignant strictures” . Filoche and
colleagues5 also reported colonoscopic
exclusion of carcinoma in 7 of 13 (54%)
suspected cases. Diverticulitis could not
be differentiated from carcinoma in five
instances: carcinoma was present in one
but was missed at colonoscopy (case 27,
Fig. 5); in the other four, suspected car
cinoma was not present (Fig. 6). This fol
lows the experience of Rozen’s group;6
in 18 similar situations Filoche and
colleagues5 found only one case of car
cinoma.
A limitation of colonoscopy in stric
tures is well demonstrated in the study of
Dean and Newell3 in which there were 17
(47%) inadequate examinations of the
diseased segment in 36 cases of divertic
ulitis. Their main reasons for failure were
sharp angulation, inability to distend the
narrow lumen and persistent fecal soiling
through the obstructed segment. Filoche
and colleagues5 established at 20% the
number of strictures that could not be
examined over their whole length. In our
study, an accurate diagnosis by en
doscopy failed in three situations: when
the segment was too narrow to permit
thorough examination (cases 12, 27 and
39), when it was impossible to reach the
level o f the stricture (cases 15,16 and 17)
and when extraluminal disease was
present (cases 28, 33 and 40 to 43).
We were particularly concerned about
seven (15%) patients with normal bowel
who underwent colonoscopy because
some form of narrowing had been seen
on roentgenograms; in four carcinoma

Table Ill-Final Diagnosis in 47 Cases of
Colonic Stricture
No. of
patients (%)
Diagnosis
15(32)
Diverticulitis (Fig. 61
7(15)
Carcinoma (Fig. 5)
Diverticulitis and carcinoma
1 (2)
2 (4)
Anastomotic stenosis
2 (4)
Endometriosis
4 (9)
Crohn's disease
1 (2)
Ulcerative colitis
1 (2)
Ischemic colitis (Fig. 1)
Radiation stenosis
1 (2)
Anastomotic band or bridge
1 (2)
Ingested foreign-body perforation
1 (2)
Fibrosis after seat belt injury
1 (2)
3 (6)
Extrinsic
Pancreatitis (Fig. 2)
1
Carcinomatosis
1
? (congenital bands) (Fig. 3)
1
Normal bowel (Fig. 4)
7(15)
242

had either been diagnosed or suspected
(Fig. 4). Colonoscopy showed normal
bowel in six, and in the other (case 17)
we relied on the result of barium followthrough examination. Hunt and associ
ates1 had a similar experience. Another
important asset of colonoscopy in stric
tures is the clarification of nondescript
radiologic pictures. Among 16 (34%)
such cases, colonoscopy was decisive in
11; extracolonic disease was present in 4.
In the remaining case (no. 27 in Table II)
carcinoma was present but not seen at
endoscopy.
Neither roentgenography nor en
doscopy could establish the correct diag
nosis in nine cases (19%). Every clinician
knows that the interpretation of radiologic and endoscopic findings must take
into account the clinical picture. A deci
sion on the management of a patient with
stricture must follow these principles.
Colonoscopy influenced the surgical
decision in two clinical settings. First, it
allowed surgery to be deferred to a more
appropriate time. In most of these cases
the patients had diverticulitis or other
inflammatory conditions in the acute
phase. The delay allowed for a more
favourable surgical condition. Second,
colonoscopy removed the need for surgi
cal exploration that would have been
undertaken either because carcinoma was
suspected or for diagnostic purposes only.
Both Hunt and associates1 and Rozen
and colleagues6 have stated the useful
ness of colonoscopy in avoiding unneces
sary laparotomies.
To our knowledge colonoscopy
wrongly influenced the surgical decision
in only one patient (case 27, Fig. 5) in
whom carcinoma was suspected but mis
takenly ruled out. Surgery was eventually
performed but after a 2-month delay.
Filoche and associates5 mentioned a
similar case, illustrating the need to con
sider radiology and endoscopy as com
plementary procedures in the investiga
tion of a patient clinically suspected of
having large bowel disease.
Summary and Conclusions
Narrowing of the colonic lumen may
result from a wide range of diseases. In
our study of 47 patients, radiologic
demonstration of colonic stricture by
single-contrast examination gave the cor
rect diagnosis in 38%. Colonoscopy
increased the accuracy of diagnosis to
81%. Both radiologic and colonoscopic
examinations failed to achieve the right
diagnosis in 19%.
The decision to operate based on clini
cal or radiologic criteria may lead to
unnecessary laparotomies or untimely
surgery. Colonoscopy did not confirm the
indication for operation in 18% of such
cases and afforded a useful delay in 32%.

Colonoscopy also avoided an unnecessary
laparotomy in 80% of patients in whom
surgical exploration was being considered
for diagnostic purposes.
Colonoscopy should complement a
contrast enema in every case of colonic
stricture.
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Palliative Percutaneous Transhepatic Biliary Drainage:
Assessment of Morbidity and Mortality
The results o f pa llia tive percutaneous
tra n sh e p a tic bilia ry drainage w ere
assessed re tro s p e c tive ly in 16 cases and
p ro s p e c tiv e ly in 7 betw een 1 9 8 2 and
1 9 8 5 . Causes o f biliary o b stru ctio n w ere
m e ta s ta tic cancer (nine), pancreatic
cancer (nine), cholangiocarcinom a (three)
and gallbladder cancer (tw o ). Internal
drainage w a s established in 7 8 .3 % . In
th e 19 p a tie nts w h o died, th e mean dura
tio n o f drainage w a s 3 .6 m on th s. Early
m o rb id ity w as 1 7 .4 % . Late septic m or
b id ity occurred in 11 patients (48 % ) (a
to ta l o f 2 8 episodes). Late deaths
(3 1 .2 % ) resulted from upper g a stro in te s
tin a l hem orrhage, hepatic abscess, septic
shock, su b h ep a tic abscess and p e rito 
n itis .
Percutaneous tran sh e p a tic biliary
drainage is associated w ith substantial
m o rb id ity (6 7 .4 % ) and m o rta lity (3 5 .5 % )
fro m in fe c tio n . Palliation w as m odest;
o n ly e ig h t p a tie nts spent more than half
th e ir su rvival tim e at home, and 10
p a tie n ts never le ft hospital. Clinical trials
are required to assess the risk-to -b e n e fit
ra tio and role o f percutaneous tra n s
he p atic bilia ry drainage versus surgical
bypass in p a tie nts w ith lesions amenable
to surgery, and b iliary drainage versus no
tre a tm e n t in pa tie nts w hose tu m o u r can
n o t be bypassed.
Les resu lta ts p a llia tifs du drainage biliaire
tran sh e p a tiq ue percutane o n t ete evalu6s
rd tro s p e c tiv e m e n t dans 16 cas e t prosp e c tiv e m e n t dans 7 autres cas traitds
entre 1 9 8 2 e t 1 9 8 5 . Parmi les causes
d 'o b s tru c tio n biliaire, on note les m etastases (neuf cas), le cancer du pancreas
(neuf), le cholangiocarcinom e (trois) et le
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cancer de la vesicule biliaire (deux). Un
drainage interne a ete 6tabli dans 7 8 .3 %
des cas. Chez les 19 pa tie nts qui s o n t
decedes, la durge m oyenne de d ra inage a
ete de 3 .6 mois. Une m orb id ity p re co ce
a ete vue dans 1 7 .4 % des cas. Des in c i
d e n ts septiques retardes so n t su rve n u s
chez 11 p a tie nts (48 % ) (un to ta l de
2 8 episodes). Les deces ta rd ifs (3 1 .2 % )
o n t ete causes par une hgm orragie gastro in te s tin a le superieure, un abc&s hepatiq u e , un choc septique, un abcfes soushepatique et une pe rito n ite .
Le drainage biliaire transhepatique p e r
cu ta ne e st entache d 'u n e m orb id ity
(6 7 .4 % ) e t d 'u n e m o rta lite (3 5 .5 % )
im p o rta n te s resultant de I'in fe c tio n .
L 'e ffe t p a llia tif fu t m odeste; seulem ent
h u it p a tie nts o n t passe plus de la m o itig
de leur te m p s de survie a dom icile, e t 10
a utres n 'o n t jam ais q u ittg I'ho p ita l. Des
essais cliniques so n t ju g g s necessaires
pour g ta b lir le rapport risques/bgngfices
e t prgciser le role du drainage biliaire
tran sh g p a tiq ue percutang par ra p p o rt a la
d g riva tio n chirurgicale chez les p a tie n ts
opgrables; de m§me. il fa u d ra it evaluer
les m grites respectifs du drainage b ilia ire
et de I'absence de tra ite m e n t chez les
p a tie n ts d o n t la tu m e u r ne perm et pas
une opgration de pontage.

The use o f percutaneous transhepatic
biliary drainage to treat malignant
obstruction o f the bile ducts has gained
popularity in the last decade. Since Molnar and Stockum1 reported the first suc
cessful case o f internal drainage in 1974,
radiologists have developed and refined
techniques to decompress the biliary
tree.2-6
McPherson and colleagues7 and Elli
son and associates8 have cautioned that
while this procedure has gained rapid
acceptance, the risk-to-benefit ratio must
be carefully assessed. Further, its mor
bidity and mortality have yet to be com 
pared with those of other modes o f treat
ment for malignant obstruction o f the
biliary tree, in a prospectively randomized
controlled clinical trial.
The present report considers the mor
bidity and mortality associated with per
cutaneous transhepatic biliary drainage in
23 cases of malignant obstruction o f the
biliary tree. We paid particular attention
to the palliative benefit o f the procedure

and to the morbidity from infectious and
other complications.

Patients and Methods
We reviewed the charts o f 16 patients
who had undergone percutaneous trans
hepatic biliary drainage between August
1982 and June 1984. We also studied
prospectively seven patients who had
undergone the same procedure between
July 1984 and January 1985. In all there
were 15 men and 8 women with a mean
age o f 68.6 years (range from 31 to 94
years). All had malignant obstruction o f
the biliary tract (Table I).
The data collected concerned previous
surgery, the cause and location o f
obstruction, the date, duration and type
o f drainage, the occurrence o f all com 
plications and the date and circumstances
o f death. To identify biliary m icrobiol
ogy and the pathogens involved in infec
tion, we took serial bile samples for aer
obic and anaerobic culture on the day o f
biliary drainage and then at the time o f
monthly catheter changes or when other
wise clinically indicated in the prospective
group. Whenever possible, we recorded
microbiologic findings on the retrospec
tive cases.
Finally, the benefit o f percutaneous
transhepatic biliary drainage was assessed
with respect to the amount o f time spent
at home between the day o f drainage and
death and the number o f hospitalizations
required during this time.

Drainage Technique
We used a modification o f the techni-

Table 1-Causes of Obstructive Jaundice
No. of patients*
Cause
9(4)
Metastatic cancer
4(2)
Colon
3(2)
Stomach
1
Breast
1
Prostate
9(6)
Pancreatic cancer
Cholangiocarcinoma
3(3)
2(2)
Gallbladder cancer
23(16)
Total
"Numbers in brackets represent patients with
tissue diagnosis of the cause of obstructive
jaundice.
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que previously described by Ferrucci and
colleagues,5 Nakayama and associates,6
and Ring’s group.9 Standard fine-needle
cholangiography was first performed to
identify the location and assess the extent
of obstruction. The modified Cope cathe
ter system (20 gauge) was used to gain
access to the biliary tree. If there was no
cholangitis, internal drainage was attemp
ted. If that was unsuccessful a straight
catheter was left in the most dependent
segment of the biliary tree and another
attempt made in 2 to 4 days, with exter
nal drainage in the interim. Whether or
not the catheter had been placed beyond
the obstruction, external drainage was
maintained for the first 24 hours, follo
wed by progressive clamping, resulting,
in successful cases, in complete internal
drainage within 8 days. During this time,
catheters were flushed four times daily
with 10 ml of normal saline, the fre
quency was reduced to once daily when
internal drainage was established. Cathe
ters were changed each month on an out
patient basis unless otherwise indicated.
Antibiotics were not given prophylactically unless patients had had a previous
episode of catheter-related cholangitis,
known bactibilia, or previous biliary tract
surgery.

surgeon’s preference, underwent surgical
bypass because of persistent fever and
intrahepatic abscesses.
Complications
Early complications of percutaneous
transhepatic biliary drainage included
catheter dislodgement, cholangitis and
fatal acute hemorrhagic pancreatitis
(Table II). None of these complications
required operative intervention. The early
morbidity was 17.4% (4 of 23) and the
rate of early death 4.3% (1 of 23).
Thirty late complications occurred in
22 patients (1.4 complications per
patient). Late morbidity from catheter
blockage and dislodgement occurred in
34.9% and 13.0% of patients respecti
vely. Cholangitis occurred late 19 times
in 11 patients (1.7 episodes per patient)
and was associated with bacteremia five
times, resulting in the death of one
patient. Three episodes of cholangitis
occurred within the first 3 weeks of drai
nage in the patient with metastatic sto
mach cancer mentioned above; operative
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C o m p lic a t io n

Findings

E a r ly ,
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n o . o f e p is o d e s !

n o . o f e p is o d e s !

n o . o f p a t ie n t s

n o .o f p a t ie n t s

D e a th s *

M in o r

In 9 o f the 23 patients percutaneous
transhepatic biliary drainage was under
taken because a surgical bypass could not
be done. Laparotomy to assess the pos
sibility of surgical bypass was not perfor
med in 14 patients, 7 of whom had
metastatic biliary tract obstruction. Of the
remaining seven, two were pre-terminal
(both died within 6 weeks of presenta
tion), two were shown radiologically to
have lesions that could not be bypassed
(obstruction at the porta hepatis), one
refused surgery and two underwent biliary
drainage because of the surgeon’s prefe
rence, despite radiologic evidence that
surgical bypass might be possible. Two of
these 14 patients subsequently had ope
rative bypass when biliary drainage fai
led, and their courses are described below.
There were no failures of insertion of
the transhepatic catheters in 23 attempts.
Internal drainage was established initially
in 15 patients and within 4 days in 3
others for an overall success rate of
78.3% (18 of 23). Five patients (21.7%)
had external drainage only.
The average duration of drainage was
3.6 months (range from 4 days to 14
months) among the 19 patients who died.
Two of the four patients alive at the time
of reporting have been drained for 1 and
4 months respectively. A third patient has
undergone surgical bypass, despite metas
tatic gastric cancer, for repeated attacks
o f cholangitis. The fourth patient, ini
tially drained percutaneously because of
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choledochoenterostomy resolved the
infections. Eight months later, the intra
hepatic bile ducts became obstructed from
progression of disease, and two catheters
were required to treat recurrent cholan
gitis due to the original organism (Kleb
siella).
Five patients had septic-related deaths.
At autopsy two were found to have intra
hepatic abscesses and a third had a subhepatic abscess. Autopsy was not
performed on the other two, but in both
the catheters were known to be providing
inadequate drainage of the left-sided bile
ducts in one case and of both left and
right-sided ducts in the other.
The late death rate related to percuta
neous transhepatic biliary drainage was
31.2% (7 of 22) (Table II). An eighth
patient died of acute myocardial infarc
tion while recovering from an episode of
cholangitis.
Bile cultures in 16 patients at the time
of initial drainage were negative in 11
(68.8%) patients and positive in 5 (31.3%)
(Table III). Cultures were not obtained
in the other seven patients. Three of the

C a t h e t e r b lo c k a g e
C a t h e t e r d is lo d g e m e n t

0

1218

—

111

3 /3

—

—

M a jo r
C h o la n g itis

2 /2

1 9 /1 1

B a c t e r e m ia

—

5 /5

1

H e p a t ic a b s c e s s

-

212

2

S u b h e p a tic a b s c e s s

-

1 /1

1

P u r u le n t a s c ite s

-

1 /1

1

111

-

1

-

2 /2

2

A c u t e p a n c r e a t itis
U p p e r g a s t r o in t e s t in a l t r a c t
h e m o r rh a g e
* 0 n e o t h e r p a t ie n t r e c o v e r in g f r o m

a n e p is o d e o f c h o la n g itis d ie d o f a c u t e m y o c a r d ia l in f a r c t io n .

T a b le Il l - M i c r o o r g a n i s m s F o u n d in B ile *
P ost
O rg a n is m

D a y o f d ra in a g e
sp

d r a in a g e

2 (2 )

1 0 (7 )

E n te r o b a c te r

1

1 0 (6 )

E s c h e r ic h ia

2

7 (5 )

K le b s ie lla

c o li

E n te r o c o c c u s

3 (2 )

7 (6 )

P r o te u s

m ir a b ilis

0

6 (5 )

P s e u d o m o n a s a e r u g in o s a

0

6 (2 )

s p , L a n c e fie ld

S tr e p to c o c c u s

g ro u p D , n o n e n t e r ic
S t a p h y lo c o c c u s
C lo s t r id iu m

e p id e r m id is

p e r f r in g e n s

C o r y n e b a c t e r iu m

sp

sp

1

4 (1 )

0

4 (0 )

1 (1 )
0

3 (0 )

3 (2 )

0

2 (0 )

0

1 (2 )

M ic r o a e r o p h ilic s tr e p to c o c c i

0

1 (1 )

A e r o m o n a s h y d r o p h ila

0
0

1 (0 )
2 (2 )

1

1 (1 )

0

1 (D

A c in e t o b a c t e r
C it r o b a c t e r

H a t n ia

sp

sp

S t a p h y lo c o c c u s a u r e u s
S tr e p to c o c c u s

g ro u p B

s p , L a n c e fie ld

‘ N u m b e r s in b r a c k e t s in d ic a t e t h e n u m b e r o f t im e s a m ic r o o r g a n is m w a s im p lic a t e d in a n e p is o d e
o f c h o la n g itis .

VOLUME 29, NO. 4, JU L Y 1986 / THE CANADIAN JOURNAL OF SURGERY

five positive cultures were in patients who
had undergone previous biliary tract
surgery.
Bile cultures remained negative in 3 of
the 11 patients, but became positive in 6,
representing a conversion rate of 54.5%.
In the remaining two cases, follow-up cul
tures were not obtained. The biliary trees
that remained sterile were in patients who
died within 3 weeks of drainage.
The palliative effects of percutaneous
transhepatic biliary drainage with respect
to improvement in hyperbilirubinemia,
pruritis and anorexia are shown in Table
IV and the duration of time spent at home
in Table V.
Discussion
All patients who underwent percutane
ous transhepatic biliary drainage in this
series had malignant obstruction of the
biliary tract. Internal drainage was estab
lished in 18 (78.3%) of 23 patients which
compares favourably with the rates of
72% and 64.3% reported by Mueller and
associates2 and Clark and colleagues10
respectively. The average duration of
drainage was 3.6 months compared with
4.3 months and 3.3 months reported by
Ferrucci and colleagues5 and Pollock’s
group4 respectively. Early morbidity
(17.4%) and mortality (4.3%) also com
pared favourably with those of other
studies.10,11
The single early death due to pancrea
titis represents the only one reported to
date from this complication, although at
least three other cases of pancreatitis
related to percutaneous transhepatic
biliary drainage have been reported.3-12
Early death from bleeding (five patients),
pneumothorax with bilious pleural effu
sion (one) and septic shock (one) have
also been rep o rted .2’3' 10' 13 In tra
abdominal hem orrhage, hemobilia,
bilothorax or bile leak, reported by others
did not occur in our series. This might be
accounted for in part by the use of a
smaller (20 gauge) needle for cannulation.

Late m orbidity from cholangitis
occurred in 50% of patients, somewhat
higher than previously reported (range of
14.5% to 36.5%2"4,6’7,11’13). The 30-day
mortality, related to biliary drainage was
35.0% (8 of 23) and compares with rates
quoted for surgical bypass, which range
from 6% to 30% .14'15
The prophylactic use of antibiotics has
been advocated by several investiga
tors, 3,9~n none of whom have been able
to demonstrate a decreased incidence of
morbidity from infection. Nevertheless,
antibiotics should be given prophylactically to patients with a history of biliary
tract surgery or instrumentation, with a
periprocedural history suggestive of
cholangitis, and to those who undergo
catheter change or manipulation. As
Keighley and colleagues16-17 and Wayne
and Whelan18 have pointed out, mor
bidity from contaminated bile can be
important; thus Wayne and Whelan
recommended prophylaxis with a combi
nation of an aminoglycoside and
ampicillin.
Our practice has been to use a firstgeneration cephalosporin for initial
prophylaxis and for subsequent manipu
lations in patients who have experienced
no m orbidity from infection. The
appropriate antibiotic(s) in those who
have suffered infectious morbidity should
be directed by the most recent bile or
blood culture. Based upon the paucity of
anaerobes cultured in either bile or blood
of our patients, anaerobic coverage was
not warranted and is not recommended.
The average duration of drainage of 3.6
months is misleading, since patients fell
into three distinct groups with respect to
survival (Table V). Eight patients lived
less than 1 month after biliary drainage
and only one was discharged from hospi
tal before death. Five patients lived from
1 to 4 months. While two were home for
at least 51% of their remaining days, the
other three never left hospital. Of the
eight patients who lived for 4 or more
months, 6 spent a minimum of 51% of
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their remaining days at home, whereas the
other one spent only 6.6% of such time
at home. These eight patients required an
average of 1.4 hospitalizations after their
drainage procedures, to treat cholangitis.
The palliative benefit of drainage is most
evident in this group of patients. While
they had serious morbidity (eight episodes
of tube blockage, nine episodes of cholan
gitis, three episodes of bacteremia and
two hepatic abscesses), four spent more
than 75% of their remaining days out of
hospital and two others between 51 % and
75%.
The morbidity from infection after per
cutaneous transhepatic biliary drainage is
high enough in this and other series7-11-13
to cast doubt on its overall palliative
benefit in all but a select group of patients
likely to survive for several months.
Of patients presenting with carcinoma
of the pancreas or periampullary region,
less than 20% have surgically resectable
lesions.14,15 Operative bypass is possible
in another 30%. Thus approximately
50% of patients are left with a palliative
drainage procedure or no treatment for
their disease. For patients who have
biliary obstruction due to metastatic dis
ease, curative resection is inappropriate,
and in less than 30% will surgical bypass
be possible because of the higher inci
dence of associated portal lymph-node
involvement. Therefore, more than 50%
of these patients may be candidates for
a palliative drainage procedure of some
sort.
The ideal trial would random ize
patients with surgically bypassable lesions
to surgery or a nonoperative drainage
procedure. For those in whom surgical
bypass cannot be performed safely, ran
domization between a nonoperative
drainage procedure and no treatment
should be undertaken. Since morbidity
and mortality from infection using per
cutaneous transhepatic biliary drainage is
high, it would be prudent to set out strin
gent guidelines concerning catheter inser
tion, irrigation and daily care, in an
attempt to keep complications at a mini
mum. The role of intraductal yttrium,
biliary endoprostheses and radiotherapy
for these lesions in selected patients has
yet to be determined.
While percutaneous transhepatic biliary
drainage plays a beneficial role in some
patients, its precise role in the treatment
of malignant obstruction of the bile ducts
remains to be defined.
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FLEXIBLE SIGMOIDOSCOPY. Ronald M.
Kalon, Emmet B. Keeffe and Clifford S.
Melnyk. 158 pp. Illust. Grune & Stratton,
Inc., Orlando, Fla., 1985. $34.50 (US).
ISBN 0-8089-1701-3.

This complete manual presents even more than
is necessary to learn the essentials of flexible
sigmoidoscopy.
Eleven chapters cover all aspects of history,
technique, indications and complications.
Comparisons are made between the various
brands of sigmoidoscopes, offering the physi
cian who wishes to purchase a sigmoidoscope
an objective means o f making comparisons
away from the persuasion of a salesman.
Unfortunately, the newest endoscopes are not
mentioned. The tip of the new instruments con
tains a microelectronic sensor that transmits
an image to a television monitor; thus, the
fiberoptic system is obviated. The cost of the
new system is high, but maintenance will be
much cheaper. The fiberoptic systems
described in this book are all fragile, and the
life of the fiberoptic system is the life o f the
entire sigmoidoscope.
The chapter on technique is the strongest
one—by reading and following the instruc
tions, the novice could become a self-taught
sigmoidoscopist. The diagrams of the tech
nique for sigmoidoscopy are most valuable.
Words cannot express the value of the infor

^

mation provided by the line drawings illustrat
ing the introduction and advancement of the
sigmoidoscope. However, they go to far. If the
sigmoidoscope is truly a screening tool, a dis
cussion of electrocoagulation and electrosnaring is beyond the province of a diagnostic tech
nique. Complete colonoscopy is almost always
necessary whenever electrosurgery is indicated,
and complete colon preparation makes elec
trosurgery safer with respect to explosion from
hydrogen and methane. Furthermore, should
a complication occur, the better-prepared
bowel for colonoscopy will likely spare the
patient a colostomy. Often a perforation in
poorly prepared bowel will necessitate exteri
orization of the perforation or proximal
diversion.
The chapter on indications again brings the
colonoscope into a conflict with the sigmoido
scope. Most doctors use the flexible sigmoido
scope as an office technique, specifically for
screening asymptomatic patients. The moment
the patient has blood in the stool, the finding
of occult blood, a mass or a change in bowel
habit, colonoscopy is required. Thus, the
expense of a flexible sigmoidoscopy is avoided.
To be cost-effective, duplication of diagnos
tic procedures must be prevented. Flexible sig
moidoscopy is not necessary if barium enema
examination or colonoscopy is to be per
formed.
continued on page 283
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Microbiologic Features and Treatment of Persistent Peritonitis
in Patients in the Intensive Care Unit
The charts of 25 patients who died in
the intensive care unit of persistent
peritonitis after abdominal operations
were reviewed to determine the micro
bial flora and the efficacy of antibiotic
treatment. All patients had undergone
two or more surgical procedures for
abdominal sepsis and 23 had at least
three-system organ failure. The most
common organisms cultured were: Staph
ylococcus epidermidis, 24 cultures from
16 patients, Candida albicans, 19 cul
tures from 10 patients, Pseudomonas
aeruginosa, 16 cultures from 12
patients, Enterobacter, 16 cultures from
8 patients and enterococcus, 14 cul
tures from 8 patients. The classic iso
lates, Escherichia coli (11 cultures from
six patients) and Bacteroides fragiiis (4
cultures from three patients) were found
infrequently. To determine the adequacy
of antimicrobial therapy for this "n e w "
flora, we examined the ability of
appropriate agents to eradicate the
micro-organism upon subsequent culture.
Candida sp. were eradicated in 54% (6
of 11) of the assessable cases, while
enterococcus and S. epidermidis were
cleared in only 2 5 % and 2 8 % respec
tively. The spectrum of intra-abdominal
organisms cultured from critically ill sur
gical patients in the intensive care unit
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differs from that seen in those with
acute peritonitis. Despite administration
of appropriate antimicrobial agents, these
organisms tend to persist, probably
reflecting impaired host defences with
multiple-system organ failure rather than
antimicrobial failure.

On a etudie les dossiers m£dicaux de 25
patients qui sont decedes a I'unite des
soins intensifs, des suites d'une peritonite persistante consecutive & une opera
tion abdominale, dans le but de determi
ner la nature de la flore microbienne et
I'efficacite de I'antibiotherapie. Tous les
patients avaient subi au moins deux
interventions chirurgicales pour sepsie
abdominale et 23 presentaient au moins
trois insuffisances fonctionnelles. Les
microorganismes les plus souvent cultives ont ete: Staphylococcus epidermidis,
24 cultures chez 16 patients, Candida
albicans, 19 cultures chez 10 patients.
Pseudomonas aeruginosa, 16 cultures
chez 12 patients, Enterobacter, 16 cultu
res chez 8 patients, et I'enterocoque, 14
cultures chez 8 patients. Les isolats classiques, Escherichia coli (11 cultures chez
six patients) et Bacteroides fragiiis (4
cultures chez trois patients), ont ete
retrouves plus rarement. Afin d'etablir
l'efficacit§ des traitements antimicrobiens sur cette "nouvelle" flore, on a
etudie la capacity des antibiotiques
appropries a faire disparaTtre les microor
ganismes lors de cultures subsequentes.
L'espece Candida a ete elimin6 dans
5 4 % (6 sur 11) des cas ^valuables, alors
que I'enterocoque et S. epidermidis disparaissaient dans seulement 2 5 % et
2 8 % des cas respectivement. Le spectre
des microorganismes intra-abdominaux
cultives chez les patients chirurgicaux
tres malades alors qu'ils sont dans le
service de soins intensifs diffdre de celui
qu'on retrouve dans les autres cas de
peritonite. Malgre I'utilisation des antibio
tiques appropries, ces organismes ont
tendance & persister, refletant probablement de la sorte une atteinte des defen
ses immunitaires et une insuffisance multifonctionnelle, davantage que I'echec de
I'antibiotherapie.

The microbiologic chacteristics of perito
nitis after perforation of the gastrointes
tinal tract are remarkably consistent.1'3
The infections are usually polymicrobial
and dominated by Escherichia coli, Bac
teroides fragiiis, streptococci (both aero
bic and anaerobic) and eubacteria. Fur
thermore, blood cultures in these patients
most often contain B. fragiiis or E. coli,
demonstrating the invasiveness of the
micro-organisms.1 The predictability of
this flora has permitted the development
of an empiric antimicrobial regimen used
in conjunction with surgery in the treat
ment of peritonitis. Clinical and ex
perimental studies have clearly demon
strated that antibiotics directed against
both aerobic and anaerobic organisms
should be given.4’5
The advent of intensive-care-unit (ICU)
monitoring, total parenteral nutrition and
broad-spectrum antibiotics have pro
duced a subgroup of critically ill patients
able to survive their initial abdominal
procedure, but whose postoperative
course is characterized by prolonged ICU
care, multiple surgical procedures and the
development of multiple-system organ
failure. The death rate in these patients
is high, ranging from 60% to 80%.6,7
The microbiologic features and optimal
antimicrobial therapy in such patients
with persistent peritonitis is unclear. To
clarify our impression that the bacterial
spectrum of abdominal infection is radi
cally altered during treatment, we
reviewed the charts of patients who died
in our surgical ICU of persistent intra
abdominal sepsis. The study revealed that
the organisms cultured from these
patients differed markedly from those
found in patients who present with acute
peritonitis.

Patients and Method
We reviewed the charts of 17 men and
8 women admitted over the 18-month
period from July 1982 to December 1983
to the surgical ICU of the University of
Minnesota Hospitals and who died with
persistent intra-abdominal infection. Per
sistent peritonitis was deemed to be
present in patients who required two or
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more interventions (either operative or
percutaneous drainage) for intra-abdo
minal sepsis.
In addition to standard demographic
data, the review determined the microbiologic features of the intra-abdominal
collections, the incidence of concurrent
bacteremias and the ability of adequate
antibiotic therapy to produce a microbiologic cure of the intra-abdominal infec
tion. Adequate antibiotic therapy was
defined as treatment with amphotericin
B for Candida sp., ampicillin or van
comycin plus an aminoglycoside for
enterococci and vancomycin for Staph
ylococcus epidermidis for at least 7 days.
Cultures were taken for both aerobic and
anaerobic bacteria. They did not rep
resent cultures taken from drains in situ
for a prolonged period, but rather cul
tures recovered either at reoperation or
insertion of a fresh percutaneous drain.
Chart Findings
The mean age of the 25 patients studied
was 61 years (range from 26 to 88 years).
The initial operative site was small intes
tine (six patients), colon (four), biliary
tract (four), pancreas (four), stomach
(three), genitourinary tract (three) and
peritoneum (one) for a necrotic infected
intraperitoneal tumour. Two biliary tract
procedures involved anastomoses to the
small intestine (Whipple operation in one
and choledochojejeunostomy in the
other). One genitourinary procedure in
volved the formation of an ileal conduit
followed by dehiscence of the small bowel
anastomosis; another, a uretoureterostomy, was complicated by a postopera
tive sigmoid leak.
The average time between the initial
operation and death was 55 days (range
from 6 to 131 days). The average num
ber of reoperations (or postoperative
cutaneous drainages) was 3.1 (range from
1 to 8). Twenty-two patients received
antibiotics effective against both faculta
tive gram-negative bacilli and anaerobes.
Multiple-system organ failure during
the course of the illness was frequent
Table 1—Multiple-System Organ Failure in
Patients Dying of Persistent Peritonitis*
% of
patients
System failure
Pulmonary (requiring ventilatory
80
support)
72
Renal (dialysis required)
Central nervous system (decreased
96
consciousness)
Hepatic (elevated bilirubin and
80
alkaline phosphatase levels)
Cardiovascular (necessitating
inotropic support, measurements
80
indicating sepsis)
'Present during the course of the illness and
not just pre-terminal events.
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(92%) (Table I). In our ICU, during an
overlapping period,8 the need for dialy
sis was associated with a 6.3% survival
rate while prolonged ventilatory support
(7 days or longer) was similarly associated
with a poor outcome (19.2% survival).
The microbial flora of persistent intra
abdominal infection is shown in Table II.
These cultures were dominated (in
decreasing order of frequency) by S.
epidermidis, Candida albicans, Pseudo
monas aeruginosa, Enterobacter and
enterococcus while the classic microbial
isolates (E. coli and B. fragilis) were less
common.
The ability of an organism to produce
a bacteremia is associated with its
pathogenicity. To examine the invasive
ness of this “ new” flora, positive blood
cultures were correlated with the presence
of the bacteremic organism in the
abdominal cultures. Twelve of the 25
patients had a total of 23 positive blood
cultures during their postoperative course
(or at autopsy in 2 patients). Three were
polymicrobial and 20 monomicrobial.
The common bacteremic organisms were
S. epidermidis (nine), Enterobacter
(four), enterococcus (three), B . fragilis
(three) and C. albicans (three). In 18 of
the 23 positive cultures, the bacteremic
organism was present simultaneously in
the peritoneal fluid culture, but not so in

3. The remaining two blood cultures had
some, but not all, organisms present in
the abdominal cultures. Of note, in the
nine with S. epidermidis bacteremia, is
that none had simultaneous positive cul
tures of central venous catheters. These
results suggest that the intra-abdominal
organisms demonstrated invasiveness by
producing a bacteremia.
To assess the adequacy of antimicrobial
therapy for the “ new” flora in these crit
ically ill patients, we examined the abil
ity of appropriate agents to eradicate the
micro-organism on subsequent cultures.
These results are shown in Table III. Only
amphotericin B, used to treat Candida sp.
demonstrated at least moderate success
(54%). Ampicillin and vancomycin were
ineffectual in ridding enterococci from
the cultures while S. epidermidis cleared
equally well with or without antibiotics.
Discussion
At any given time the gastrointestinal
tract contains more than 1012 bacterial
organisms comprising over 400 species.9
When the continuity of the tract is
breached and bacteria are released, host
defences eliminate most of these organ
isms. The resulting peritonitis contains a
well-defined and consistent flora,13
which is invariably polymicrobial, domi-

Table II—Microbiology of Persistent Peritonitis
Organisms

No. of positive
cultures

No. of
patients

24
14
4
1
16

16
8
3
1
12

11
8
16
1

6
6
8
1

4

3

5
1
1

3
1
1

19
10
2
1

10
5
2
1

Aerobes

Staphylococcus epidermidis
Enterococcus
Alpha hemolytic streptococcus

Lactobacillus
Pseudomonas aeruginosa
Facultative gram negative bacilli

Escherichia coli
Klebsiella (pneumonia and oxytoca)
Enterobacter (cloacae and aerogenesl
Citrobacter freundii
Anaerobes

Bacteroides fragilis
Clostridium (perfringens, clostridiformis
and unidentified species)

Fusobacterium nudeatum
Corynebacterium sp
Fungus

Candida albicans
C. glabrata
C. tropicaUs
Aspergillus

Table III—The Ability of the Appropriate Antibiotic to Effect Microbiologic Cure
Appropriate therapy
Inappropriate therapy
Patients
No. of
Organism
Organism
No. of
Organism
assessable*
patients
cleared
patients
cleared
Candida sp
14
11
6
3
0
4
S. epidermidis
12
1
4
8
Enterococcus
7
7
2
'Patients received at least 7 days therapy with the appropriate antimicrobial agent and a follow-up
culture was available to assess efficacy of therapy.
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nated by E. coli, enterococci, B. fragilis,
anaerobic streptococci and eubacteria.
The management of these infections is
also well defined, combining surgical cor
rection of the underlying disease with the
administration of broad-spectrum anti
biotics.10 The need to provide antibiotic
therapy, active against both aerobic and
anaerobic bacteria, has been demon
strated, both experimentally and clini
cally.4,5 Using a rat peritonitis model,
Weinstein and colleagues11 demonstrated
a biphasic response to fecal contamina
tion of the peritoneal cavity. This model
closely mimics the clinical setting of bowel
perforation in man. The first or perito
nitis phase, was associated with a death
rate of 40%. Bacteria recovered included
mainly E. coli, enterococci and B. fragilis.
The death rate correlated with the initial
inoculum size of E. coli.12 The survivors
entered the second, or abscess phase, and
were found to have abscesses at autopsy.
The flora of these abscesses was domi
nated by the three bacteria just mentioned
plus Fusobacterium sp. Gentamicin
prevented death and clindamycin pre
vented abscess formation while the two
drugs combined prevented both death and
abscess formation.5
The findings from clinical studies cor
roborated these experimental findings.
Thadepalli and colleagues4 compared
cephalothin and kanamycin to clindamy
cin and kanamycin in 100 patients with
penetrating abdominal trauma. The aer
obic infection rate was identical, but
anaerobic infections developed in 11 of
52 patients treated with cephalothin and
kanamycin versus 1 of 48 patients treated
with clindamycin and kanamycin. Simi
larly, Berne and colleagues13 showed that
the combination of gentamicin and clin
damycin in treating perforated appendi
citis resulted in fewer septic complications
than either cefamandole or cefoperazone
alone, both cephalosporins with poor
anti-anaerobic activity. Thus, the most
favourable results in peritonitis are
achieved when antibiotics are directed
against both the aerobic (usually E. coli)
and the anaerobic (usually B. fragilis)
components.
Progress in metabolic and hemody
namic support in conjunction with con
ventional treatment has improved initial
survival from peritonitis. However, these
patients may subsequently manifest mul
tiple-system organ failure. In the critically
ill surgical patient, such failure is a
predominant cause of late death after ini
tial resuscitation.14 We reviewed patients
who died in our surgical ICU of persis
tent intra-abdominal infections to deter
mine whether intensive therapy may have
altered the microbial flora of these infec
tions and also to see if appropriate adjust
ments of antimicrobial therapy could
effect a microbiologic cure.

As expected, from a defined group of
patients who died of sepsis in the surgi
cal ICU, a high percentage (92.5%) had
at least three-system organ failure during
their clinical course. Studies from our
institution8 have shown that surgical
ICU patients suffering renal or pulmo
nary failure have extremely high death
rates (95% and 80% respectively). Fry
and associates15 dem onstrated that
patients with abdom inal abscesses
manifesting organ failure in three or more
systems had greater than 80% mortality.
They also showed that recurrent abscesses
correlated significantly with an increas
ing likelihood of death.
The most frequently isolated organ
isms were S. epidermidis, C. albicans, P.
aeruginosa, Enterobacter sp. and
enterococcus. The classic microbial iso
lates, E. coli and B. fragilis were found
much less frequently. Since almost all
patients received broad-spectrum antibi
otics, one would expect these relatively
resistent micro-organisms to appear. The
pathogenicity and origin of these organ
isms need to be considered.
The pathogenic roles of P. aeruginosa
and Enterobacter sp. are above question
and gram-negative bacteremias are
associated with a 40% death ra te .16
Pseudomonas aeruginosa is one of the
most frequently recovered organisms in
the neutropenic bacteremic patient.17 On
the other hand, the virulence of S. epider
midis, enterococcus and C. albicans, espe
cially when isolated from intra-abdominal
sources, is not as clear.
Pathogenicity has been judged by the
ability to cause bacteremia. O f the 25
patients in this study 48% had bactere
mias (or candidemias) and cultures from
these patients were dominated by S.
epidermidis, C. albicans and entero
coccus, indicating that these organisms
have a propensity for invasion. Enterococcal bacteremias have been associated
with death rates of 34% to 6 8% .18~21
Dougherty and colleagues,19 focusing on
bacteremias originating from in tra
abdominal sites, reported the highest
death rate (68%). Their data also sug
gested that antienterococcal therapy may
improve survival. Conversely, the data of
Garrison and colleagues20 demonstrated,
as did our present study, that antibiotics
specifically directed against enterococcus
neither reduced the death rate nor ef
fected cure. The death rate in patients
with S. epidermidis bacteremia has ranged
from 27% to 46%.22,23 Burchard and
colleagues23 showed that specific antibi
otic therapy reduced the death rate from
49% to 10%. In the patients in that study,
central venous catheters represented the
main focus of infection. We were unable
to demonstrate a role for therapy directed
against S. epidermidis in our patients. In
fact, 50% of the bacteremias cleared

without treatment. It is difficult to draw
conclusions concerning the role of
antimicrobial therapy against entero
coccus and S. epidermidis isolated from
intra-abdominal sites in these critically ill
patients. We continue to administer
drugs, based on the scanty evidence in the
literature of their ability to reduce deaths
and that enterococcemia may lead to
enterococcal endocarditis.19 We believe
that these low virulence organisms
represent markers, reflecting global
depression of host immune defences in
the critically ill patient but do not exert
a specific pathogenicity.
The im portance o f C andida in
intraperitoneal infections is better
defined. Solom kin and colleagues24
retrospectively reviewed 56 episodes of
intraperitoneal infection in which various
Candida sp. were identified. They showed
the colonization of three or more sites
with Candida predisposed to blood inva
sion. Furthermore, patients treated with
amphotericin B, before candidemia, had
a better survival rate than those not
treated. They suggested that colonization
of three sites was sufficient rationale for
instituting amphotericin B therapy. In a
subsequent paper6 these same authors
included 22 patients with organ failure in
their assessment of antifungal therapy.
They found that the survival rate was
much lower (18%) in patients with organ
failure before treatment than in patients
without organ failure (78%). With such
poor survival, it is difficult to justify
antifungal therapy. The paper did not
specifically examine the ability of
amphotericin B to sterilize colonization
sites in these critically ill patients. Our
review suggests it is only moderately
effective (54% sterilization) and that the
risk of candidemia probably persists
despite therapy.
It is interesting to speculate on the ori
gin of the flora of these persistent intra
abdominal infections. In 9 of the 25
patients, there was a fistulous communi
cation to the gastrointestinal tract or
biliary system. In the remaining patients
it is possible that the organisms recovered
were residual organisms spilled at the ini
tial episode of peritonitis and, by selec
tive antibiotic therapy, they survived and
ultimately infected the collection. En
terococci, S. epidermidis and C. albicans
fall into the holes of antibiotic therapy.
P. aeruginosa and Enterobacter sp. tend
to be relatively antibiotic resistant. Evi
dence is increasing that these organisms
originate from the gastrointestinal tract
by the phenomenon of “ bacterial trans
location” .25 Wells and colleagues26
showed that B. fragilis abscesses in rats
attracted (and were ultimately colonized)
by enterococci and S. epidermidis from
the gastrointestinal tract. Stone and
associates27 observed Candida dissemina-
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tion in dogs whose gastrointestinal tracts
were inoculated with high doses o f Can
dida. Bacterial translocation is en
couraged by impairment o f host cellular
immune response.28 The fact that this
defect is present in patients with multiplesystem organ failure supports this con
cept.29 Further studies are needed to
define the route by which bacteria (and
yeast) leave the gastrointestinal tract to
colonize sites o f inflammation and
produce systemic spread.
In summary, the microbial flora o f crit
ically ill patients with persistent intra
abdominal infection differs radically
from that in patients admitted with acute
peritonitis. It is dominated by organisms
that tend to be multiple-antibiotic resis
tant and that individually are often con
sidered low in virulence. Specific anti
microbial therapy, although still rec
ommended, did not sterilize these cul
tures, probably reflecting impaired host
defences in patients with multiple-system
organ failure.
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Presidential Address, 1985: Collecting

We are all collectors — collecting and
organizing information being a very
important part of medical practice. View
ing and collecting medical data are just
the same as collecting stamps, and the
personal computer has made it much
easier for us. But we must get started,
decide what to collect and how to dis
play it. In vascular surgery, primary and
secondary patency have been used to
display results. In the author's opinion,
the concept of actual palliation (a living
patient with a patent graft) gives a much
better reflection of what has actually
been accomplished. In the “ high-tech”
future surgeons must know more about
their collections than anyone else — or
they will be directed by those who do.
Let's accept the challenge now.

Nous sommes tous des collectionneurs
puisque la collection et I'organisation de
I'information constituent une partie
importante de la pratique medicate.
L'examen et la collection des donnees
medicates s'apparentent a la collection
de timbres et I'ordinateur personnel nous
a rendu la tache beaucoup plus facile. II
faut neanmoins se lancer, decider de ce
qui sera collectionne et de quelle fapon
cela sera visualise. En chirurgie vasculaire, la permeability primaire et secondaire a servi a visualiser nos resultats.
Selon I'auteur, le concept de palliation (un
patient vivant qui a une greffe permea-
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ble) illustre beaucoup mieux ce qui a ete
accompli. Dans un avenir oil prevaudra la
haute technologie nous devrons mieux
connaitre nos collections que quiconque;
sinon, ceux qui sauront nous meneront.
Acceptons le defi. Des maintenant.

To collect is defined in Webster’s Diction
ary as to gather together or assemble.
All of us collect — if only information
for income tax! Any memorabilia or
knick-knack can make a good collection
and may be profitable. Most of us have
collected stamps or coins to some degree.
I still have all my Popular Mechanics and
Lionel trains, collecting dust and my
wife’s wrath, and I’ll bet most of you
have your favourite old ski in the base
ment. These are a little like the old doc
tor with a series of one case — interest
ing but hardly a collection.
What is a collection? Unsoaked stamps
have been saved, but they are definitely
not a collection. Collections are
organized, attractively displayed and have
a common theme. The whole point of the
collection is that it can be observed,
enjoyed, refined and, if organized, under
stood.
In postgraduate training we collect a
great deal of information. One of the
important aims is to infuse the trainee
with enthusiasm for adding in some way
to medical knowledge or development.
Two people, particularly, influenced me

in this regard. Charles Rob had one of the
most incisive minds I have ever encoun
tered. There were hooks all over it, ask
ing questions and looking for answers,
collecting and organizing. Rounds were
exciting. His surgery had the same preci
sion and flair.
The second person was Professor
Milnes Walker of Bristol who was a world
authority on surgical control of portal
hypertension. A humble and most gra
cious host, he had two sets of bar graphs
displayed on his office walls; one showed
patients after portacaval shunting and the
other after transesophageal ligation of
their varices. He extended the bar graph
on each follow-up visit and coded
“ rebleeds” , hepatic encephalopathy and
death. The up-to-date results in his area
of major interest were there for all to see:
a brilliant surgeon and an academic col
lector.
Then, as now, treatment of femoropopliteal occlusive disease was a very hot
topic. I first did a femoropopliteal vein
graft in June 1964, and I have collected
results of vein grafting procedures ever
since. My collection was organized as bar
graphs, and I marked revision with a line,
occlusion with an X and death with a
cross. I kept this on the wall of my office,
soon covered by a curtain so that it didn’t
frighten patients. As the follow-up time
increased the early cases looked a little
like Flanders fields, with its crosses row
on row!
Then the day of the main-frame com
puter was upon us. Henry Litherland
recognized its value to the collector and
developed a form to collect pertinent data
associated with the surgery of occlusive
vascular disease.1 A year later Henry
Hildebrand drew up a form for
aneurysms. Using these forms we started
a prospective study of vascular disease at
St. Paul’s Hospital in Vancouver in 1967,
back loading my femoropopliteal collec
tion at that time. There have been a few
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revisions in the last 18 years, one to
improve collection of data on “ redo”
cases and the other, a format change to
satisfy the “ data punchers” . The point
is, that by making the decision to collect,
we now have an organized prospective
data base o f patients, their surgical com
plications and subsequent operations
since 1967. The fact that a few things have
been changed has not been a real
problem.
What To Collect
Several problems confront any collec
tor and the most important is what to col
lect. In the field of stamp collecting, each
collector makes decisions. Some collec
tors collect stamps from all over the
world, but they are rarely able to sustain
interest or input for such a wide collec
tion. Even the stamp collector who
specializes has decisions to make. Will he
collect every existing ultra-rare stamp in
his area? — a good “ Penny Black” is
worth $100 000.! Does it ruin the collec
tion not to have it? A mistake I made was
to stop collecting Canadian stamps
prospectively about the end of World
War II, they were just so common. Re
trospective stamp collecting is a much
more expensive exercise.
Without making tedium of the compar
ison, collecting medical data is no differ
ent. We must get started and decide what
to collect; we can be satisfied with a data
base that provides us with complete infor
mation on say 90% of the group as long
as we can identify the missing informa
tion and find it. In writing up 100 cases,
I would hope to pull no more than 15
charts and should go directly to them for
one or two pieces of information. As
numbers increase or interest focuses, new
categories are necessary and a good data
collection form has some leeway to accept
them. Clearly, there is no need to look up
all the vein grafts to pick out the in-situ
grafts, so we changed a few numbers
recently to identify them.

couraging beep. Linked mathematical
changes are instantaneous. You can ask
the computer what will happen if your
next 10 patients fail or succeed. The inter
face between the collector and the per
sonal computer is software. Good soft
ware programs are termed friendly.
Compatible computers with friendly pro
grams often lead to collectors being mar
ried to their computers.
Medical literature has become an over
whelming collection. Reports are being
abstracted daily and are available to all
of us on-line through a personal computer
and modem. There is no question that this
is the educational route of the future. The
most up-to-date literature is available at
one’s finger tips the evening before a

presentation or the arrival of a visiting
professor. The microcomputer was
refined for business purposes only 2 years
ago and has become a fact of life in that
short time.

K N O W YOUR
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FIG. 3--Big brother will be watching.

FIG. 1—Actual pallation curve (graft patent and patient alive) truly reflects patient bene
fit from operation.
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The next problem confronting the col
lector is where to keep the collection and
how to gain access to it. Valuable collec
tions are often locked up in a bank vault,
but active portions of the collection,
where one is completing a page or adding
to a contemporary area, must be availa
ble. Obtaining information from a main
frame computer through the interface of
a programmer can be a little like borrow
ing money from a difficult banker, you
may not get what you want! The great
advantage of the personal computer is
that it is interactive, which means that as
you change an entry it is immediately visi
ble on the screen or rejected with a dis
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HG. 2—Menu-driven software program to analyse patient data base on personal computer
the stamp album for the vascular collector.
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Organization
The final problem is organizing the col
lection. The stamp collector buys an
album with organized pages, ponders
over the stamps and enters the best one.
The more sophisticated collector divides
the collection into mint and used or may
have special interest in topics or cancels.
The better and larger the collection, the
more important is the organization and
the display.
I have been particularly interested in
displaying the results of medical collec
tions. Much like stamps, our patients
change as they progress through treat
ment. The patient who is being assessed
is like the mint stamp; the patient after
successful surgery, very fine used; after
reoperation, socked on the nose; and
treatment failure, faulty.
For our purpose in vascular surgery we
can condense these phases into: primary,
that is the durability of the original con
struction; secondary, our ability to keep
it functioning with revisionary operations;
and actual palliation, which we define as
the combination of a successful graft and
a living patient. With this display format
for an aortofemoral collection, the results
are informative and should influence
future management (Fig. 1). They can be

compared to results of femoropopliteal
grafting for the same complaint.2 It is
difficult to say which curve is the most
valuable, but in my opinion it is the actual
palliation curve that best reflects patient
benefit from the operation.
Over the last 2 years I have developed
a menu-driven software program for the
personal computer that analyses a patient
data base and produces life tables and
graphs under the above headings (Fig. 2).
The end point for primary patency is
usually revision or thrombectomy, but
any late occurrence, reconstruction above
or below, or false aneurysm, can qualify,
depending on the study. Graft occlusion
(failure) ends the secondary patency.
Patient groups can be selected on the basis
of outflow, symptoms, age, sex or any
combination of factors the collector has
entered. When combined with the data
collection form, this is the stamp album
for the vascular collector.
If we can define the exact criteria and
aim of a study before we start, collecting
can be very efficient. This was possible
in the annual vascular surgery audit for
which we decided to utilize only informa
tion that was easily retrievable in
retrospect and to use hospital morbidity
as the cut-off date, thereby eliminating
long-term follow-up.3

Future
What does the future hold for medical
collectors? Undoubtedly, we will all end
up with computer access directly from our
offices, whether it be a personal computer
or a dumb terminal connected to a minior main-frame computer. Hospitals are
gradually breaking down their computer
fear. Medical records departments are
great savers of questionable information.
Perhaps through more direct input from
medical personnel, we can identify what
is important to us and delegate some of
the leg work to those who are trained to
do it.
Some collectors are born and others are
made. In the “ high-tech” future we are
all involved and big brother will be watch
ing (Fig. 3). It behooves us to know more
about our collections than any one else,
or we will be directed by those who do.
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Edwards Foundation Lecture.
Femoropopliteal and Infrapopliteal Reconstruction:
State of the Art 1985
A review of recent reports in the surgical
literature and the author's recent
experience suggest that autogenous vein
grafts remain the best method for arterial
reconstruction below the inguinal liga
ment. The in-situ vein graft appears
superior to reversed grafts for femoroinfrapopliteal reconstruction. Bypass
grafts of polytetrafluoroethylene or
human umbilical vein have not achieved
satisfactory long-term patency even in
the femoropopliteal position and should
probably be used sparingly.

La revue des dernieres communications
dans la presse chirurgicale ainsi que
I'experience recente de I'auteur indiquent
que la greffe de veine autogene demeure
la meilleure technique de reconstruction
arterielle sous le niveau du ligament
inguinal. La greffe veineuse in situ paraft
etre superieure a la greffe inversee dans
les cas de reconstruction f6moroinfrapoplitee. Les derivations a I'aide de
tubulure de polytetrafluoroethylene ou de
veine ombiiicale humaine n'ont su assu
rer une permeabilite satisfaisante a long
terme, meme en position femoropoplitee,
et doivent probablement etre utilisees
avec parcimonie.

in vascular surgery. There is widespread
agreement that the most effective means
of treating femoropopliteal and femorotibial arterial occlusive disease is bypass
grafting with autogenous vein. However,
the late results of reversed saphenous vein
grafting in the lower extremities have
generally been inferior to those achieved
with repair of occlusive disease of the aortoiliac system, the internal carotid arter
ies, the renal arteries, or the great vessels
arising from the aortic arch.
The major cause of vein-graft failure
is myointimal hyperplasia of the graft
itself. Experimental evidence suggests that
these lesions are the direct result of
intimal injury, often occurring at the time
the graft is harvested.1 Recent work by
LoGerfo and colleagues2 indicated that
careful handling o f autogenous
saphenous vein,, when it is removed in
preparation for grafting, coupled with the
use of papaverine to prevent venous
spasm, may reduce the incidence of
intimal damage and subsequent hyper
plastic lesions. Some clinical reports also
suggest that careful handling of the vein
m ay yield im proved results for
femoropopliteal and infrapopliteal vein
grafts.2,3
In-Situ Grafting

Arterial reconstruction below the ingui
nal ligament, particularly that of the
infrapopliteal vessels, remains a problem
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There still remains the problem of size
discrepancy using reversed saphenous
vein, when the small distal end is attached
proximally to the circumferentially larger
and often thick wall of the common
femoral artery. This situation frequently
leads to a narrowing at the proximal
anastomosis with damage to the intima
distal to that point because of resulting
flow disturbance and shear stress. This
problem can be solved by the use of the
saphenous vein in situ and, stimulated by
the excellent results of the Albany
group,4 many surgeons have adopted the
in-situ grafting technique with valve inci
sion using instruments developed by
Leather and associates.5 The in-situ tech
nique is also thought to cause less intimal
damage to the vein because it is left in its

natural bed and is perfused by arterial
blood at physiologic pressure.
The early and intermediate results of
the in-situ vein grafting technique in
fem oropopliteal and fem oro-infrapopliteal reconstructions have been
gratifying in our hands and in those of
other surgical groups.6-7 We found that
the cumulative 2i-year patency rate of
femoropopliteal m-situ vein grafts was
82% in a series of 54 grafts and for
femoro-infrapopliteal in-situ vein grafts
87% for a series of 47 grafts. These results
are at least as good as those achieved on
our service with the reversed saphenous
vein graft in the femoropopliteal position
and are superior to those in the femoroinfrapopliteal position.
The in-situ operation takes no longer
to perform than reversed vein grafting
and actually reduces the operating time
for femoro-infrapopliteal bypasses in
most instances. The technique has also in
creased our use of vein grafts. Previous
experience indicated that the use of
reversed autogenous vein grafts of less
than 4 mm external diameter was accom
panied by too high a graft failure rate to
be worthwhile. However, the use of 3-mm
diameter veins is feasible with the in-situ
technique. This is probably because the
larger end of the vein is anastomosed to
the large common femoral artery and the
smaller end to a small thinner-walled dis
tal artery, and also because the incidence
of myointimal hyperplasia in the vein
graft itself is lower. For these reasons we
believe that the in-situ vein graft is now
the preferred method of arterial recon
struction below the inguinal ligament.
Polytetrafluoroethylene Grafts
Management of the patient who has
limb-threatening ischemia and whose
saphenous vein is either too diseased for
use or has already been removed remains
a problem. There has been widespread
interest over the past decade in infrainguinal bypass grafts of polytetrafluoro
ethylene. The early enthusiasm for this
material has been tempered considerably
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by the late results reported from a num
ber of vascular surgical services.8,9 Our
experience suggests that bypasses of polytetrafluoroethylene grafts to the tibial ves
sels stay patent on the average for such
a short period as to be contraindicated.
The 5-year patency rate of 30% for 230
femoropopliteal polytetrafluoroethylene
grafts is discouraging when compared
with the results achieved using autoge
nous vein.
One problem with polytetrafluoroethy
lene grafts, in concert with other artifi
cial prostheses crossing the knee joint, is
buckling of the graft when the knee is
flexed to 90° and beyond. Manufacturers
have attempted to prevent this problem
by incorporating external rings into the
graft material. However, the grafts then
appear to buckle the popliteal artery and
failure rates, in our experience, have not
lowered. Polytetrafluoroethylene grafts,
both experimentally and clinically, are
also associated with the development of
a myointimal hyperplastic lesion at the
distal anastomosis that appears to begin
in the wall of the artery opposite the
anastomotic suture line and to expand to
involve the entire circumference of the
artery and the lower portion of the graft
itself.10 The reason for this complication
is not known, but it may be that the com
pliance mismatch between a stiff poly
tetrafluoroethylene tubing and a compli
ant host artery is responsible for damage
to the arterial intima.
It has been suggested that the use of
antiplatelet agents may improve the long
term patency of polytetrafluoroethylene
grafts. The only experimental evidence
supporting this concept is a report from
Green and associates,11 in which a small
number of patients treated with antiplate
let agents were compared with those
treated with placebo. It was found that
only those patients with polytetrafluoro
ethylene grafts placed above the knee
joint appeared to benefit from such ther
apy. A controlled double-blind study in
which our service participated, failed to
show improved patency of polytetraflu
oroethylene grafts in patients treated with
antiplatelet agents when compared with
those treated with a placebo.12
In any event, the discouraging long
term patency rates of polytetrafluoroethy
lene in the infrainguinal position reported
by a number of experienced surgeons sug
gest that grafts of this material should be
used sparingly. The late results are simi
lar, to those reported in the early 1960s for
Dacron prostheses in the infrainguinal
region, and these grafts are now rarely
used for femoropopliteal reconstruction.
There are reports suggesting that
human umbilical vein may be superior to
polytetrafluoroethylene for grafting in the
femoropopliteal position.9 We have been
unable to duplicate these results on our
service and have found that patency rates

with umbilical vein are essentially the
same as those with polytetrafluoroethy
lene. The umbilical vein graft is more
difficult to use technically, is subject to
unpredictable early failure, is very
difficult to thrombectomize successfully,
and is associated with late aneurysm for
m ation.13
Alternatives

Since none of the artificial materials
appear to be an alternative to autogenous
vein grafts for femoral-distal popliteal
and infrapopliteal reconstruction, a num
ber of surgeons have turned to compo
site grafts for patients whose saphenous
veins are unsuitable or missing. Conduits
of polytetrafluoroethylene or Dacron
above the knee are attached to shorter
segments of autogenous vein to carry the
graft below the knee joint. There is some
evidence that composite grafts have a
patency superior to that of artificial
prostheses alo n e .14,15 However, the
Achilles’ heel of a composite graft is the
proximal prosthesis, which continues to
have the disadvantages noted, even
though it is attached distally to an
autogenous venous graft. Our experience
suggests that the results with composite
are better than those of plastic prostheses
alone when used below the knee. How
ever, we believe that attaching the vein to
the prosthesis by an end-to-end anasto
mosis should be avoided; this appears to
result in buckling of the compliant vein
by the non-compliant prosthesis with each
pulse beat. A better technique is to
anastomose each separately to a segment
of popliteal artery above the knee joint
if possible, or to use an end-to-side
anastomosis of the vein to the prosthesis.
We believe an attempt should be made
to use autogenous arm-vein grafts, which
have been shown by several groups to
have satisfactory long-term patency in the
infrainguinal position, or composite
venous grafts formed of arm vein and
lesser saphenous vein, which is frequently
ignored by vascular surgeons although it
is usually intact and of adequate calibre.
Use of such grafts, combined with prox
imal endarterectomy of the superficial
femoral artery, will often permit satisfac
tory infrapopliteal reconstruction in
patients whose saphenous veins have been
removed or destroyed. There has been a
rekindling of interest in the use of a more
extensive endarterectomy of the superfi
cial femoral and popliteal arteries, partly
the result of a new motor-driven endar
terectomy instrument that appears to do
a better job than the old-fashioned loop
strippers. The late results reported by one
surgical group16 using this technique,
rival those achieved with autogenous
venous grafts. At present, if at all possi
ble, autogenous tissue reconstruction
should be used below the inguinal liga

ment if a high late failure rate is to be
avoided.
The Future

Hope should not be abandoned that a
satisfactory small-vessel prosthesis will
ultimately be developed. Modern tech
niques of endothelial cell culture, partic
ularly recent advances in the purification
and utilization of endothelial cell-growth
factor, have opened the way towards the
clonal expansion of endothelial cells har
vested from short segments of autogenous
vein for use in the lining of a prosthesis.
Advances in polymer chemistry also sug
gest that the construction of an appropri
ately compliant prosthesis to accept an
autogenous endothelial lining may be
feasible in the near future. Perhaps an
even more attractive idea is the growth in
tissue culture of a totally autologous
prosthesis composed of an endotheliallined smooth-muscle tube, which has
been found experimentally to be feasible
if not commercially practical.
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Utility and Application of Pulmonary Artery Catheterization
in Aortic and Aortoiliac Disease
To determine how useful pulmonary
artery catheterization is in abdominal aor
tic surgery and which patients are most
likely to benefit from the procedure, the
author studied 28 patients with aneu
rysms and 22 with obstructive disease.
Patients with multiple risk factors,
except those with leaking aneurysms,
were assessed before operation by pul
monary artery catheterization and
volume loading (15 ml of 5 % albumin/kg over 12 hours). All patients who
underwent operation were assessed and
monitored by pulmonary artery catheteri
zation, beginning immediately postoperatively.
In 26 patients the procedure made a
substantial contribution to assessment or
care of their condition, not suggested by
the usual clinical and technical modali
ties. In four patients the proposed sur
gery was affected; it was cancelled in
one, delayed in two and replaced by a
lesser procedure in one. Tw o other
patients, thought to have unacceptable
cardiac function, were considered suita
ble for operation after catheterization
was done. Eleven patients with suboptimal cardiac index and 2 with volume
overload were recognized early after sur
gery. T w o patients with oliguria follow
ing repair of a ruptured aneurysm had
optimal cardiac indices and renal perfu
sion assured by pulmonary artery cathe
terization, which helped to identify
unsuspected pulmonary hypertension in
three patients, bleedir g in one and intes
tinal infarction in one.

Twenty-seven patients were challenged
before surgery with 5 % albumin and
their response was analysed. In 7 there
was no response to the colloid challenge
and they suffered much more morbidity
than the 20 patients who had a positive
hemodynamic response to challenge.
Multiple regression analysis of disease
and risk factors among the 50 patients
showed that age and cardiac status were
independent and were the most
dominant of all variables in determining
the likelihood of benefit from pulmonary
artery catheterization.

Dans le but de determiner I'utilite du
catheterisme de I'artere pulmonaire dans
la chirurgie de I’aorte abdominale et
d'identifier les patients les plus susceptibles de beneficier de cette intervention,
I'auteur a etudie 28 patients souffrant d'an6vrisme et 22 de maladie
occlusive. Les patients presentant des
facteurs de risque multiples, a I'exception de ceux qui avaient un anevrisme
suintant, ont ete evalue avant I'operation
par catheterisme de I'artere pulmonaire
et charge de volume (15 ml d'albumine
a 5%/kg sur une periode de 12 heures).
Tous les patients qui ont subi I'operation
ont ete evalues et surveilles par cathete
risme de I'artere pulmonaire en commencant des la fin de I'intervention.
Chez 26 patients, I'intervention a contribue de facon importante a revaluation
des soins apportes a leur etat, contribu
tion que n'auraient pu apporter les
moyens cliniques et techniques habituels. Dans quatre cas, I'operation envisagee a ete modifiee; une chirurgie a ete
annuiee, deux ont ete retardees et une a
ete remplacee par une intervention
reduite. Deux patients que I'on croyait
inaptes a I'operation en raison d'une
insuffisance de la fonction cardiaque se
sont qualifies au catheterisme, Onze
patients ayant un index cardiaque sousoptimal et deux ayant une surcharge de
volume ont ete identifies peu apres I'ope
ration. Deux patients presentant une oligurie apres reparation d'un anevrisme

rupture ont montre au catheterisme de
I'artere pulmonaire, un index cardiaque
optimal et une bonne perfusion renale;
ceci a permis d'identifier une hyperten
sion pulmonaire insoupconnee chez trois
patients, du saignement chez un et un
infarctus intestinal chez un autre.
Avant I'operation, 27 patients ont ete
mis a I'epreuve a I'aide d'albumine a 5 %
et leur reponse a ete analysee. Sept
d'entre-eux n'ont pas reagi a cette
epreuve au colloide; on a constate chez
eux une morbidite beaucoup plus consi
derable que chez les 20 qui ont repondu
positivement a I'epreuve hemodynamique.
Chez 50 malades, une analyse de
regression multiple portant sur la maladie
et les facteurs de risque a montre que
I'age et I'etat de la fonction cardiaque
etaient independants; de toutes les varia
bles, elles etaient les plus importantes
pour determiner la probabilite de benefi
cier d'un catheterisme de I'artere pulmo
naire.

The role of invasive hemodynamic
monitoring in patients who undergo
major vascular surgery remains con
troversial. These patients tend to be
elderly, many have critical vascular dis
ease in other areas and many have chronic
lung disease. The basic monitors of pulse
rate, blood pressure and urinary excretion
rate in patients who undergo surgery are
often unreliable in the patient with aorticvascular disease, as a result of preopera
tive beta blockade, aortic clamping and
operative diuretic therapy. Central venous
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pressure is not a reliable monitor of the
rapid changes that may take place and is
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often misleading, especially in the
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of the benefits, and to see if patients
deriving benefit could be identified.

Results

Methods

Usefulness o f Pulmonary Artery Cathe
terization

Fifty consecutive patients, 28 with
aneurysmal disease and 22 with obstruc
tion, were assessed by pulmonary artery
catheterization. Patients (33 of the 50)
with multiple clinical risk factors, exclud
ing those with ruptured aneurysms,
underwent baseline studies preoperatively. Twenty-seven of this group were
challenged with 5% albumin solution (15
ml/kg over 12 hours) to evaluate cardiac
performance and optimize preload before
operation. All who had direct aortic sur
gery (48 patients) were assessed immedi
ately after by pulmonary artery catheteri
zation and monitored for at least 48
hours.
As each patient was assessed and
treated, the substantial contributions
made by catheterization to the assessment
or care of that patient, not indicated by
other clinical or technical modalities, were
noted prospectively and classified accord
ingly as major (3), intermediate (2) or
minor (1).
After identifying patients in whom
catheterization was considered useful, our
group developed a statistical model that
included individual variables, to see if we
could identify those patients likely to der
ive benefit from pulmonary artery cathe
terization. The variables included age,
sex, cardiac status (New York Heart
Association, 19732), clinical risk factors
of renal, cerebral, respiratory and meta
bolic origin, and the presence preoperatively of hypertension; these were consi
dered together with the nature of the
disease treated, obstructive or aneu
rysmal.
Apart from benefits in individual
patient care, the initial preoperative infor
mation obtained from catheterization,
with the response to challenge with 5%
albumin, was examined to see if outcome
and morbidity were predictable by that
initial assessment.

In 26 of 50 patients the procedure made
substantial contributions to assessment or
patient care (Table I). These were major
in 10 cases, intermediate in 7 and minor
in 9.
Cancellation o f surgery.—A 74-yearold man with chronic obstructive pulmo
nary disease, aortoiliac obstruction and
ascending aortic aneurysm had his surgery
cancelled because the catheterization
indices deteriorated after challenge with
5% albumin.
Alteration o f a planned procedure.—
In one 70-year-old man with an ascend
ing aortic aneurysm whose catheterization
indices deteriorated following challenge
with 5% albumin, the aneurysm surgery
was cancelled and axillobifemoral graft
ing carried out 6 days later.
Delay o f surgery.—Two patients whose
initial assessment revealed marginal
cardiac indices and elevated pulmonary
capillary wedge pressures had their oper
ations postponed. Digitalis was prescribed
and 7 days later when their condition was
improved the aortic operations were per
formed.
Upgrading o f fitness assessment.—Two
patients were considered poor candidates
for aortic surgery by medical assessment.
Following pulmonary artery catheteriza
tion and a good response to 5% albumin
challenge they were considered to be at
less risk and they subsequently underwent
uncomplicated aortic surgery.
Optimal cardiac index and renal
insufficiency.— Two patients had persis
tent oliguria after repair of ruptured
abdominal aneurysms. Optimal renal per
fusion was assured by pulmonary artery
catheterization in circumstances in which
overload and adult respiratory distress
syndrome were potential hazards.
Recognition o f volume /preload defi
ciency.—In three patients volume defi
ciencies were recognized postoperatively

Table 1—Contribution of Pulmonary Artery Catheterization to
Individual Care of 50 Patients with Aortic Aneurysms or Obstruction
Weighting*
No. of patients
Contribution
1
3
Cancellation of surgery
3
1
Replacement by lesser operation
2
3x 2
Delay of operation
2
Upgrading of fitness assessment
1x 2
Assurance of optimal cardiac index
2,3
2
in oliguric patients
Recognition of:
Volume/preload deficiency with
1 x 5, 2 x 4, 3 x 2
11
hypertension
2x 2
2
Volume overload
3x 3
3
Pulmonary artery hypertension
1
1
Postoperative bleeding
1
1
Intestinal infarction
*1 - minor benefit, 2 - intermediate benefit, 3 - major benefit.

by pulmonary artery catheterization, but
the information obtained from basic
monitoring was within the normal range.
These patients required an average of 630
ml of red blood cells and plasma to
restore normal catheterization indices.
Twenty-seven patients had moderate
hypertension early after operation; in 8
of them, relative volume/preload defi
ciency was exposed after vasodilator ther
apy for increased systemic vascular
resistance—an average of 890 ml of red
blood cells and plasma corrected the
abnormality with return to normal
indices. The volume deficiencies in these
patients, in the absence of pulmonary
artery catheterization data, might not be
evident until renal recovery from opera
tive diuretic therapy and oliguria
occurred.
Volume overload.—Two patients who
suffered interstitial pulmonary edema and
had evidence of respiratory failure after
aortic surgery were found by cathe
terization to have volume overload. The
clinical distinction between respiratory
failure, pneumonia and adult respiratory
distress syndrome may be difficult
without pulmonary artery catheteri
zation.3
Pulmonary artery hypertension.—
Three patients had serious pulmonary
artery hypertension, with systolic pres
sures over 35 mm Hg. Lesser degrees of
pulmonary artery hypertension were fre
quent. Those with severe hypertension are
at special risk because they are more sen
sitive to volume overload and have an
increased susceptibility to adult respira
tory distress syndrome; in some instances
pulmonary hypertension can impair left
ventricular performance.4’5
Early recognition o f bleeding.—A
69-year-old man with infrarenal aortic
obstruction and renal artery stenosis had
hypertension, treated with (3-blockers.
Two hours after repair of the obstructed
abdominal aneurysm and aortorenal
bypass, pulmonary artery hypotension
developed and there was a drop in cardiac
index without systemic hypotension. With
volume infusion, the catheterization
indices returned to normal, but after 1
hour the previous abnormal indices of
pulmonary artery catheterization were
again noted. The patient was returned to
the operating room and suture-line bleed
ing controlled. At no time did the patient
manifest systemic hypotension, tachy
cardia or a decrease in urine volume. Pul
monary artery catheterization in this
instance served as an early warning
system.
Intestinal ischemia.—As a result o f a
hemodynamic failure of a cross-femoral
graft a 74-year-old man underwent oper
ation for aortoiliac obstruction. He had
coronary artery disease and had had a
myocardial infarction. At operation, in
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addition to aortobifemoral grafting, a
stricture of his small intestine was
resected. Forty-eight hours later he
became hypotensive and tachycardiac.
His cardiac index (6.3) on pulmonary
artery catheterization was double that of
the early postoperative value (3.1), his
systemic vascular resistance index had
dropped from 1065 to 878 and his arteri
ovenous oxygen difference was 2. At
laparotomy total colectomy was required
for colonic infarction. In a patient such
as this who is still on the respirator and
heavily sedated 48 hours after operation,
other causes of hypotension, cardiac- or
volume-related, would be difficult to
exclude without pulm onary artery
catheterization.
Colloid Challenge with 5% Albumin:
Relationship to Outcome
In addition to the individual contribu
tions by pulmonary artery catheterization
to patient assessment and care, the rela
tionship between the response to chal
lenge by 5% albumin to outcome after
operation was examined. The 27 patients
challenged by 5% albumin who subse
quently had aortic surgery responded in
one of two ways. In 20 patients (group
1), the mean cardiac indices increased
(from 2.93 ± 0.4 m l/m in»m r2 to 3.6 ±
0.62 m l/m in*m ~2); in the other 7
patients (group 2) cardiac indices did not
increase (3.18 ± 0.21 ml/min*m~2 ver
sus 2.98 ± 0.3 m l/m in*m -2). In
Fig. 1 the net change in cardiac index is
shown for each patient together with the
mean change and standard deviation for
all 27 patients. The cardiac index in all
group 2 patients fell below one standard
deviation from the mean.
Outcome.—In group 1 patients there
was major morbidity in two but no deaths
(Fig. 2). One patient required reoperation
for bleeding and the other a colectomy for
intestinal ischemia. In group 2, there was
major morbidity in four patients. One
patient had cardiac arrest in the operat
ing room and a second experienced ven
tricular fibrillation in the intensive care
unit shortly after surgery. A third patient
had recurring cardiac failure and died at
home 60 days after operation. A fourth
suffered from adult respiratory distress
syndrome and sequential organ failure
and died 14 days after operation. This
was the only death in the series in electively treated patients.

However, when benefit was quantified
(from 1 to 3) and interacting terms were
examined by multiple regression analysis,
the common features were those of age
and cardiac status as independent and
dominant variables in the models. The
R2 in this analysis was 50.84.
When unruptured aortic aneurysms
and obstructions were examined, both
separately and together, the variables
became part of a more homogeneous pat
tern with higher R2 values, from 63 to
70; again age and cardiac status appeared
as the dominating factors.
Since pulmonary artery catheterization
is essentially a cardiac assessment, a fur
ther model was constructed interacting
cardiac status with all other variables. The
stepwise regression process again showed
age and its interaction with cardiac sta
tus to be the important variables. The for
mula in Fig. 2 characterizes precisely
(with R2 = 50.17) those patients deriv
ing benefit from pulmonary artery
catheterization and the degree of benefit
they might expect.

Cardiac index,
mL/min-nT^

Discussion
In our group of patients who required
abdominal aortic surgery, pulmonary
artery catheterization was frequently
beneficial, especially for elderly patients
with cardiac impairment. In studies of
survivors of critical illness, it has been
shown that those with the capacity to pro
vide above-normal performance (“ op
timal goals versus normal values” ) with
respect to cardiac index, oxygen delivery
and other indices, are more likely to sur
vive.6'7 It may be that those who cannot
improve their cardiac performance sub
stantially above a resting baseline level are
poor candidates for major aortic surgery.
They could be identified by constructing
cardiac performance curves, but this is
difficult, time-consuming and is only
valid if end-diastolic volumes are meas
ured.8 Observing cardiac response, by
pulmonary artery catheterization, to a
standard colloid challenge may be more
practical and simple.
In older patients with cardiac impair
ment who are candidates for aortic sur
gery, assessment and monitoring by pul
monary artery catheterization will
frequently be of benefit and should help
to minimize the increased morbidity and
mortality of that group.
I would like to thank Dr. Harry Love, Chair
man, Department of Mathematics, University
of Prince Edward Island, for his assistance in
the analysis of material presented in this paper.
I also thank Mr. Merril Smith of the Audi
ovisual Department, Queen Elizabeth Hospi
tal for his assistance in preparing the graphs
and photographs.
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Low-Dose Intra-arterial Streptokinase Infusion Therapy
of Peripheral Arterial Occlusions and Occluded Vein Grafts
To study the effectiveness of low-dose
thrombolytic therapy the authors report
their experience with local, low-dose,
intra-arterial streptokinase infused at a
rate of 5000 units/h in four patients with
occluded vein grafts and eight with
peripheral arterial occlusions presenting
with limb-threatening ischemia. The
patients had had symptoms for 4 hours
to 6 weeks. The streptokinase infusion
successfully declotted two occluded vein
grafts and restored distal blood flow in
five patients with peripheral arterial
occlusion. Complications resulting in
early withdrawal of thrombolytic therapy
included surgical wound hematomas in
two patients. Tw o patients had severe
bleeding at the arterial puncture site
leading to the death of one of them.
Treatment after cessation of thrombo
lytic therapy included femoropopliteal
bypass in three patients, percutaneous
transluminal balloon dilatation of a
stenotic popliteal artery in one patient
and thromboembolectomy in three
patients. Tw o patients required belowknee amputation because of irreversible
ischemia.
The authors conclude that in carefully
selected patients, intra-arterial infusion
of streptokinase locally in low dosage is
an important adjunct in the treatment of
limb-threatening ischemia caused by
occluded vein grafts and acute arterial
thrombosis. They warn that selective
thrombolytic therapy with streptokinase
must be used with caution since it may
be associated with serious complica
tions.
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On decrit les resultats d'une etude sur
I'efficacitS d’un traitement thrombolytique par perfusion locale intra-arterielle de
streptokinase a faible dose. Le produit a
ete administre a raison de 5000 unites/h chez quatre patients ayant une
occlusion de greffe veineuse et chez huit
souffrant d'occlusion artdrielle peripherique qui ont ete vus pour une ischemie
susceptible d'entrafner la perte d ’un
membre. Les symptomes etaient pre
sents depuis des periodes allant de 4
heures a 6 semaines. La perfusion de
streptokinase a permis de dissoudre le
caillot dans deux cas d'occlusion de
greffe veineuse et a retabli la circulation
sanguine distale chez cinq patients souf
frant d'occlusion artdrielle peripherique.
Chez deux patients, un hdmatome au
point d'incision a entraine I'arret precoce
du traitement thrombolytique. Deux
autres patients ont eu une hemorragie
importante au point de piqure arterielle,
ce qui a cause la mort de I'un des deux.
A I'arret de la th£rapie thrombolytique, le
traitement s'est poursuivi par pontage
fdmoropoplitd chez trois patients, dilata
tion transluminale percutanee par ballonnet dans un cas de stdnose de I'artSre
poplitee et thromboembolectomie dans
trois cas. Deux patients ont du subir une
amputation en dessous du genou a
cause d'une ischgmie irreversible.
Les auteurs concluent que chez des
patients soigneusement choisis, la perfu
sion locale intra-arterielle de streptoki
nase a faible dose contribue de faqon
importante au traitement de I'ischemie
causee par I'occlusion d'une greffe vei
neuse ou par thrombose arterielle aigue,
mettant en peril la survie du membre. Ils
mettent en garde contre I'utilisation sans
precaution du traitement thrombolytique
seiectif a la streptokinase, car celui-ci
peut etre relie & des complications
serieuses.

The effectiveness o f regional administra
tion o f thrombolytic agents at low dosage
to treat peripheral arterial occlusions has
been confirmed by reports o f several
authors.1-8 Hargrove and associates9
reported successful recanalization o f
totally occluded femoropopliteal vein

grafts in four patients receiving low-dose
streptokinase infusion. Current concepts
and guidelines for the use o f thrombolytic
agents are well established and have been
reviewed in detail by Bell and M e e k .10
W e evaluated this treatment in 12 patients
with limb-threatening ischemia, consi
dered ideal candidates for local, low-dose,
thrombolytic therapy.
Patients and Method
Four patients with occluded fem oro
popliteal vein grafts and eight with arte
rial occlusions were treated with local,
low-dose, streptokinase infusion at the
Health Sciences Centre in W innipeg
between September 1982 and March 1985.

F IG . 1— Preoperative angiogram of
occluded left femoropopliteal vein graft (left).
Completely declotted vein graft after 43 hours
of intra-arterial streptokinase infusion (right).

VOLUME 29, NO. 4, JU LY 1986 / T H E C A N A D IA N J O U R N A L O F S U R G E R Y

259

Of the 12 patients, 8 were men and 4
women, ranging in age from 52 to 80
years. All had acute limb-threatening
ischemia. The duration of symptoms
ranged from 4 hours to 6 weeks. Screen
ing eliminated any contraindications to
thrombolytic therapy.
Coagulation studies, including platelet
count, thrombin, prothrombin and par
tial thromboplastin times were measured
before, during and after therapy. Transfemoral angiography identified the sites
of occlusion, except in one patient in
whom a transaxillary approach was used.
After the site of occlusion had been
visualized angiographically, a no. 4 or 5
French angiographic catheter was placed
through the same arterial puncture site,
under fluoroscopic control, as close to the
thrombus as possible to deliver the max
imum concentration of streptokinase to
the site of thrombosis. Streptokinase was
administered at a rate of 5000 units/h for
up to 72 hours. To avoid catheter throm
bosis, we found that dilution of strep
tokinase to 1000 units/ml with normal
saline by way of a sage pump was most
satisfactory. Vital signs and arterial punc
ture sites were monitored in the intensive
care unit. Coagulation studies were per

Fig- 2a

formed every 12 hours and when
necessary.
Patients were assessed frequently by
Doppler and pressure measurements.
Follow-up arteriographic studies were
performed 24 to 72 hours from the onset
of therapy. Moderate arterial lesions
remaining after therapy were treated
by direct surgery or transluminal
angioplasty.
When streptokinase infusion was suc
cessful the patient was placed on heparin
followed by oral anticoagulation for 3 to
6 months.
The following three case reports illus
trate the typical course of patients with
arterial lesions and occluded vein grafts
treated by streptokinase infusion.
Case Reports
Case 1

Physical examination revealed a pale, cool,
left leg with a 4 + femoral pulse but no palpa
ble distal pulses. Motor and sensory functions
were intact. Arterial flow at the ankle was
undetectable by Doppler. Left transfemoral
arteriography, performed immediately after
admission, demonstrated complete occlusion
of the left femoropopliteal bypass graft with
a patent common femoral artery (Fig. 1). A
no. 5 French infusion catheter was inserted
through the same arterial puncture site by
means of a guide wire and the catheter tip
advanced approximately 3 cm into the occluded
femoropopliteal vein graft under fluoroscopic
control.
A continuous infusion of streptokinase at
5000 units/h produced complete lysis of the
clot in 43 hours with resumption of good flow
(Fig. 1).
No lesion requiring surgical correction was
demonstrated on the follow-up arteriograms.
Coumadin was prescribed and at the time of
discharge the ankle pressure was 92 mm Hg
with a brachial pressure of 160/90 mm Hg.
The graft became occluded again after 15
months and was treated successfully with strep
tokinase infusion. The graft has remained
patent for the past 14 months.

A 68-year-old woman had a 10-hour history
o f acute pain in the left leg.
Thirty-two months earlier, because of rest
pain, she had undergone femoropopliteal
bypass grafting below the knee, using reversed
saphenous vein and proximal superficial place
ment o f a femoral artery onlay patch to the
left common femoral artery.

A 62-year-old white man presented at a local
hospital with rest pain of sudden onset in the

Fig. 2b

Fig. 2c

Case 2

FIG. 2—(a) Angiogram of occluded distal superficial femoral artery and interposition vein graft, (b) Angiogram 33 hours after strep
tokinase therapy shows completely declotted occluded segment but aneurysmal dilatation of distal superficial femoral artery, (c) Angiogram
at end of operation showing reconstruction with polytetrafluoroethylene interposition graft.
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left leg. He was treated with heparin
intravenously for 3 days before transfer to the
Health Sciences Centre in Winnipeg.
The patient had undergone bilateral popliteal
aneurysm resections and interposition grafting
with reversed saphenous vein, 9 and 6 years
earlier respectively. Aortoiliac bifurcation
grafting had been performed 3 years before
when an abdominal aortic aneurysm was
resected. He had been a smoker for many years
and had suffered myocardial infarction 2
months before admission.
On examination the left leg was pale and
cool with intact motor and sensory functions.
There was 4+ femoral pulse but no palpable
distal pulses. A left transfemoral arteriogram
demonstrated both a distal superficial femoral
artery and interposition vein-graft occlusion
(Fig. 2a).
A no. 4 French intra-arterial infusion
catheter was placed, under fluoroscopic con
trol, proximal to the occlusion site and a con
tinuous intra-arterial streptokinase infusion
(5000 units/h) begun. The saphenous vein
interposition graft was completely declotted
after 33 hours of continuous infusion. In the
follow-up post-infusion arteriogram there was
a proximal aneurysm in the superficial femoral

artery and stenosis at the proximal anastomo
sis (Fig. 2b). An interposition polytetrafluoroethylene graft was placed to correct the
lesion (Fig. 2c).
Postoperatively, the patient had good, pal
pable, pedal pulses, and his ankle pressure was
110 mm Hg with a brachial pressure of 129/79
mm Hg.
Coumadin therapy was prescribed, and at
follow-up 11 months later the graft was still
patent.

A no. 4 French infusion catheter was inserted
by the transfemoral route on the same side and
its tip advanced under fluoroscopic control to
the occlusion site. A continuous intra-arterial
infusion of streptokinase (5000 units/h) opened
the popliteal artery and distal vessel, all the way
to ankle and foot, in 48 hours (Fig. 3b).
After the infusion, ankle pressure was 140
mm Hg with a brachial pressure o f 175/95 mm
Hg. The patient was discharged on coumadin
therapy and 33 months postoperatively the left
limb vessels were patent.

Case 3

Results

A 71-year-old white man experienced sud
den onset o f rest pain in his left leg. A left
transfemoral angiogram (Fig. 3a) revealed
proximal occlusion of the left popliteal artery.
He was transferred to the Health Sciences
Centre 3 weeks later.
His relevant medical history included chronic
hypertension, renal insufficiency, cardiac
arrhythmia and a myocardial infarction
suffered 4 years earlier. Physical examination
revealed a pale, cool, left leg with intact motor
function and decreased sensation. There was
a normal femoral pulse but no distal pulses.

In six of seven patients (Table I) throm
bolytic therapy was successful, the arter
ies were patent and the limbs preserved.
One patient (no. 7) required below-knee
amputation owing to distal thrombosis,
even though proximal lysis was obtained.
In four patients streptokinase was discon
tinued because of hematoma formation.
Two large retroperitoneal hematomas
arose from the angiography puncture site
above the inguinal ligament and one
patient died as a result.
Discussion

Fig- 3a

Fig. 3b

FIG. 3—(a) Angiogram of occluded left popliteal artery, (b) Patent popliteal artery after
48 hours of intra-arterial streptokinase infusion therapy.

Streptokinase is a product o f /3hemolytic streptococci, group C, and
produces clot lysis by activating the
human fibrinolytic system.11 It combines
with the inactive proenzyme plasminogen
to form an activator complex that in turn
enzymatically converts available plas
minogen to plasmin, the active fibrino
lytic enzyme.12 Streptokinase has two
half-lives: the first is 18 minutes and
represents clearance after binding with
antistreptokinase antibodies, and the
second is 83 minutes.
Operative intervention in late occlusion
of vein grafts has often been unsatisfac
tory because of difficult thrombectomy
or the presence preoperatively of uniden
tified lesions such as a valve cusp steno
sis.13 Lysis of the clot is less traumatic
than thrombectomy and a lesion
precipitating the occlusion may be iden
tified. In one patient with a vein graft
there was no demonstrable cause for graft
occlusion after lysis had been accom
plished. In five patients with arterial
occlusions, lysis of the clot permitted
identification of lesions such as arterial
stenosis and aneurysm as causes o f acute
arterial thrombosis that were treated suc
cessfully by surgical reconstruction or bal
loon dilatation. When arterial thrombo
sis occurs with severe distal disease, lytic
therapy may be preferable to surgery.
However, infusion time required for com
plete lysis may be up to 72 hours so if
ischemia is severe, limb viability may
preclude lytic therapy. If there is good
motor function and only minor sensory
deficit in the limb, lytic therapy may be
initiated under close observation. It
would appear safe to operate within 2
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hours of cessation of the streptokinase if
lysis is unsuccessful or if ischemia
progresses. There are a number of con
traindications to streptokinase therapy.
They are: surgery within the past 10 days
(including invasive biopsy, thoracentesis
and paracentesis); an intra-arterial diag
nostic procedure within the past 10 days
(excluding uncomplicated arterial bloodgas measurement employing a 22-gauge
or smaller needle); active gastrointestinal
bleeding and conditions in which there is
a high potential for bleeding (e.g., ulcer
ative colitis or diverticulitis); defective
hemostasis (including coagulation-factor
deficiency or thrombocytopenia); a recent
(within 2 months) stroke or a condition
involving potential central-nervoussystem embolism (e.g., mitral-valve dis
ease with atrial fibrillation or subacute
bacterial endocarditis); recent trauma
with possible internal injuries or external
cardiac massage; intracranial neoplasms;
severe hypertension (diastolic pressure
more than 125 mm Hg); active and
progressive cavitating lung disease; acute
or chronic hepatic or renal insufficiency;
ulcerative cutaneous or m ucousmembrane lesions; a history of severe
allergic reaction to the thrombolytic
agent.10
Low-dose local infusion is associated
with a low frequency of hemorrhagic
complications. Nevertheless patients must
be monitored in an intensive care unit and
clotting parameters assessed, particularly
throm bin, prothrom bin and partial
thromboplastin times. In spite of close

monitoring, hemorrhage occurred in five
of our patients. Two were treated within
6 days of surgery with resulting forma
tion of wound hematomas that forced us
to withdraw treatment. We do not recom
mend use of this therapy earlier than 1
month after major surgery. Two patients
bled severely from their initial arterio
graphy puncture site. For this reason we
recommend that if one contemplates
streptokinase therapy, the initial puncture
site should be planned with the introduc
tion of the infusion catheter in mind.
Systemic complications such as fever or
anaphylaxis were not a problem in this
group of patients.
We have observed the development of
clot around the catheter, due to stasis in
the arterial segment being infused and
because of this the catheter must some
times be repositioned. The tip of the infu
sion catheter should be placed in the clot
initially and may be advanced as lysis
occurs to maintain a high dose at the site
of the thrombus. Fragmentation of the
clot with distal embolization has been
observed and could account for worsen
ing of the ischemia in one patient.
It should be emphasized that all
patients who had successful clot lysis were
placed on intravenous heparin therapy 4
hours after cessation of the streptokinase
infusion. Patients who do not have sur
gically correctable lesions are placed on
oral anticoagulation before discharge
from hospital.
Streptokinase can be used with success
for the lysis of clot in acute arterial occlu

sion when surgery may be contraindicated
because of systemic or local factors.
Patients being treated should be closely
monitored in an intensive care unit as lifethreatening hemorrhage may occur even
with local low-dose infusion of strep
tokinase. Surgically correctable lesions
may be demonstrated and appropriately
treated after clot lysis.
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There has been a serious shortage of
suitable kidneys for transplantation since
this procedure became the treatment of
choice for many patients with end-stage
renal failure. Some harvested kidneys are
discarded due to complicated or injured
renal vasculature and some potential liv
ing related donors are judged unsuitable
because their kidneys have multiple ves
sels. The authors review the basic
microsurgical techniques they have used
in such situations to salvage kidneys for
transplantation. They emphasize the exvivo, "bench", microsurgical method for
protecting the kidney from prolonged
warm ischemia time (as with multiple
complicated in-situ anastomoses).
Several illustrative case reports from
their recent experience are presented.
The authors conclude that microvascular
surgery is an important adjunct to the
armamentarium of the transplant
surgeon.
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Depuis que la greffe renale est devenue
le traitement de premier choix de I'insuffisance renale terminale, on observe une
serieuse penurie d'organes convenables
pour la transplantation. Certains des
reins recueillis doivent etre rejetes a
cause de la complication du reseau vasculaire renal ou d'une lesion de celui-ci.
et certains donneurs potentiels apparentes sont juges inadequats parce que
leurs reins poss&dent de multiples vaisseaux. Les auteurs passent en revue les
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techniques de microchirurgie qu'ils ont
utilisees dans de telles circonstances afin
de r6cuperer des reins pour la greffe. Ils
soulignent I'utilite de la methode de
microchirurgie ex-vivo sur "banc
d'essai” pour proteger le rein d'une
periode d'ischemie (comme il en survient
dans les cas d'anastomoses in situ compliquees). Ils decrivent plusieurs cas tir6s
de leur experience personnels recente
pour illustrer le cas. Les auteurs concluent que la chirurgie microvasculaire
est un complement important de I'arsenal therapeutique du chirurgien specialiste de la greffe.

Renal transplantation is now the treat
ment of choice in the majority of patients
with end-stage renal disease. Although
approximately 60 people in every million
annually in North America suffer renal
failure and require definitive replacement
therapy, the number of kidneys harvested
annually is only about 23 per million peo
ple. This means that only one-third of
those requiring a cadaver kidney are likely
to receive one. Within this group of har
vested kidneys, about 10% are discarded
for various reasons, some with multiple
vessels. A number of living related donors
are also considered unsuitable because of
multiple vessels. In view of the economic
advantage and improvement in health of
the recipient, an attempt should be made
to salvage kidneys with reparable vascu
lar damage (incurred primarily during
harvesting) and those with anatomic vas
cular variations.1 With microsurgery,
such organ salvage procedures can be
safely and reliably performed.2-4 We
review the surgical techniques applicable
to various vascular arrangements and
present illustrative examples from our
recent experience.
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Surgical Equipment
Standard microsurgical instruments

and monofilament nonabsorbable sutures
(Ethilon, Prolene, Surgilene) of 7-0, 8-0,
9-0 and 10-0, are used, depending on the
diameter of the lumen and thickness of
the vessel wall. An operating microscope
providing 10 x magnification is used to
anastomose finer vessels (2 mm diameter
or less) and opthalmologic loupes yield
ing 3.5 x magnification for larger ves
sels. Ex-vivo, “ bench” , microvascular
surgery is performed with the kidney
cooled in a basin of iced saline.
Multiple Renal Arteries
Over 20% of patients have multiple
renal arteries unilaterally and approxi
mately 10% bilaterally. For cadaveric
donors, a Carrel aortic patch containing
the origins of all renal arteries and
anastomosed end-to-side to the recipient
external iliac artery is preferred.
However, an aortic patch should not be
taken from a living donor. Occasionally,
the origins of the cadaver donor renal
arteries are far apart and would necessi
tate a large Carrel patch and a very long
anastomosis; in such instances the arter
ies are best taken separately from the
donors and microvascular arterioplasty
performed ex vivo before transplantation.
Following are examples, with illustrative
case reports, of the common vascular
arrangements.
Arteries o f Comparable Calibre
The preferred method for anastomos
ing two arteries of approximately equal
size is the side-to-side technique to cre
ate a common opening and a single
arterial anastomosis to the recipient. The
side-to-side anastomosis is done with a
double-armed 7-0 vascular suture running
up both cut edges of the vessels (Fig. 1),
with reinforcing sutures at the apex and
near the end of the new single-vessel
opening. This procedure is done in the
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cold basin, thus warm ischemic time is
minimized with the single anastomosis
required for revascularization. The com
mon opening is also hemodynamically
preferrable to two separate smaller
openings.
Case 1.—A 38-year-old woman underwent
nephrectomy donation for her 35-year-old
brother who had rejected two cadaveric renal
grafts. A renal arteriogram of the donor rev
ealed double right renal arteries and a single
left artery with early branching (0.5 cm) (Fig.
2). To minimize the risk to the donor, the left
arterial branches were ligated distal to the
branching. The two vessels were then
anastomosed ex vivo to create a single open
ing before revascularization end to side to the
recipient external iliac artery. The rewarm
ischemic time (venous and arterial anastomo
sis) was 30 minutes. Both donor and recipient
did well. The recipient’s serum creatinine value
2 months postoperatively was 100 /unol/L.

Arteries o f Unequal Calibre
Although some surgeons5,6 maintain
that small upper pole branches may be
ligated, we believe that these small
branches should be revascularized
whenever possible to avoid potential seg
mental renal infarction, urinary fistula,
postoperative hypertension and graft rup
ture. A lower pole branch should
definitely be revascularized to protect the
ureteral blood supply.
The preferred method is end-to-side
implantation of the smaller polar artery,
which is first spatulated into the main
artery (Fig. 3). Interrupted 8-0, 9-0 or
10-0 monofilament sutures are used,
depending on the size of the polar branch.
A small plastic cannula (e.g., 24-gauge
Angiocath) passed through the opening
of the main artery into the anastomotic
site may prevent injury to the back wall
of the side branch during anastomosis.
The single renal artery is anastomosed as
with a standard transplant.
Case 2.—A 62-year-old man received a cada
veric kidney harvested at another hospital. The
donor became hypotensive during the multior
gan harvest (heart, kidneys and liver) and in
the hurried dissection, the anatomy was not
well appreciated. The left kidney had three
arteries, two of comparable size and a third
smaller mid-pole vessel (Fig. 4). The smaller
artery was ligated and the two larger ones were
divided separately. A branch of the upper pole
artery was partially caught in a ligature. The
ligature was released and the vessel was
reanastomosed end-to-side to the upper pole
artery with 10-0 sutures. The mid-pole vessel
was trimmed and anastomosed likewise to the
upper pole artery with interrupted 9-0 sutures
(Fig. 4). The two arteries of comparable size
were joined side-to-side, creating a single open
ing. A single anastomosis, end-to-end, to the
recipient hypogastric artery was performed.
Anastomosis rewarm time was 28 minutes with
excellent kidney perfusion. The patient did well
and 3 months after transplantation had a serum
creatinine level of 160 /tmol/L.
264

Alternative methods of dealing with
multiple renal arteries include using the
recipient inferior epigastric artery5 for a
separate lower-pole arterial anastomosis
and branches of the recipient’s hypogas
tric artery for branch anastomoses.2,3
This branched autogenous vascular graft
method has been found useful by some
surgeons.2,3 Atherosclerotic disease of
the recipient artery would render the
method less attractive, although endar
terectomy has been advocated.4
In addition, several in-situ revascular
ization techniques have been used for kid
neys with m ultiple arteries.6 These
include: multiple separate in-situ arterial
anastomoses end-to-side to the external
iliac artery; one branch end-to-side to the
external iliac artery and one branch endto-end to the hypogastric artery; and
separate anastomoses to branches of the
hypogastric artery. The main disadvan
tage of these methods is that the rewarm
ischemic time is prolonged. This is cru
cial in cases in which cyclosporine is used
as the immunosuppressive agent as it has
been found that prolonged warm ischemic
time (greater than 45 minutes) com
pounds the nephrotoxic effect of
cyclosporine.7 Multiple in-situ vascular
anastomoses are also cumbersome and
the likelihood of technical error is
increased.
Multiple Renal Veins

Smaller venous branches can safely be
ligated. However, double veins of equal
size should be anastomosed as with two
arteries of equal calibre to avoid venous
outflow obstruction.

Fig. 2a

FIG. 2—(a) Renal arteriogram of live donor
showing double right renal arteries (white
arrows) and single left renal artery with very
early branching (black arrow), (b) Schematic
drawing of left donor nephrectomy. Two
arterial branches were taken separately and
reconstructed ex vivo.

Case 3.—A 43-year-old woman received a
cadaveric kidney with two equal-sized arteries
widely spaced along the aorta and with two
equal-sized veins. A common caval patch with
the two veins was not used as it would have
been too wide. A single ostium was created
from the two arteries with 8-0 Prolene. The two
veins were then anastomosed side-to-side in a
similar fashion, using a double-armed 7-0 Surgilene suture. The warm ischemic reanastomo
sis time with the resultant single artery and sin
gle vein was 32 minutes. The nadir of serum
creatinine was 190 gmol/L, but the recipient
had multiple rejection episodes. His condition
stabilized with a serum creatinine value of 270
/unol/L 1 month postoperatively.
FIG. 3—End-to-side anastomosis of two ves
sels of unequal calibre.

FIG. 1—Side-to-side anastomosis of two
vessels of comparable calibre to create single
ostium.

FIG. 4—Schematic drawing of harvested left
kidney and its microsurgical reconstruction.
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Vascular Injury During Harvesting
When an unsuspected polar vessel or
a small, early branch is severed, the tech-

niques mentioned for dealing with mul
tiple vessels are applicable. An additional
problem may be loss of vessel length as
a result of the injury.

Severed Side Branches Without
Loss o f Length
Both ends of the severed vessels should
be examined carefully and trimmed. They
are reanastomosed using interrupted 9-0
or 10-0 sutures, preferably with the aid
of the operating microscope. Often an
area of “ non-clearing” is evident on the
renal surface where the initial flushing
with preservation fluid does not reach the
segment supplied by the severed branch.
Efforts should be made to flush out the
small branch either before or after
microsurgical repair.
Severed Side Branch or Polar Vessel
With Loss o f Length
If length of a vessel is lost or a portion
damaged by ligatures and the side branch
does not reach its original ostium, the
small vessel can often be reimplanted endto-side to the main renal artery at a site
closer to the renal hilum.
The following case demonstrates situ
ations in which side branches are severed
with and without loss of vessel length.
Case 4.—A 55-year-old diabetic man
received a cadaveric kidney from a 39-year-old
donor, harvested elsewhere. At the time of har
vesting, a lower-pole branch with early take
off was severed. The distal end was damaged
by a ligature. At the time of flushing, an area
2 x 2 cm in the upper pole did not clear (Fig.
5). On closer examination, a small upper pole
branch obscured by perinephric fat had been
sharply transected. There was no loss of ves
sel length from this upper pole branch. The
lower pole branch with some loss of length was
reimplanted into the side wall of the main
artery with 8-0 interrupted Ethilon sutures at
a site closer to the renal hilium. The upper pole
branch was reanastomosed end-to-end with
interrupted 10-0 Ethilon sutures. The main
renal artery was then flushed in the cold basin
to ensure watertight anastomoses and to flush
out the “ non-cleared” area in the upper pole.
Surgical anastomosis rewarm ischemic time was
38 minutes. The recipient had acute tubular
necrosis, lasting 3 weeks, before the kidney
started functioning but did well. His serum
creatinine value 5 months after operation was
150 /unol/L.

In cases in which loss of length from
the severed vessel precludes direct anasto
mosis to the main renal artery, interposi
tion of a vascular graft (preferably
autogenous) or use of the inferior epigas
tric artery may be feasible.5
Clinical Outcome

Fig. 5c
FIG. 5—(a) Repair of kidney with severed
upper pole branch and area of “ non-clearing” .
Lower pole branch was damaged by ligature,
(b) Arterial anastomoses before revasculariza
tion. (c) Kidney in patient with patent
anastomoses.

Fig. 6c
FIG. 6—(a) Digital intravenous angiogram
of transplanted kidney showing normal vas
culature after microvascular reconstruction.
Subtraction angiogram of same kidney show
ing (b) arterial and (c) capillary phase.

We have used microsurgical angio
plasty techniques to handle kidneys with
multiple vessels. In the past 8 months, 11
such repairs on transplant kidneys were
performed. The average ex-vivo operat
ing time was 45 minutes. Kidneys that
required extensive microvascular recon
struction were repaired ex vivo before the
recipient was anesthetized. Repairs that
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were less complex (e.g., side-to-side
anastomosis o f double arteries) were per
formed just before vascular anastomosis
o f the recipient vessels.
We did not routinely perform arteriog
raphy to assess the microvascular repair,
because o f the inherent risks. Radioactive
nuclear scans of all transplanted kidneys
have demonstrated prompt perfusion
with no segmental filling defects. Digital
intravenous angiography and standard
arteriography on selected patients demon
strated normal vasculature (Fig. 6). There
was no case of hemorrhage, calyceal
fistula formation or immediate postoper
ative hypertension.

Discussion
Discarding a donor organ is a waste of
precious material and discouraging to
donor hospitals. Efforts to reduce this
wastage must be pursued. In the past,
organs may have been discarded because
o f multiple arteries or vascular injury. We
believe the majority of kidneys can be sal
vaged by applying the basic microsurgical techniques outlined. Moreover, mul
tiple renal vessels requiring multiple (and
often cumbersome) in-situ anastomoses
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Potentiators: urinary acidifiers, oral anticoagulants, sulfo
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can be modified structurally to facilitate
the revascularization procedure. The exvivo microvascular techniques are not
complex and do not require elaborate sur
gical equipment. A combination o f the
basic anastomotic techniques is often
required to deal with various vascular
arrangements. This portion of the surgery
can be performed ex vivo in the cold basin
before the recipient is anesthetized, so
that patient anesthetic time is not
prolonged. More importantly, the vascu
lar anastomoses to recipient vessels are
much simpler. The warm ischemic time
is shortened, compared with the time
required for multiple in-situ anastomoses,
which is of paramount importance in
patients receiving a nephrotoxin like
cyclosporine. The Canadian Multicentre
Transplant Study Group7 observed that
the cyclosporine nephrotoxicity effect is
exacerbated by a warm ischemic time
exceeding 45 minutes.
In summary, we have outlined the var
ious clinical situations in which microsurgical repair can be used to salvage some
kidneys for transplantation and to facili
tate revascularization in other kidneys.
We conclude that microvascular surgery
is an important adjunct to the armamen
tarium of the transplant surgeon.
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Les complications du traitement du cancer
du col uterin par radiotherapie
Le traitement du cancer du col ut6rin par
radiotherapie a conduit 6 des complica
tions soit digestives, urologiques ou
gynecologiques chez 275 des 939
malades (2 9 .3 % ) traitees a I'hopital
Notre-Dame de Montreal, de 1979 a
1981.
Dans 55 cas (5 .9 % ), il a fallu recourir
a un traitement chirugical pour pallier a
73 complications: 42 complications
digestives sous forme d'occlusions (25),
de fistules (13) et de perforations (4); 22
complications urologiques sous forme
d'occlusions (16), de fistules (5) et
d'hemorragie (1); 6 complications
gynecologiques, sous forme d'hemorrhagie (3) ou de necrose uterine (3); 1
necrose cutanee, 1 vasculaire et 1
osseuse.
Les auteurs n'ont pas trouve de corre
lation directe entre I'incidence des com
plications et certains facteurs favorisants
tel que le type de radiotherapie adminis
tree, I'age des malades trait6s, le stade
de la neoplasie et la presence de chirurgie gynecologique anterieure au traite
ment radiotherapeutique. Par contre, la
relation entre I'incidence des complica
tions et la dose de rayons administree et
la presence de chirurgie gynecologique
posterieure au traitement radiotherapeu
tique est hautement significative.
Dans le groupe des complications trai
tees par la chirurgie, la morbidity a ete
elevee: les 55 malades ont du subir en
moyenne 2.36 interventions, 2.98
anesthesies generates, 1.81 hospitalisa
tions d'une duree moyenne de 75.7 jours
et 21 patientes sont devenues porteuses
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d'une ou plusieurs stomies definitives. La
mortalite a et6 de 5 .4 5 % .
Le traitement chirurgical a et6 individu
alise pour chaque cas. Les complications
digestives et urologiques ont ete traitees
par une derivation lorsqu'une resection
aurait ete trop extensive ou dangereuse.
Des resections limitees ont ete utilisees
pour traiter aussi bien les occlusions et
les fistules que les perforations chaque
fois que cela etait possible. La majorite
des lesions du rectum ont ete traitees
par operation de Hartmann et
colostomie.

Of 939 patients treated by radiotherapy
for carcinoma of the cervix at the hopital
Notre-Dame in Montreal, between 1979
and 1981, 275 (2 9 .3 % ) had digestive,
urologic, gynecologic, vascular, osseous
and cutaneous complications. Surgery
was necessary to treat 73 complications
in 55 patients (5 .9 % ): 42 digestive (25
occlusions, 13 fistulas and 4 perfora
tions); 22 urologic (16 occlusions, 5
fistulas, 1 hemorrhage); 6 gynecologic (3
hemorrhage and 3 uterine necrosis); 1
cutaneous, 1 vascular and 1 osseous
necrosis.
No direct correlation was found
between the incidence of the complica
tions and certain predisposing factors
such as the type of radiotherapy,
patients' age, stage of the disease and
gynecologic surgery before radiotherapy.
However, there was a strong correlation
between the incidence of complications
and the dose of radiotherapy and the
need for gynecologic surgery after radi
otherapy.
High morbidity was observed in the 55
patients treated surgically: they had to
undergo a mean of 2.36 operations
each, 2.98 general anesthetics, 1.81
hospitalizations (mean duration 75.7
days); 21 had one or more definitive
stomas. The death rate was 5 .4 5 % .
Surgical treatment was individualized.
Limited resections were performed for

occlusions, fistulas and perforations
whenever it was technically feasible to
treat digestive and urologic complica
tions.
A bypass procedure was used when
resection would have been too extensive
or dangerous. The majority of rectal
lesions were treated by colostomy and a
Hartmann procedure.

La radiotherapie est un mode therapeutique accepte dans le traitement du can
cer invasif du col uterin. La survie globale a 5 ans qui etait d’environ 35% dans
les annees 40, est actuellement de 65%.!
Dans notre centre, une etude recente a
montre que la survie a 5 ans a atteint
78.6% et celle a 10 ans, 74.3% pour les
neoplasies du col au stade lb (FIGO) trai
tees par cette modalite.2
Cette therapeutique est cependant grevee de complications dont l’eventail est
tres large.3-18 Dans la majorite des cas,
un traitement medical suffit a enrayer les
complications d’ileite, de rectite et de
cystite mais chez un nombre non negligeable de malades, la gravite des compli
cations impose une approche chirurgicale.6,17,18-32
La presente etude porte la nature et
l’etendue du traitement des complications
post-radiotherapie en fonction de la dose
administree, du type de radiotherapie
re?ue, de I’age des malades traitees, du
stade de la neoplasie, de la duree des examens de surveillance et de la presence ou
de l’absence de chirurgie anterieure ou
posterieure a l’irradiation. On s’est atta
che plus particulierement a etudier la mor
bidity et la mortalite ainsi que le resultat
du traitement des complications postradiotherapie ayant necessity une correc
tion chirurgicale.
Materiel et methodes

Dejanvier 1969 a decembre 1981, 1086
malades porteuses d’un cancer invasif du
col uterin ont ete traitees par radiotherapie a I’hopital Notre-Dame.
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Les dossiers medicaux de ces patientes
ont ete etudies. Cent quarante-sept n ’ont
pas ete retenus pour les raisons suivantes: abandon premature du traitement,
absence d’examens de post-cure ou radio
therapie a titre palliatif pour une maladie a un stade trop avance. Ce qui porte
le nombre total de dossiers utilises a 939.
La periode de surveillance varie d ’un
a 14 ans. Cinq cent cinq malades ont ete
suivies d ’un a 5 ans, 294 de 5 a 10 ans et
140 pendant plus de 10 ans apres leur trai
tement.
Les techniques d ’irradiation ont varie
suivant le stade clinique de la maladie.
Cependant, les doses a la tumeur se situerent entre 5000 rad en 5 semaines et 7500
rad en 7 semaines, avec des extremes de
3600 a 13 200 rad. Ainsi, 9.9% des mala
des ont re?u moins de 5000 rad, 39.5%
ont re?u entre 5000 et 8000 rad, 41.3%
entre 8000 et 10 000 rad et 9.3% 10 000
rad et plus (tableau I).
En general, le traitement consista dans
l’irradiation du bassin, des trous obturateurs aux cretes iliaques, par un champ
de 225 cm2 suivie d’une surdose a la
tumeur de 2000 rad par irradiations endocavitaires (sonde endo-uterine plus colpostat ou moulage vaginal radifere) (727
cas). Cependant, 166 patientes n ’eurent
qu’une irradiation externe et 46 malades
eurent une irradiation endocavitaire
isolee.
Tous les plans de traitement furent faits
avec des courbes d ’isodose calculees au
moyen d’un ordinateur.
Repartition des stades cliniques
Trois cent quarante-trois malades
furent traitees pour cancer au stade I
(36.5%), 290 pour un stade II (30.9%),
187 pour un stade III (19.9%) et 42 pour
un stade IV (4.5%). Enfin, 77 patientes
(8.2%) n’ont pu etre classifies, le dia
gnostic de cancer du col ayant ete effectue chez elles sur un echantillon anatomopathologique apres hysterectomie pour
raisons diverses.
Distribution de 1’age
La moyenne d’age des patientes traitees
fut de 54.8 ans avec un ecart de 18 a 85
ans. Au moment du traitement, 26.6%
des malades avaient moins de 45 ans,
36.9% avaient entre 45 et 60 ans et 36.5%
avaient 60 ans et plus.

complications requerant un traitement
chirurgical): la classe 0 a MI represente
I’absence ou la presence de reactions
aigues temporaires reversibles survenant
pendant le traitement de radiotherapie et
se resolvant dans les semaines qui suivent
l’arret de celui-ci. Elies se presentent sous
forme de douleurs abdominales, diarrhees, cystites, rectites et dyspareunies.
La classe M il represente les complica
tions tardives survenant de quelques mois
a plusieurs annees apres la radiotherapie
et evoluant de fagon chronique sous
forme de subocclusion, diarrhees, cys
tites, rectites, episodes d ’hemorragie
digestive basses et fistules mineures
repondant en general de fagon satisfaisante a un traitement medical.
La classe CH represente les memes
complications que la classe precedente
mais s’exacerbant ou se compliquant et
necessitant une approche chirurgicale
pour leur traitement.
Traitement chirurgical anterieur
ou posterieur a la radiotherapie
C ent quatre-vingt-deux malades
avaient subi des interventions chirurgicales gynecologiques majeures soit
anterieurement (134), posterieurement
(44) ou encore anterieurem ent et
posterieurement (4) a la radiotherapie.
Chez les patientes operees avant la radi
otherapie, on denombre 26 hysterecto
mies subtotales, 83 hysterectomies totales
et 25 hysterectomies radicales.
Apres le traitement radiotherapeutique,
11 malades ont subi une hysterectomie
totale, 20 une hysterectomie radicale et 13
patientes ont subi une exenteration pelvienne soit pour completer le traitement
radiotherapeutique, soit pour traiter les
recidives.
Enfin, quatre malades ont subi une
hysterectomie anterieurement a la radi
otherapie et celle-ci fut suivie d’une exen
teration pelvienne.
De plus, 31 patientes ont eu des inter
ventions chirurgicales mineures longtemps avant le traitement de la neoplasie
uterine telles que cure de hernie inguinale,
appendicectomie, ovariectomie, et resec
tion de diverticule de Meckel. Ce dernier
groupe ne fait pas l’objet d’une etude
statistique particuliere dans les relations
entre le traitement chirurgicale anterieur
ou posterieur a la radiotherapie et les
complications.

partir de plusieurs facteurs (variable —
predictrice) consideres simultanement.

Resultats
Incidence, morbidity, mortality et
traitement des complications
Classe 0-M I.—Dans cette categorie de
complications, on denombre 664 malades
(70.7%) (tableau II). Elles ont ete traitees
avec succes par des moyens conservateurs:
mesures hygieniques et dietetiques telles
que regime pauvre en residus, analgesiques, antispasmodiques, emollients,
lavements aux steroides et repos.
La morbidite a ete negligeable et la
mortalite a ete nulle.
Classe M IL —On y compte 220 malades
(23.4%) (tableau II). Ces complications
evoluant de fagon chronique ont en
general repondu de fagon satisfaisante au
traitement medical tel que decrit dans la
classe 0-M I mais dans un certain nombre
de cas, elles ont evolue vers la classe
suivante (CH).
Dans cette classe, le taux de rehospitali
sation pour traitement ou investigation a
ete de 14% et la mortalite a ete nulle.
Classe CH.—Chez 55 malades (5.9%),
il a fallu recourir a un traitement chirur
gical pour pallier a 73 complications postradiotherapeutiques (tableau II).
Le delai d’apparition des complications
a varie d ’un mois a 13 ans (moyenne: 2
ans et 8 mois).
On releve 42 complications digestives
dont 25 occlusions de l’intestin grele ou
du colon, 13 fistules entero-vaginales ou
entero-cutanees et 4 perforations intestinales.
On compte 22 complications urologiques sous forme d’occlusions ureterales,
Tableau 1-Dose d'irradiation a la tumeur
chez 939 patientes
Dose, rad x 103

No.(%) de patientes

< 5
5 -6
6 -7
7 -8
8 -9
9-10
10-11
> 11

93 (9.9)
64 (6.8)
124(13.2)
183(19.5)
244 (26.0)
144(15.3)
56 (6.0)
31 (3.3)

Tableau II—Incidence des complications

Classification des complications
post-radiotherapie

Analyse statistique

Nous avons classifie les complications
survenues apres la radiotherapie suivant
une modification du systeme de classifi
cation propose par Kagan et collaborateurs33 (M = reactions aigues aux radia
tions ou com plications chroniques
requerant un traitement medical; CH =

La statistique du x2 a ete utilisee pour
verifier l’independance de certaines vari
ables.
Les resultats ont par ailleurs fait l’objet d ’une analyse de regression multiple,
l’objectif de cette methode statistique
etant de predire l’apparition de l’une ou
P autre complication (variable — cible) a
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Classe

No. (%) de patientes

(L M I
664 (70.7)
Mil
220123.4)
CH__________________________ 55 (5.9)
0 -M I - reaction secondaire a la radiotherapie
aigue et reversible, Mil - complication tardive
et chronique necessitant un traitement medical
soutenu, CH - complication necessitant un
traitement chirurgical.
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de fistules urinaires hautes ou basses et
d’hemorragie.
Enfin, il y eut six complications
gynecologiques dont trois hemorragies
intarissables et trois necroses massives de
l’uterus, une complication cutanee sous
forme de necrose etendue de la region
sacree, une complication vasculaire sous
forme de fibrose retro-peritoneale ayant
entraine un syndrome de Leriche, et une
complication osseuse sous la forme de
fracture pathologique des deux cols du
femur.
Les occlusions digestives ont ete trai
tees par 6 viscerolyses, 4 derivations ileocoliques, 7 resections sementaires du
grele, 16 resections coliques segmentaires
ou hemicolectomies et 1 amputation du
rectum. Elies ont conduit a six colosto
mies definitives et six colostomies temporaires.

-de 5
(93)

Les fistules digestives ont necessite trois nephrectomie, 1 uretero-sigmoidostomie
operations de Hartmann, cinq resections et 1 hemostase vesicate, avec 5 conduits
coliques et deux resections segmentaires ileaux definitifs.
Quant aux complications gynecolo
du grele. Neuf malades dans ce groupe
ont eu des colostomies definitives et deux, giques, elles ont necessite trois ligatures
des deux arteres hypogastriques, deux
des colostomies temporaires.
Les perforations digestives ont ete trai hysterectomies elargies et une exentera
tees par operation de Hartmann chez tion anterieure avec une stomie definitive.
La complication de necrose cutanee a
deux malades, une resection du grele chez
une autre et une caecostomie chez la ete traitee par un lambeau de rotation,
quatrieme. Deux stomies ont ete defini debridement et nouvelle greffe cutanee.
La complication vasculaire a ete traitee
tives et une temporaire.
Vingt-deux complications urologiques par un pontage axillo-femoral droit et
sont survenues chez 15 malades; soit 16 femoro-femoral. Enfin, une des deux
stenoses ureterales, 2 fistules uretero- fractures pathologiques du col du femur
vaginales, 2 fistules vesico-vaginales, 1 a ete traitee par prothese de Moore.
Le traitement de ces complications a
fistule uretero-cutanee et 1 cystite hemorragique. Elies ont conduit a 10 uretero- necessite un total de 130 interventions
cysto-neostomies, 6 trans-uretero-uretero- chirurgicales avec pour chaque malade
stomies, 2 ureterolyses, 2 ileo-uretero- une moyenne de 1.81 ±0.75 hospitalisa
stomies, 1 cystectomie complete. 1 tions (ecart de 1 a 6) d’une duree de
75.7 ± 48.6 jours (9 a 219) et une moyenne
2.98 ± 1.9 anesthesies generates (1 a 10).
La morbidite postoperatoire a ete
importante avec 15 episodes de septicemie, 5 fistules digestives, 4 eventrations,
5 necroses de colostomie, 13 infections de
plaie, 6 ileus paralytiques, 2 pneumonies,
3 insuffisances renales graves dont une
seule a ete reversible, 3 thrombo-phlebites
profondes, 1 embolie pulmonaire, 1
infarctus du myocarde, 2 pathologies psychiatriques et 1 atteinte du nerf VIII par
toxicite a la gentamicine. Sur les 55
malades traitees, 21 sont devenues porteuses d’une ou plusieurs stomies externes
definitives.
Trois patientes sont decedees dans la
periode postoperatoire immediate.

5-6
6-7
7-8
8-9
9-10
(64) (124) (183) (244) (144)
Dose refue,milliers de rad

10-11
(56)

11 +
(31)

FIG. 1_Distribution des types de complications (classes Mil = colonnes hachurees, CH
colonnes pointillees) en fonction de la dose d’irradiation.
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,

%

Relation entre la dose d ’irradiation
et les complications
II existe une relation tres significative
entre la dose de rayons administree, le
nombre et la gravite des complications
post-radiotherapie (x2 = 112, 6, dl =
14, p < 0.0001). Comme en temoigne la
figure 1, des 93 malades ayant regu moins
de 5000 rad, aucune n’est classifiee M il,
et une seule (1.1%) est classifiee CH,
tandis que des 31 patientes ayant regu 11
000 rad ou plus, 67.7% sont classifies
Mil et 12.9% CH.
Relation entre le type de radiotherapie
administree et les complications

-

de 5000

8000

a

10 000

10 000
• t plus

Dose re^ue, rod
FIG. 2_Relation entre la dose recue et le type d’irradiation utilise (combinee = colonnes
intillees, externe = colonnes hachurees, interne = colonnes lignees).

Bien que le taux de complications Mil
et CH soit plus eleve lorsque des tech
niques d’irradiations combinees ont ete
utilisees, la relation n’est pas statistiquement significative (p = 0.1191) (fig. 2).
Cependant, l’analyse statistique fait
ressortir que ce sont les patientes qui ont
ete traitees par radiotherapie externe et
interne combinees qui ont regu le plus
d’irradiation (x2 = 178.3, dl = 6, p <
0.0001) (fig. 3).
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Relation entre I'age des malades traitees
et les complications
On ne trouve pas de relation statistiquement significative entre l’age auquel les
malades ont regu de la radiotherapie et
les complications post-radiotherapie (fig.
4). Tout au plus, decele-t-on une tendance
a une dimunition du taux de complica
tions M il et CH avec la progression de
l’age des groupes traites.
Relation entre le stade de la neoplasie
traitee et les complications
On note que plus les stades sont
precoces, plus leur traitement se solde par
des complications de type M il et CH
(tableau III). Cependant, la relation n’est
pas statistiquement significative (p =

lement en fonction d ’autres facteurs tels
que la susceptibilite individuelle, la radiosensibilite specifique des organes touches,
le type de radiotherapie administree, l’age
des malades traitees, le stade de leur neoplasie, la presence de chirurgie au niveau
de la sphere irradiee anterieurement ou
posterieurement a la radiotherapie, l’obesite, la diabete et les maladies inflammatoires du petit bassin.35
Des doses optimales ne depassant pas
5000 rad sont recommandees afin d ’eviter les complications.3 ' 13->9.27,28,36 ^ c e s
niveaux, le risque de lesion des visceres
se situe entre l°7o et 5%, mais il atteint
progressivement des taux de 25% a 50%
lorsque la dose de rayons utilisee depasse
ce plafond optimal.34
Notre serie confirme cet etat de chose.
Elle demontre que la relation entre la dose

0.17).

Relation entre la duree des examens
de surveillance et le type de complications
Comme le demontre le tableau IV, les
complications de type M il sont passees
de 18.4% apres 1 a 2 ans de surveillance
post-therapeutique pour se stabiliser aux
alentours de 25% par la suite.
Les complications necessitant une solu
tion chirurgicale sont passees de 2.2% a
10.5% entre la 2e et la 5e annee de sur
veillance pour se stabiliser ensuite aux
environs de 5%.

d ’irradiation et le taux de complications
est hautement significative (p < 0.0001).
Au total, sur les 939 malades, les 220
(23.4%) qui ont souffert de complications
de type M il, avaient toutes regu plus de
5000 rad et 55 (5.9%) ont presente des
problemes de type CH (tableau II). Aux
extremes, sur les 93 patientes ayant ete
traitees avec moins de 5000 rad, aucune
n ’a ete classee M il et une seule (1.1%) a
ete classee CH, alors que dans le groupe
des 31 malades traitees avec 11 000 rad
et plus, 21 (67.7%) ont souffert de com
plications M il et 4 (12.9%) ont du avoir
recours a une solution chirurgicale (CH)
(fig- 1).
Le delai d’apparition des complications
peut etre extremement long. Dans notre
etude, il a ete limite a 14 ans par la duree
de la surveillance post-therapeutique,

100

%
80

60

40

20
Relation entre la presence ou I’absence
de chirurgie anterieure ou posterieure
a I’irradiation et Vapparition
des complications
Le taux de complications n ’est pas
greve par la chirurgie gynecologique subie
avant la radiotherapie, quelqu’en soit le
type (tableau V).
Le nombre de patientes ayant subi une
intervention en periode pre- et postradiotherapie est trop limite (4) pour pouvoir avoir une signification statistique.
Par ailleurs, le taux de complications
CH est significativement plus eleve
(p < 0.001) chez les patientes operees
apres le traitement de radiotherapie
(tableau VI). Ce sont en particulier les
malades qui ont subi des hysterectomies
radicales et des exenterations pelviennes
qui sont les plus fragiles.

0
Combinee

Externe

Interne

n *727

n * 166

n “ 46

FIG. 3—Distribution des complications selon le type d ’irradiation regue (M il = colonnes
hachurees, CH = colonnes pointillees).

Discussion
Les techniques modernes de radiothe
rapie permettent une orientation et une
concentration optimale de la dose cytotoxique vers et sur la lesion neoplasique
visee. Malgre tout, les visceres sains avoisinants sont la plupart du temps atteints
a des degres divers par les rayons
utilises34 et le degre de gravite de cette
atteinte est dose-dependant et varie ega270

m oins de
4 5 a ns

45a60ans

6 0 ans et
p lu s

FIG. 4—Distribution des types de complications en fonction de I’age (Mil = colonnes hachu
rees, CH = colonnes pointillees).
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Ainsi, ce sont les malades qui ont subi un cerne les complications de type CH lorstraitement de radiotherapie combine que l’on compare le groupe ayant neces
(interne et externe) qui ont regu le plus de sity un traitement chirurgical additionnel
rayons (figs. 2 et 3); les malades jeunes a la radiotherapie pour le traitement de
leur cancer par rapport au groupe exempt
ont un taux plus eleve de complications
mais ce sont elles qui ont ete traitees le de chirurgie (tableau VI). Ce sont en parplus agressivement; ainsi, 64.4% des ticulier les malades qui ont subi des hyste
patientes de moins de 45 ans ont regu plus rectomies radicales et des exenterations
de 8000 rad contre 58.3% pour les patien pelviennes qui paient le plus lourd tribut.
tes agees de 45 a 60 ans et 49.7% pour (Notre etude comporte cependant un biais
puisque pour des raisons techniques, nous
les malades agees de plus de 60 ans (p <
n ’avons pu introduire les 31 malades
0.0008).
Enfin, la relation entre le taux de com ayant subi des interventions abdominales
mineures avant le traitement de leur can
plications et les stades traites est egalecer du col.)
ment essentiellement dose-dependante.
Les reactions secondaires aux radia
Les stades precoces ont en general ete trai
tions de type 0-MI sont aigues. Elies sont
tes plus vigoureusement que les stades III
et IV ce qui explique leur taux de com le lot de la majorite des malades traitees
par radiotherapie pour cancer du col.
plications legerement plus eleve (tableau
Elies sont heureusement benignes et ne
III).
Par ailleurs, bien que 31.3% de nos durent que le temps du traitement radiomalades ayant subi une intervention gyne- therapeutique. La morbidite est negligeable et un traitement conservateur minimal
cologique anterieure a la radiotherapie
aient presente des complications de type suffit a la juguler. Elle est le resultat d ’une
M il et CH, la relation avec le groupe atteinte des cellules muqueuses radiosenn’ayant jamais subi de chirurgie n ’est pas sibles du tractus gastro-intestinal et n ’a
significative (tableau V), contrairement pas de relation avec les complications taraux resultats d ’autres publications.6-35-37 dives.34
Les complications de type M il sont
La relation est par ailleurs hautement
significative (p < 0.001) en ce qui con- plus insidieuses et ont d’emblee un caractere de chronicite. Le plus souvent, elles
apparaissent dans un delai de 6 mois a 2
Tableau Ill-Distribution (%) des types de complications Mil et CH en
ans apres le traitement. Dans notre etude,
fonction des stades traites
leur frequence se stabilise aux alentours
Stade IV
Stade III
Stade II
Stade 1
de 25% apres ce delai. Elles correspon
(n = 42)
(n = 187)
(n = 290)
(n - 343)
Classe
dent a une vasculite obliterative, une atro21.4
phie muqueuse et une fibrose de la paroi
21.9
23.1
25.7
Mil
2.4
3.7
7.6
5.8
intestinale.34
CH
La morbidite de ces complications
77 classifications sont manquantes.
requiert de frequentes hospitalisations
pour investigation ou traitement. Un trai
tement conservateur ne reussit pas touTableau IV—Distribution (%) des types de complications Mil et CH en
jours a stabiliser le processus. La resis
fonction de la duree de la surveillance post-therapeutique
tance au traitem ent m edical avec
Duree, ans
rectorragies severes, tenesme et douleurs
>
10
5 -1 0
2 -5
1 -2
Classe
rebelles, occlusions digestives et fistules,
23.6
25.9
26.1
18.4
Mil
et deterioration de l’etat general conduit
4.3
6.1
10.5
2.2
CH
une certaine porportion de ces malades
vers la classe CH. Cette evolution peut
survenir n’importe quand et elle est
Tableau V—Distribution (%) des types de complications Mil et CH en
imprevisible meme lorsque le delai ecoule
fonction de la chirurgie pre- et post-radiotherapie
depuis le traitement radiotherapeutique
Chirurgie
Chirurgie
Absence de
est de plusieurs annees. La symptomapost-radiotherapie
pre-radiotherapie
chirurgie
tologie peut faire penser a une recidive de
(n = 44)
(n - 134)
(n = 757)
Classe
la neoplasie. Elle impose des examens pel15.9
26.1
23.5
Mil
viens sous anesthesie generate, de multi
15.9*
5.2
5.3
CH
ples biopsies, des rectosigmoidoscopies,
des pyelographies endoveineuses et des
*p < 0 .0 0 1 .
cystoscopies.
Comme on peut s’y attendre, en raison
Tableau VI—Distribution (%) des types de complications Mil et CH en fonction de
de leur relation etroite avec la sphere genila chirurgie post-radiotherapie
tale et de leur radiosensibilite, ce sont
Chirurgie post-radiotherapie
l’ileon, le colon sigmoidien et le rectum
Exenteration
qui sont les localisations des complica
Hysterectomie
Hysterectomie
Absence de
pelvienne
tions post-radiotherapeutiques les plus
radicale
totale
chirurgie
(n - 13)
In = 20)
frequentes et ce sont ces lesions qui neces(n - 11)
(n = 757)
Classe
sitent le plus souvent une correction chi38.4
0.0
18.2
23.5
Mil
23.2*
rurgicale. Les complications urologiques
20.0*
0.0
5.3
CH
prennent la seconde place, suivies des
*P < 0.001.
complications gynecologiques. Les attein-

mais il peut atteindre 20 ans et
plus.18,34' 37 De plus, l’incidence des com
plications reste stable dans le temps (plus
ou moins 25% pour la classe M il et plus
ou moins 5% pour la classe CH).
Ceci attire une fois de plus l’attention
sur l’importance des antecedents radiotherapeutiques pour Revaluation d ’un
malade presentant un probleme abdomi
nal quel que soit le delai ecoule depuis
1’irradiation.
C ontrairem ent a d ’autres e tu 
des,1w s , 2?,35,38,39 nous n ’avons pas trouve
de correlation directe entre l’incidence des
complications M il et CH et certains facteurs favorisants etudies tels que le type
de radiotherapie administree, l’age des
malades traitees et le stade de la neoplasie. Le seul denom inates commun statistiquement significatif reste la dose de
rayons administree. L ’analyse de regres
sion multiple confirme cet etat de chose:
l’etude des variables telles que la dose
d’irradiation, l’age, le type de radiothe
rapie administree, le stade de la neoplasie et la presence ou l’absence de chirurgie anterieure ou p o sterieure a
l’irradiation revele que seule la dose
d’irradiation est significative (r - multi
ple = 0.326, F = 99.8, p < 0.0001).
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tes des gros vaisseaux et des structures
osseuses et cutanees sont plus rares.
La majorite des lesions digestives et
urologiques se manifestent par des suboc
clusions ou des occlusions des visceres.
Un nombre non negligeable de celles-ci
evoluent cependant vers la fistulisation.
Les complications gynecologiques sont
essentiellement d’ordre hemorragique et
necrotique.
Les modalites du traitement chirurgical des complications digestives sont
l’objet d ’une controverse dans la litterature. Les interventions de derivation ont
pour avantage de limiter les dissections
extensives ce qui evite de compromettre
la vascularisation deja deficiente des anses
intestinales touchees par la radiothe
rapie.7’25’26'37 Se basant sur le fait que les
derivations n ’empechent pas la progres
sion de la radio-enterite et que, par con
sequent, elles ne mettent pas la malade a
l’abri de complications futures, d’autres
auteurs preconisent des interventions de
resection.12’20 Enfin, certains croient que
ch aq ue cas devrait etre in d ivi
dualise.17,24’29’32
Dans notre serie, les derivations ont ete
utilisees essentiellement chez les malades
pour qui une resection aurait ete exten
sive et dangereuse. Chaque fois que cela
a ete possible, une resection limitee a ete
pratiquee pour traiter aussi bien les occlu
sions et les fistules que les perforations.
Les lesions du rectum ont ete traitees
majoritairement par colostomie de deri
vation avec operation de Hartmann. Les
fistules entero-vaginales ont ete traitees
soit par resection soit par diversion temporaire avec interposition d’epiploon sur
le foyer de la fistule.
Sur le plan urologique, on a tente d’utiliser, chaque fois que cela etait possible,
l’arbre urinaire inferieur; ainsi, 10 des 16
stenoses ureterales ont pu etre corrigees
par uretero-neo-cystostomie. Dans la
majorite des autres cas, il a fallu recourir a des derivations conduisant chez un
tiers des patientes a des conduits ileaux.
Bien que la mortalite postoperatoire
(5.45%) soit relativement acceptable dans
les circonstances, la morbidite a ete elevee et ce en raison non seulement de la
precarite des tissus operes mais egalement
de la malnutrition et des deficiences
immunitaires dont sont atteintes la majo
rite de ces patientes. Plusieurs d’entreelles ont du subir des interventions iteratives et la duree moyenne des hospitali
sations a ete tres elevee (75.7 jours).
Enfin, 38% des 55 malades traitees sont
porteuses d ’une ou plusieurs stomies
externes definitives.

Conclusions
Le traitement du cancer du col par
radiotherapie a cause par ordre de fre
quence des complications enteriques, uro
logiques, gynecologiques, vasculaires,
272

cutanees et osseuses chez 29.3% des 939
malades qui ont ete traitees dans notre
institution sur une periode de 13 ans. La
frequence des complications a ete directement proportionnelle a la dose de
rayons administree et la relation avec
d’autres facteurs favorisants n’a ete
qu’indirecte.
Dans 5.9% des cas, les complications
ont necessity un traitement chirurgical. La
resection du segment malade a ete [’inter
vention de choix dans les complications
digestives et urologiques et les derivations
ont ete reservees aux cas ou la resection
n’etait pas realisable.
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Parathyroid Exploration for Primary Hyperparathyroidism
Parathyroidectomy was studied
retrospectively in 107 patients with
primary hyperparathyroidism. This condi
tion was diagnosed by measuring both
the total serum calcium and ultrafilterable calcium (non-protein-bound) levels.
The identification of ultrafilterable cal
cium is an important adjunct to
parathyroid surgery as it allows the diag
nosis of hyperparathyroidism when the
total serum calcium level is normal. The
surgical technique for selective
parathyroidectomy and multiple biopsies
was uniform. Parathyroid adenoma was
discovered in 73 patients, diffuse hyper
plasia in 26 and combined disease in 8.
Postoperatively, two patients suffered
from permanent hypocalcemia and three
had hypercalcemia.

Les resultats de la parathyroidectomie
ont ete etudies retrospectivement chez
107 patients souffrant d’hyperparathyroVdie primaire. La maladie a ete diagnostiquee par determination de la calcemie
totale de meme que des taux de calcium
ultrafiltrable (non lie). L'identification du
calcium ultrafiltrable est une aide impor-
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The surgical technique was similar in
all cases. Through a collar incision, care
ful exploration identified the parathyroid
tissue in a bloodless field. A small seg
ment was excised from each parathyroid
gland encountered and sent for immedi
ate histologic study. Parathyroid ade
nomas were completely removed and nor
mal glands left in situ unless they were
abnormally large. When all the glands
were hyperplastic, they were excised, leav
ing a glandular remnant with an estimated
mass of 40 to 60 mg. Glands, or portions
thereof left in situ, were marked with
black silk sutures in case re-exploration
Surgery of the parathyroid glands for was necessary later.
We disagree with the practice of discon
primary hyperparathyroidism is con
troversial. The preferred surgical tech tinuing exploration if an adenoma along
nique varies1-3 and the histologic find with one normal gland is found, because
ings are often difficult to interpret by even there is ample evidence that multiple ade
the most skilled pathologist.4 We review nomas can exist.5,6 Further, we do not
retrospectively 107 patients who had concur that if two glands are hyperplas
parathyroid exploration for primary tic, then all glands must be so.7 Subtotal
hyperparathyroidism to study the diag parathyroidectom y as advocated by
nostic methods used, the reliability of Paloyan and associates3 was not per
accurate measurements of total and formed routinely. Our surgical technique
ultrafilterable serum calcium levels, the was similar to that of Clark and
results following a uniform surgical colleagues8 in which all glands are iden
tified and selective excision is performed.
approach and the histologic findings.
We did not localize glands by arteriog
raphy, selective venous sampling or toluidine blue staining. In recent years tomog
Patients and Methods
raphy and ultrasonography have localized
During a 20-year period, the senior enlarged glands in some patients but use
author (J.R.M .) performed parathyroi of these techniques does not preclude
dectomy on 107 patients with a diagno thorough surgical exploration.
sis of primary hyperparathyroidism. As
in most series, women were affected more Diagnosis
often than men. There were 79 women
The presence of a calcium research
(average age 56 years) and 28 men (aver
laboratory at the Kingston General
age age 45 years).
The principal clinical features o f this Hospital permitted accurate measure
disorder were renal stones (44 patients), ments o f total serum calcium and
bone disease comprising osteoporosis and ultrafilterable calcium (non-proteinosteitis fibrosa (44 patients), constitu bound) levels. The diagnosis of hyper
tional symptoms that included fatigue, parathyroidism was based on the demon
lassitude, anorexia, depression and gener stration of elevated total serum and or
alized pain (51 patients), and gastrointes ultrafilterable serum calcium levels with
tinal complaints—peptic ulcer, indiges the exclusion of other causes of hyper
tion, constipation (26 patients). In 13 calcemia. The upper limits of normal in
cases, unsuspected hypercalcemia was dis this laboratory (for both sexes) for total
covered during routine biochemical serum calcium and ultrafilterable serum
calcium are 2.54 m m ol/L and 1.46
screening.

tante a la chirurgie parathyroidienne car
elle permet le diagnostic d'hyperthyroidie
meme en presence d'une calcemie totale
normale. La technique chirurgicale de
parathyroidectomie selective ainsi que
cede des biopsies multiples ont ete uniformes. Un adenome parathyroTdien a ete
decouvert dans 73 cas, une hyperplasie
diffuse dans 26 cas et une maladie combinee, 8 fois. En postoperatoire, deux
patients ont ete atteints d'hypocalcemie
permanente et trois ont presente une
hypercalcemie.
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mm ol/L respectively. Measurement of
urinary cyclic adenosine monophosphate
excretion (immunoassay kit supplied by
New England Nuclear, Boston, Mass.)
and serum immunoreactive parathyroid
hormone (immunoassay kit supplied by
Nichols Institute Diagnostics, San Juan
Capistrano, Calif.) were of limited diag
nostic value.

Adenoma was discovered in 73 patients
(including one adenocarcinoma), diffuse
hyperplasia in 26 and combined adenoma
and hyperplasia of the parathyroid glands
in 8. In the eight patients with hyperpla
sia, glands were diagnosed as normal on
microscopic examination of frozen sec
tions, but focal nodules of hyperplasia
were evident on examination of the per
manent sections.
Surgical exploration identified 84% of
the glands in 102 patients (assuming an
average o f four parathyroid glands per
patient); more than four glands were
found in the other 5—five glands in 4 of
them and eight glands in the fifth. The
anatomic locations of the glands, espe
cially the inferior pair, were highly vari
able, as reported by others.9 Ectopic
glands were found in the thyroid glands,
the thymus gland, the carotid sheath, on
the lower trachea, posterior to the esopha
gus, in the posterior superior mediasti
num and retrosternally. In one case there
were bilateral adenomas and, in another,
five discrete adenomas were located
within one parathyroid gland, confirm
ing that multiple parathyroid adenomas
do exist,5 although they are not com
mon. The 1.9% incidence of multiple ade
nomas in this series is similar to the 1.9%
incidence described by Verdonk and
Edis.6 The adenomas ranged in weight
from 35 mg to 35 g.

third of the three remaining, normal
appearing glands were removed. This
patient subsequently proved to have
benign familial hypercalcemia. In the
second patient, three glands were found:
one adenoma weighing 255 mg was ex
cised, one gland, thought to be hyperplas
tic on frozen section but subsequently
proved normal was excised and a 40-mg
remnant of a third gland, histologically
normal, was left in situ. During re
exploration, a fourth gland was not found
and hemithyroidectomy failed to reveal
parathyroid tissue within the specimen or
to alter the elevated calcium levels. In the
third patient only three parathyroid
glands were found; two were normal
histologically and the third contained an
adenoma weighing 170 mg. It seems likely
that this patient has a second adenoma
in a fourth gland that was not found.
There were no deaths or serious com
plications. Specifically, there was no case
of permanent hoarseness postoperatively
or major wound problems. A temporary
Horner’s syndrome was noted in one and
a small pneumothorax in two patients.
Other biochemical diagnostic methods
were not as accurate as the ultrafilterable serum calcium level. Measurement of
urinary cyclic AMP excretion resulted in
13 of 22 patients having surgically proven
parathyroid adenomas. This was espe
cially true in patients with mild hyper
calcemia (total serum calcium equal to or
less than 2.7 mmol/L) and in whom uri
nary cyclic AMP excretion was normal
(12 of 16). However, cyclic AMP excre
tion was elevated in five of six patients
in whom total serum calcium levels
exceeded 2.7 mmol/L. Measurement of
serum immunoreactive parathyroid hor
mone was likewise proven of limited value
because normal values were found in 59%
of the patients with surgically proven ade
nomas.

Results

Discussion

Operative Findings

Follow-up of the 107 patients, ranging
from 4 months to 20 years, revealed that
two who had adenomas removed have
permanent hypocalcemia. In one only two
glands were found, the adenoma was
completely excised and in the other, nor
mal gland, a biopsy only was done. In the
second case an adenoma was completely
excised and biopsies were done on the
three normal glands. These are the only
cases in the series in which biopsy of nor
mal glands could be incriminated as the
cause of hypocalcemia.
Three patients remain hypercalcemic
despite a second neck exploration. In one,
four glands were identified. One gland
that appeared grossly enlarged, but sub
sequently proved to be histologically nor
mal was excised, and biopsies were done
on three normal glands at the first proce
dure. Upon re-exploration two and one274

The controversy over subtotal versus
selective parathyroidectomy for hyper

parathyroidism has been reported by
many authors.2’3'10>u The policy fol
lowed in this series was that of so-called
“ selective” excision of parathyroid tissue,
based upon the gross and microscopic
appearance of the parathyroid glands at
exploration.
The reported frequency of hypocalce
mia after routine subtotal parathyroidec
tomy varies widely (Table i2.3.8,12-14).
Paloyan and colleagues3 reported a rate
of 2%, Beahrs15 13% and Bruining11
37%. It is difficult to understand why
routine subtotal parathyroidectomy
should not, eventually, lead to a higher
rather than a lower rate of subsequent
hypocalcemia than selective excision with
preservation of more of the normal
parathyroid tissue.
Persistent hypercalcemia postopera
tively results from failure to identify and
excise enough hyperfunctioning para
thyroid tissue, usually the consequence of
variation in number and location of
parathyroid glands.
The importance of accurate measure
ments of ultrafilterable serum calcium
levels in diagnosing hyperparathyroidism
deserves special attention. In this series
10 of the 107 patients had clinical
manifestations of underlying hyperpara
thyroidism but normal total serum cal
cium levels. In each of them, the
ultrafilterable serum calcium level was
elevated above the normal limit of 1.46
mmol/L. Postoperatively, they had nor
mal total and ultrafilterable serum cal
cium levels.
The criteria for histologic differentia
tion between parathyroid adenoma and
hyperplasia have been questioned,4 and
frozen-section diagnosis from a tiny
biopsy specimen of tissue cannot always
be made with accuracy. For this reason
the gross appearance o f exposed
parathyroid glands must be combined
with the pathologist’s interpretation of
frozen sections, in order to make an
accurate diagnosis in the operating room.
Thorough exploration of the neck is
required, even if an adenoma is found
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early in the operation, because of the fre
quent association of adenoma with hyper
plasia (7.8% in this series), the occasional
occurrence o f multiple parathyroid
adenomas5,6 and the possibility of more
than four glands. Some authors believe
that too thorough a search may endanger
the blood supply and functional survival
o f normal parathyroid glands, but the
occurrence of permanent hypocalcemia in
this series would indicate that it is not
likely to be a major problem if the oper
ative field is kept reasonably dry and care
ful biopsy of these “ normal glands” is
performed away from the blood supply.
Complete mediastinal exploration
through a sternal splitting incision was
carried out only once in this series.
Our policy is to consider it necessary
only after a second neck exploration,
including thyroidectomy, has failed to
reveal the presence o f abnormal para
thyroid tissue.
However, when four parathyroid
glands or an adenoma cannot be found
during exploration o f the neck, the

retrosternal tissue, including the thymus
gland, is removed through the neck inci
sion before part of the thyroid gland is
excised. Parathyroid glands are occasion
ally found in this location and can be
removed without splitting the sternum.
Our sincere thanks to the pathologists at the
Kingston General Hospital and to the staff of
the calcium research laboratory.

6. VERDONK CA, ED1S AJ: Parathyroid “ double ade
nom as": fact or fiction? Surgery 1981; 90: 523-526
7. W ang CA: Parathyroid re-exploration, a clinical and
pathological study of 112 cases. A n n Surg 1977; 186:
140-145
8. C lark OH, W ay LW, HUNT TK: Recurrent hyper
parathyroidism. Ann Surg 1976; 184: 391-402
9. W ang CA: The anatomic basis o f parathyroid surgery.
Ann Surg 1976; 183: 271-275
10. E dis AJ, Bearhs OH, van HEERDEN JA , et al: “ Con
servative” versus “ liberal” approach to parathyroid neck
exploration. Surgery 1977; 82: 466-473

References
1. H a FF RC, ARMSTRONG RG: Trends in the current
management of primary hyperparathyroidism. Surgery
1974; 75: 715-719
2. PALMER JA, Brown WA, Kerr WH, et al: The surgi
cal aspects of hyperparathyroidism. Arch Surg 1975; 110:
1004-1007

11. BRUIN1NG HA: Surgical Treatment o f Hyperpara
thyroidism; With an Analysis o f 267 Cases, Van Gorcum,
Assen, 1971
12. COFFEY RJ, lee TC, CANARY JJ: The surgical treat
ment o f primary hyperparathyroidism: a 20 year
experience. Ann Surg 1977; 185: 518-523

3. PALOYAN E, P aloyan D, P ickelman JR: Hyperpara
thyroidism today. Surg Clin North Am 1973; 53: 211-220

13. RANSOM K, H ardin CA, LUKERT B: Surgical treatment
o f primary hyperparathyroidism. A m J Surg 1977; 134:
763-764

4. FORNAS1ER VL, Rabinow ich S: A current look at
hyperparathyroidism by the pathologist. Clin Dig 1980;
35: 29-34

14. KELLY TR: Primary hyperparathyroidism. A personal
experience with 242 cases. A m J Surg 1980; 140: 632-635

5. H arness JK, Ramsburg SR, N ishiyama R H , et al:
Multiple adenomas of the parathyroids: do they exist?
Arch Surg 1979; 114: 486-474

D e n n is L. M o d r y ,

m d , m s c , f r c s c ;*

15. BEAHRS O: In discussion of BLOCK MA, FRAME B,
JACKSON CE, et al: Primary diffuse microscopical hyper
plasia of the parathyroid glands: surgical importance.
Arch Surg 1976; 111: 348-354

M ic h a e l P , K a y e ,

md|

Heart and Heart-Lung Transplantation:
the Canadian and World Experience
from December 1967 to September 1985
By Sept. 1. 1985, 62 centres around the
world were identified as having partici
pated in heart transplantation; of these
14 had also performed combined heartlung transplantation. Between December
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1967 and December 1984, 1599
recipients had undergone 1644 trans
plant procedures. By September 1985,
112 heart-lung transplant procedures
had been performed in 110 patients.
Overall survival at 1 and 3 years respec
tively, excluding perioperative mortality,
averaged 8 0 % and 6 5 % ; for heart trans
plantation alone survival rates were 8 5 %
and 7 5 % , respectively.
In Canada, of 81 heart and 5 heartlung transplant procedures that were per
formed in nine centres between April
1981 and September 1985, 38 heart
and 2 heart-lung transplants were car
ried out in the first 9 months of 1985.
Sixty-four of the heart and 2 of the
heart-lung transplant recipient were
alive from 20 days to 4.42 years
postoperatively.
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Reprint requests to: Dr. Dennis L. Modry,
Ste. 1002, 8215 — 112th Street, Edmonton,
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Au 1er septembre 1985, 62 gtablissements de par le monde avaient ete iden

tifies comme ayant participe a des greffes cardiaques; parmi ceux-ci, 14 avaient
aussi realise des greffes coeur-poumons.
De decembre 1967 £ decembre 1984,
1599 receveurs avaient subi un total de
1644 greffes. En septembre 1985, 112
greffes coeur-poumons avaient ete pratiquees chez 110 patients. A I'exclusion
des deces peroperatoires, la survie globale a 1 et 3 ans a ete en moyenne de
8 0 % et 6 5 % respectivement; pour les
greffes cardiaques seules, ces taux
etaient respectivement de 8 5 % et 7 5 % .
Au Canada, sur 81 greffes cardiaques
et 5 greffes coeur-poumons pratiquees
dans neuf etablissements entre avril
1981 et septembre 1985, 38 greffes
cardiaques et 2 transplantations co eurpoumons ont ete realises au cours des
9 premiers mois de 1985. Soixantequatre greffds cardiaques et 2 receveurs
de greffes coeur-poumons ont surv^cu
de 20 jours a 4.42 annees apres leur
operation.
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The pioneering efforts of Shumway and
Lower in the late 1950s and the 1960s
resulted in the development of surgical
techniques for both heart and heart-lung
transplantation that routinely allowed
animal survival intra- and postoperatively.1 Extended survival was then
achieved following heart transplantation
by immunosuppressing the animals with
azathioprine and prednisone.2 A reliable
method of determining organ rejection
based on a 20% decrease in cumulative
electrocardiographic voltage was recog
nized and, finally, a means of reversing
rejection episodes with pulsed doses of
steroids was developed.3 4 These efforts
provided the experimental basis for
human-to-human heart transplantation.5
Stimulated by the first few cardiac
transplant procedures, nearly 50 other
centres around the world undertook
cardiac transplantation, with little prepa
ration beyond the surgical technique
itself. Over 100 transplants were per
formed in 1968 alone and 250 by the end
of 1970. With the death of most recipients
because of infection or rejection, initial
enthusiasm waned and most centres aban
doned heart transplantation.
Over the ensuing decade, only five
centres continued heart transplantation.
By the end of the 1970s, new diagnostic
and management strategies had been
developed, leading to improved survival,
particularly at Stanford University Med
ical Center, and with the introduction of
cyclosporine immunosuppression in De
cember 1980, a renaissance in cardiac
transplantation occurred around the
world. Despite three initial failures of
combined heart-lung transplantation in
the late 1960s and early 1970s, heart-lung
transplantation was successfully restarted
clinically by Reitz and colleagues.6.
Since the introduction of cyclosporine
for clinical cardiac transplantation, 62
centres worldwide have participated in
heart or heart-lung transplantation in
1599 recipients.
The information for this report derives
from the International Heart Transplan
tation Registry,7 the Canadian Heart
Transplantation Registry, personal com
munication with the 9 Canadian centres
that have active heart transplant pro
grams, the 14 centres pursuing combined
heart and lung transplantation, and the
recent literature.
The report reviews experience in heart
transplantation from December 1967 to
December 1984 (world experience) and
until September 1985 (Canadian ex
perience), and in heart-lung transplanta
tion from March 1981 to September 1985.

heart-lung transplantation numbers 55
according to the International Heart
Transplantation Registry7 (62 by per
sonal communication). Of the 62 centres,
39 are in the United States, 9 in Canada
and 14 elsewhere.
Fifty-five centres in nine countries per
formed 1644 transplants in 1599 recipients
between December 1967 and December
1984. One thousand patients received new
organs in the United States, 53 in Canada
and 546 elsewhere. The near-exponential
rise in transplantation is illustrated by the
fact that 44.6% (713 patients) of all
transplant procedures were performed in
1984.
The predom inant age group for

recipients ranged from 35 to 55 years. Ten
recipients were younger than 10 years and
9 older than 60 years (Fig. 1).
Cyclosporine was used for immunosup
pression in 1014 of the recipients. Figure
2 compares actuarial survival for 120
patients who underwent cardiac trans
plantation with (46 patients) and without
(74 patients) cyclosporine immunosup
pression, excluding those who died within
30 days of operation. At 3 years, 74% of
recipients who had cyclosporine immuno
suppression versus 47% of those who did
not, remained alive. In order to achieve
more homogeneous groups of patients,
the above data were re-analysed for only
those patients transplanted after 1978. If

Overview
The number of centres performing
heart transplantation alone or heart and

HG. 2 Actuarial survival of 120 patients who underwent heart transplantation with and
without cyclosporine immunosuppression (p < 0.0001). (Reproduced by permission from Kaye
MP, Elcombe SA, O ’Fallow WM: J Heart Transpl 1985; 4: 290-292.)
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FIG. 3—Actuarial survival of patients who underwent heart transplantation with and without
cyclosporine immunosuppression during and after 1978. Deaths within 30 days of operation
are excluded. (Reproduced by permission from Kaye MP, Elcombe SA, O’F'allow WM: J Heart
Transpl 1985; 4: 290-292.)

mortality in the first 30 days is again
excluded, 3-year survival still remains sig
nificantly (p < 0.0001, Mayo compu
ter main-frame) improved with cyclospo
rine therapy (Fig. 3). Figure 4 illustrates
that 1- and 2-year survival rates following
combined heart and lung transplantation
are comparable to those of heart trans
plantation alone.
From a study o f the effect of age on
survival following cardiac transplanta
tion at centres where more than 20
transplant procedures have been per
formed, the International Registry for
H eart T ransplantation developed a
proportional-hazards model involving age
and cyclosporine use to determine the
probability of survival for recipients using
cyclosporine for immunosuppression by
their age at the time of transplantation
(Fig. 5). Because o f the small number of
patients at 4 and 5 years, caution must be
used in interpreting the apparent dip in
all survival curves that may relate simply
to extrapolation of the mathematical
model. While these curves represent the
means of data generated by a number of
centres, the goal of any transplant pro
gram must be to perform better than the
best, which at this time is Stanford
University Medical Center (Fig. 6).
Heart Transplantation in Canada

YEAR

FIG. 4—Actuarial survival of patients who underwent heart or heart-lung transplantation.
Survival 1 and 2 years after heart-lung transplantation is comparable to that of heart trans
plantation alone. (Reproduced by permission from Kaye M P, Elcombe SA, O ’Fallow WM:
J Heart Transpl 1985; 4: 290-292.)

FIG. 5—Probability of surviving 1, 2, 3, 4 or 5 years after transplantation for recipients rang
ing in age from 5 to 60 years.

In 1968 and 1969, 20 cardiac transplant
procedures were performed in Ontario
and Quebec. Most patients died of infec
tion or rejection within 1 year, but one
patient from Quebec survived over 4 years
before dying of rejection and a cerebro
vascular accident and one patient from
Ontario survived over 5 years. From 1970
until 1980, no further cardiac transplant
procedures were performed in Canada,
but in April 1981, Dr. Neil McKenzie at
the University Hospital in London, Ont.,
reintroduced cardiac transplantation, and
in May 1983 he performed Canada’s first

FIG. 6—Actuarial survival for patients who
underwent heart transplantation at Stanford
University Medical Center (including periope
rative mortality). O = not transplanted,
------------- = January 1968 to December 1973,
-------- = January 1974 to December 1980,
----------= December 1980 to May 1985.
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combined heart and lung transplantation.
Table I summarizes the subsequent
developments in this country. Excluding

the 20 transplants performed before 1970,
81 heart transplants in 80 recipients and
5 combined heart-lung transplants have

been performed. The age of the recipients
has ranged from 12 to 60 years,
The indications for heart transplanta-

Table 1-Heart Transplantation in Canada: April 1981 to September 1985
Centre
University Hospital, London, Ont.
Hopital Notre-Dame, Montreal
Institut de Cardiologie de Montreal
Hopital Sainte-Justine, Montreal
University of Ottawa Heart Institute
Toronto General Hospital
Royal Victoria Hospital, Montreal
Toronto Western Hospital
University of Alberta Hospitals,
Edmonton

Patients transplanted

Start of
program

M

F

Total

4/81
7/82
4/83
1/84
5/84
6/84
1/85
3/85

33
9
8
1
5
2*
5
2

6
3
4
0
1
0
1
0

39t
12
12
1
6
2
6
2

Age range,
yr
12-58
21-48
17-52
15
30-51
32, 60
42-56
26,37
41,53

7/85

Totals

2

0

2

65

15

80

'H eart—lung procedures.
t1 patient underwent a second procedure giving a total of 81 transplants in 80 patients.

Table II—Indications for Transplantation
Indication

Table V—Indications for Heart-Lung Transplantation

No. of
procedures

Cardiomyopathy
Ischemic heart disease
Valvular heart disease
Idiopathic hypertrophic
subaortic stenosis
Rejection

38
37
4

Total

81

1
1

Table Ill-S urvival* and Rehabilitation
No. (%)

Feature
Transplantations
Currently alive
Fully rehabilitated
Partially rehabilitated
Not rehabilitated

80
64 (80.0)
54 (84.4)
9(14.1)
1 (1.6)

49
44
1
1
3
3
2
1
1
1
1
1
1
1
2

Primary pulmonary hypertension
Eisenmenger's syndrome
Valvular heart disease and pulmonary hypertension
Multiple pulmonary emboli
Emphysema*
Alpha-1 antitrypsin deficiency*
Cystic fibrosist
Eosinophilic granuloma
Fibrosing alveolitist
Primary pulmonary fibrosis
Pulmonary asbestosist
Pulmonary lymphangioleiomyomatosist
Pulmonary staphylococcal infection
Pulmonary sarcoidosis
Chronic rejection*§

112

Total

'Duration of survival ranged from 20 d to 4.42

V■

No. of procedures

Indication

*1 patient still alive.
tDied.
4 Died at 23 months from progressive fibrosis and bronchial obstruction.
§2 patients underwent second procedure, giving 112 transplant procedures in 110 patients.

Table IV—Heart-Lung Transplantation: World Experience March 1981 to September 1985
Centre
Stanford University Medical Center
Hopital de la Pitie, Paris
University of Pittsburgh
Texas Heart Institute, Houston
University of Munich
University Hospital, London, Ont.
Johns Hopkins Hospital, Baltimore
University of Brussels
Harefield Hospital, Harefield,
Middlesex, England
Papworth Hospital, Cambridge,
England
Toronto General Hospital
Arizona Heart Institute, Phoenix
University of Capetown
Hanover Medical School, Hanover,
W, Germany
Totals

Patients transplanted

Start of
program

M

F

Total

3/81
3/82
5/82
7/82
2/83
5/83
7/83
8/83

17
5
11
2
2
1
3
1

10
2
15
2
0
2
1
2

27*
7
26t
4
2
3
4
3

Age range,
yr
19-45
18-42
12-45
38-55
21-27
35-47
20-35
24-

12/83

9

12

21

3.5-52

4/84
6/84
12/84
2/85

1
2
1
1

4
0
1
2

5
2
2
3

30-40
32-60
39-42
20-28

4/85

0

1

1

40

56

54

110

3.5-60

*1 patient underwent a second transplantation, giving 28 transplant procedures in 27 patients,
t l patient underwent a second transplantation, giving 27 transplant procedures in 26 patients.
278

VOLUME 29, NO. 4, JU LY 1986 / THE CANADIAN JOURNAL OF SURGERY

tion in Canada are outlined in Table II
and, like most other centres, include
predominantly cardiomyopathy and
ischemic heart disease.
Table III summarizes the survival and
rehabilitation data in the 80 heart-trans
plant recipients. Meaningful actuarial sur
vival curves cannot be generated owing
to the relatively small number of patients
and because 38 (41.5%) of the 80 received
heart transplants in the first 9 months of
1985. Nevertheless, 64 (80%) patients are
alive from 20 days to 4 years and 4
months after transplantation. Of these,
54 (84.4%) are fully rehabilitated (i.e.
follow-up longer than 3 months back at
work or carrying out preoperative activi
ties, or capable of returning to work or
carrying out preoperative activities). For
9 (14.1%) of the 64 patients the follow
up is less than 3 months and 1 patient has
no rehabilitation potential.
Sixteen recipients died — of rejection
(3), infection (2), right ventricular failure
(3), respiratory failure (3), “ stone heart”
(2), pancreatitis (1), thrombotic throm
bocytopenia (1) and myocardial infarc
tion (1).
Heart-Lung Transplantation:
World Experience

Combined heart and lung transplanta
tion was first performed in 1969; by the
end of 1971 three such procedures had
been performed, with the longest survival
being only 23 days.8-10 All patients died
of infection or bronchial disruption, or
both. No further heart-lung transplants
Table VI—Heart—Lung Transplantation:
Survival and Rehabilitation*
Feature

No. (%)

Transplantation
Currently alive
Fully rehabilitated
Partially rehabilitated
Not rehabilitated

110
59 (53.6)
48 (81.4)
10(16.9)
1 (1.7)

‘ Duration of survival ranged from 17 d to 4.42
V-

were performed until March 1981, when
Reitz and Shumway, stimulated by suc
cess in the laboratory with primates and
immunosuppression with cyclosporine in
clinical cardiac transplantation, per
formed the first clinically successful com
bined heart-lung transplant in a 45-yearold woman, who is still alive and well 4.5
years later.6
One year elapsed before another centre,
La Pitie in Paris, followed the Stanford
lead. Table IV summarizes results from
the 14 transplantation centres that have
carried out heart-lung transplantation.
Between March 1981 and September
1985, 56 males and 54 females, ranging
in age from 3.5 years to 60 years, have
undergone a total of 112 procedures.
The indications for these 112 proce
dures are outlined in Table V. The
predominant indicators were primary pul
monary hypertension and Eisenmenger’s
syndrome.
A most interesting group of patients,
those with primary lung parenchymal dis
ease (i.e., cystic fibrosis, emphysema)
accounts for only a small proportion of
the recipients to date but represents a
huge reservoir of potential candidates.
The ultimate utility of combined heartlung transplantation for the management
of patients with primary nonvascular lung
disease in unknown, and only 6 of 17 such
patients remain alive.
Table VI reviews the survival and
degree of rehabilitation achieved in the
110 transplant patients. Of these, 59
(53.2%) patients are alive from 17 days
to 4 years and 5 months after the proce
dure. Actuarial survival data are not
available for the entire group, but 70%
at 3 years is the survival rate for patients
transplanted at Stanford University Med
ical Center (personal communication).
Overall, of the patients currently alive
48 (81.4%) are fully rehabilitated, 10
(16.9%) are partially rehabilitated and 1
(1.6%) has no opportunity for rehabili
tation.
That heart-lung transplantation rep
resents a more complex and technically
difficult procedure than heart transplan
tation is reflected in the large number of

Table VII—Heart—Lung Transplantation: Cause of Death in 51
Recipients
Cause of death
Infection
Multisystem organ failure +postop bleeding
Acute respiratory failure
Tracheal dehiscence
Cerebral edema + infection
Renal failure
Myocardial infarction
Tracheo-aortic fistula
Respiratory failure: donor-recipient mismatch
Respiratory failure due to chronicrejection
Liver failure
Lymphoma

No. of patients
15
5
2
2
2
1
1
1
1
1
1

patients who have died of multisystem
organ failure, often related to hemor
rhage perioperatively. The cause of death
in 52 patients is summarized in Table VII.
Overall survival and quality of life fol
lowing cardiac transplantation have been
greatly improved since the introduction
of cyclosporine immunosuppression. The
most up-to-date information from the
Registry of the International Heart Trans
plantation Society (December 1985) indi
cates 1- and 4-year survival rates of 90%
and 80% respectively, although the results
for heart-lung transplantation are not
quite as good. Some centres have reported
a 90% 4-year survival, including patients
older than 50 years.
With over 114 centres around the world
(December 1985) actively performing
heart or heart-lung transplantation, it is
likely that throughout the next decade
cardiac-transplant patients will enjoy a
quality of life comparable to that of the
normal population, and the results of
heart-lung transplantation will improve
accordingly.
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novantrone

Mitoxantrone Hydrochloride Injection
For Intravenous Infusion Only
ANTINEOPLASTIC

CAUTION
NOVANTRONE* IS A POTENT DRUG AND SHOULD BE USED ONLY BY PHYSI
CIANS EXPERIENCED WITH CANCER CHEMOTHERAPEUTIC DRUGS (SEE
WARNINGS AND PRECAUTIONS). BLOOD COUNTS SHOULD BE TAKEN AT FRE
QUENT INTERVALS PRIOR, DURING AND POST THERAPY. CARDIAC MONITOR
ING IS ADVISED IN THOSE PATIENTS WHO HAVE RECEIVED PRIOR ANTHRACYCLINES, PRIOR MEDIASTINAL RADIOTHERAPY OR WITH PRE-EXISTING
CARDIAC DISEASE.
PHARMACOLOGICAL ACTION
Although its mechanism of action has not been determined, mitoxantrone is a DNAreactive agent. It induces nuclear aberrations with chromosome scattering in cell
cultures (human colon carcinoma line) and is a potent inhibitor of RNA and DNA
synthesis. Compared on an equimolar basis, mitoxantrone is seven times more
potent than doxorubicin in inhibiting the uptake of 3H-uridine and four times more
potent in inhibiting the uptake of 3H-thymidine by mouse lymphoma L5178Y cells in
vitro.
INDICATIONS
NOVANTRONE* is indicated for chemotherapy in patients with carcinoma of the
breast, including locally advanced and metastic disease. Also for relapsed adult
leukemia and lymphoma patients with hepatoma.
CONTRAINDICATIONS
NOVANTRONE* is contraindicated in patients who have demonstrated prior hyper
sensitivity to anthracyclines.
WARNINGS
Since NOVANTRONE* produces myelosuppression (see ADVERSE EFFECTS], it
should be used with caution in patients in poor general condition or with pre-existing
myelosuppression.
Cases of functional cardiac changes, including congestive heart failure and
decreases in left ventricular ejection fraction have been reported. These cardiac
events have occurred almost exclusively in patients who have had prior treatment
with anthracyclines, prior mediastinal radiotherapy or with pre-existing heart disease.
Cardiac monitoring is advisable in such patients. It is suggested that cardiac monitor
ing also be performed in other patients during therapy exceeding 160 mg/m2
(approximately 12 courses) of NOVANTRONE*, as experience during prolonged
treatment is limited.
NOVANTRONE* may impart a blue-green colouration to the urine for 24 hours
after administration, and patients should be advised to expect this during active
therapy. A reversible blue coloration in the sclerae has been reported in two cases.
Safe use of NOVANTRONE* in pregnancy has not been established. No information
is available concerning the presence of NOVANTRONE* in the milk of nursing
mothers. Safety for intrathecal use of NOVANTRONE* has not yet been established.
PRECAUTIONS
Full blood counts should be undertaken serially during a course of treatment. Dosage
adjustments may be necessary based on these counts [see DOSAGE section].
It is recommended that NOVANTRONE* not be mixed in the same infusion with
other drugs. [See DRUG COMPATIBILITY section],
ADVERSE EFFECTS
NOVANTRONE* is clinically well tolerated, demonstrating a low overall incidence of
adverse events, particularly those of a severe, irreversible or life-threatening nature.
Some degree of leucopenia is to be expected following recommended doses of
NOVANTRONE*. With dosing every 21 days, suppression of WBC counts below
1000/mm3 is infrequent; leucopenia is usually transient, reaching its nadir at about 10
days after dosing, with recovery usually occurring by the 21st day. Thrombocytope
nia can occur, and anaemia occurs less frequently. Myelosuppression may be more
severe and prolonged in patients having had extensive prior chemotherapy or radio
therapy or in debilitated patients.
The most commonly encountered side effects are nausea and vomiting, although
in the majority of cases these are mild (WHO Grade 1) and transient. Alopecia may
occur, but is most frequently of minimal severity and reversible on cessation of
therapy.
Other side effects which have occasionally been reported include allergic reactions
(one with anaphylaxis), abdominal pain, amenorrhoea, anorexia, constipation,
diarrhoea, dyspnoea, fatigue, weakness, fever, gastrointestinal bleeding, stomatitis/
mucositis, and non-specific neurological side effects. Tissue necrosis following
extravasation has been reported rarely.
Changes in laboratory test values have been observed infrequently, e.g.,
increased liver enzyme levels, elevated serum creatinine and blood urea nitrogen
levels (with occasional reports of severe impairment of hepatic function in patients
with leukemia).
Cardiovascular effects, which have only occasionally been of clinical significance,
include decreased left ventricular ejection fraction (determined by ECHO or MUGA
scan), EKG changes and acute arrhythmia. Congestive heart failure has been
reported. Such cases generally responded well to treatment with digitalis and/or
diuretics. In patients with leukemia there is an increase in the frequency of cardiac
events, the direct role of NOVANTRONE* in these cases is difficult to assess, since
most patients had received prior therapy with anthracyclines and since their course is
frequently complicated by anemia, fever, sepsis, and intravenous fluid therapy.
In leukemia patients treated with a single course of 12 mg/m2 1.V. daily x 5 days, the
following drug-related toxicities occured: moderate or severe jaundice or hepatitis in
8%, moderate nausea or vomitting in 8%, moderate or severe stomatitis/mucositis in
9-29%, diarrhea in 9-13%, and moderate or severe alopecia in 11%.
CLINICAL RESULTS
Introduction
Clinical trials experience has established the dosage range, efficacy and safety pro
file of NOVANTRONE.
A single dose can be given intermittently every three or four weeks. The recom
mended initial treatment dose in good risk patients is 14 mg/m2.
Efficacy
Breast
Efficacy data are available on 349 patients with locally advanced or metastatic breast
carcinoma. Results are dependent on many predisposing factors including prior
chemotherapy and/or radiotherapy, the health of the patients, sites of metastases,

and dose of the agent employed. In a European multi-centre first-line single-agent trial
using an initial dose of 14 mg/m2, the overall response rate was 39%, which com
pared favourably to doxorubicin therapy at a dose of 60-75 mg/m2 when given to
patients with similar stage disease. In an ongoing study of a direct comparison with
doxorubicin, given as second-line therapy to breast cancer patients who failed a
standard first-line combination, response rates are 27% for NOVANTRONE and 23%
for doxorubicin. The mean duration of response observed after NOVANTRONE was
greater than those reported after doxorubicin. Responses have been seen in all major
sites of metastases including lymph nodes, lung, bone, skin and viscera, in patients
both with and without prior hormonal therapy. Available data suggest that
NOVANTRONE is comparable in efficacy with doxorubicin in the treatment of
advanced breast cancer. Myelosuppression with 21-day treatment intervals is com
parable with that observed with doxorubicin. Multiple courses of single-agent
NOVANTRONE therapy, in some cases for longer than twelve cycles, have been
administered with excellent tolerance and a good response. NOVANTRONE showed
incomplete cross-resistance with doxorubicin since responses have been observed
in patients in whom doxorubicin had failed or who relapsed after response to that
drug. A continuing large-scale clinical trials program with combination therapy also
demonstrated early positive results for efficacy and safety. In seven studies, over 100
cycles of combination therapy have been given to 77 patients.
Additional Indications
A total of 966 patients have been treated with NOVANTRONE* for three other indica
tions of which 259 patients had non-Hodgkin's lymphona (NHL). 546 had leukemia,
and 161 had hepatocellular carninoma (HOC). The following summarizes the accrual
of these 966 patients:

Indication
NHL
Leukemia
(including pediatric cases)
HCC

Lederle-Sponsored
Studies
(No. Treated)
186
282

Independent Studies
Reported in the
Literature
(No. Treated)
73
264

_75

J36

543
423
NON-HODGKIN’S LYMPHOMA. Three key studies evaluated single agent
NOVANTRONE* in 148 patients with relapsed or refractory advanced NHL at a dose
of 14 mg/m2, IV, every 3 weeks. Of 127 patients evaluable for response in two trials,
there were 10 complete responses (CR) and 42 partial responses (PR) producing an
overall therapeutic response rate of 41%. The median duration of responses in the
multicenter study (122 evaluable patients) was 195 days. Many patients’ responses
lasted in excess of one year. Responses were seen in all histological subtypes of
NHL. Response to NOVANTRONE* was independent of prior chemotherapy and
independent of whether the patient received prior doxorubicin. This demonstrated a
lack of complete cross-resistance between NOVANTRONE* and other drugs includ
ing anthracyclines.
NOVANTRONE* was evaluated in combination with other agents for the treatment
of NHL. A total of 28 patients were treated with different regimens. A first-line compar
ative trial of the combination of intermediate dose METHOTREXATE with LEUCOVORIN rescue + bleomycin + doxorubicin + cyclophosphamide + vincristine +
dexamethasone (m-BACOD) versus the same com bination with 10 m g/m 2
NOVANTRONE* replacing doxorubicin (m-BNCOD) has shown activity: 4 PRs in 6
evaluable patients with m-BNCOD and 3 PRs in 6 with m-BACOD. The combination
of NOVANTRONE* at 10 mg/m2, daily for 3 days, + vincristine + dexamethasone
(NOD) produced 3 PRs in 5 evaluable patients. A first-line comparative trial of the
combination of cyclophosphamide + vincristine + prednisone + doxorubicin
(CHOP) versus the same combinations with 10 mg/m2 NOVANTRONE* replacing
doxorubicin (CNOP) has only recently begun.
NOVANTRONE * at 5 mg/m2, daily for 3 days every 3 weeks produced one CR and
2 PRs in 8 evaluable patients with NHL; ten patients were enrolled. Several other
studies reported in the literature and not sponsored by Lederle support the activity of
NOVANTRONE* in the treatment of NHL.
LEUKEMIA. Four key studies sponsored by Lederle evaluated single agent
NOVANTRONE* in 181 adult patients with refractory or relapsed acute nonlymphocytic leukemia (ANLL) or chronic myelogenous leukemia in blast crisis (BCML) at doses ranging from 8 to 12 mg/m2, IV, daily for 5 days, every 3 weeks. A dose
response effect was evident. Optimal activity was seen at a dose of 12 mg/m2, daily for
5 days. At this dose level, there were 19 CRs in 49 evaluable adult patients with ANLL
in relapse producing an overall response rate of 39%. The median duration of com
plete response in the largest (121 patients) single agent study was 98 days. Several
patients had remissions lasting in excess of one year. There were four studies com
prising 63 patients in which NOVANTRONE* was evaluated in combination with
other agents in the treatment of leukemia. The highest complete remission rate of
49 % (11 CRs in 23 e va lu a b le p a tie n ts w ith A N LL) was o b ta in e d w hen
NOVANTRONE* at 10 to 12 mg/m2, daily for 3 days, was combined with cytosine
arabmoside at 100 mg/m2 daily for 7 days. When NOVANTRONE* at 10 mg/m2, daily
for 5 days was combined with the same dose of cytosine arabinoside, it produced 2
CRs in 8 evaluable patients. Treatment of patients with acute lymphoblastic leukemia
using 10 mg/m2 NOVANTRONE*, daily for 3 days, + vincristine + prednisone
produced 10 responses in 16 evaluable patients, for a response rate of 62.5%.
Activity was also seen in B-CML. Since no standard therapy exists for this disease
and bone marrow is never truly normal in this disorder, both CRs and PRs were
considered evidence of efficacity. The optimal dose of NOVANTRONE* was 12
mg/m2, daily for 5 days, producing 6 responses in 17 evaluable patients.
Experience in pediatric leukemia patients is limited. Twenty-four patients were
treated with 6 to 8 mg/m2 NOVANTRONE *, daily for 5 days. There were 3 responses
in 24 evaluable children.
Fourteen adult leukemia patients received 20 to 37 mg/m2 NOVANTRONE* once
every two weeks. No therapeutic responses were observed using this schedule.
Several other studies reported in the literature and not sponsored by Lederle
support the activity of NOVANTRONE* in the treatment of ANLL and B-CML.
HEPATOCELLULAR CARCINOMA. Three clinical trials sponsored by Lederle have
been conducted using NOVANTRONE* in the therapy of HCC. NOVANTRONE*
was administered to 65 patients intravenously at 12 mg/m2 every 3 weeks in two
studies, and in one study with 10 patients at 6 to 10 mg/m2/day by continuous hepatic
artery infusion for three consecutive days, every 3 weeks. Considering the short life
span of patients presenting with HCC, a response of stable disease was included
along with PRs and CRs in assessing efficacy. In these three studies, the overall
therapeutic response rate was 46.7% (11 CRs and PRs + 10 stable disease in 45
evaluable patients). Activity was confirmed in other studies not sponsored by Lederle.
Durations of response were variable among these studies and ranged between 3 and
52 weeks.
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Safety
Data on the overall safety profile of NOVANTRONE (based on 989 patients) demon
strated advantages of NOVANTRONE compared to the anthracyclines with respect
to both the quality of life and the long-term safety of patients. The majority of side
effects with NOVANTRONE are m ild in nature. Rem oval of patients from
NOVANTRONE treatment for reasons of toxicity has been rare in clinical studies. A
number of patients have reported no side effects at all. In addition, the relatively low
risk of serious side effects has permitted treatment of patients on an out-patient basis.
The most common acute effects were nausea and/or vomiting (only 3.5% severe or
very severe with NOVANTRONE, compared to 10-15% reported with doxorubicin),
stomatitis/mucositis (only- 0.3% severe or very severe with NOVANTRONE) and
alopecia (only 0.9% severe or very severe, and 15% overall with NOVANTRONE
compared with 85% severe or very severe and 100% overall reported with doxoru
bicin). Serious local reactions have been reported rarely following extravasation of
NOVANTRONE at the infusion site.
With respect to myelosuppression, initial NOVANTRONE doses of 14 mg/m2 every
three weeks are well tolerated in good-risk patients. Severe degrees of myelosup
pression have been rare. The median white cell nadir in a European second-line
study was 2.5x103; in a European first-line study only 4.8% (2/42) of patients experi
enced a nadir of less than 1,000. The nadir usually occurs around day 10 or 11 and
returns to normal baseline value by day 21, in time for the next course of treatment.
After multiple courses of NOVANTRONE, white blood cell and platelet nadirs show no
further decrease beyond those observed in the first few cycles, indicating no cumula
tive or permanent effects of NOVANTRONE on marrow reserves.
NOVANTRONE* had an exceptional safety profile and was well-tolerated by
patients treated for NHL, leukemia and hepatoma, as well as for breast cancer.
However, due to the pathophysiology of leukemia and the higher doses of
NOVANTRONE* employed, the safety profile differed from that seen in NHL and in
hepatoma (see ADVERSE EFFECTS). The most severe and life-threatening events,
i.e. bleeding and infection, are well described morbid complications of acute
leukemia. Many of the episodes of hepatic dysfunction were probably related to the
increased bilirubin load and increased exposure to hepatitis viruses as a result of the
multiple transfusions of blood products necessary in the proper treatment of this
disorder.
Cardiotoxicity
Adverse cardiac experiences have been infrequent. In contrast, doxorubicin has
been reported to produce chronic cardiomyopathy and irreversible congestive heart
failure in up to 11% of patients given nine or more courses of that drug at the usual
dose sche dule (60 m g/m 2 every three weeks). W hether or not related to
NOVANTRONE, only 119 cardiac-related episodes have been reported from a total
data-base of more than 3,200 treated patients, including only 29 (0.9%) reports of
clinical congestive heart failure, of which only one had no other known predisposing
factors. The risk of cardiotoxicity is increased with prior anti-neoplastic drug or radia
tion therapy. In patients without predisposing factors, development of congestive
heart failure with NOVANTRONE therapy is rare.
Clinical experience suggests there is no need to lower the dose for patients with
existing renal or hepatic disease.
In summary, NOVANTRONE* is well tolerated and provides a better quality of life
for patients compared with doxorubicin and yet shows comparable efficacy.
NOVANTRONE has been used alone or in combination in patients with or without
prior chemotherapy, as well as in those who have received prior adjuvant therapy. It is
less cardiotoxic than anthracyclines such as doxorubicin and thus represents a clear
therapeutic advance over currently available compounds.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
There is no known specific antidote for NOVANTRONE. As would be expected from
the pharmacological actions of the drug, haematopoietic, gastrointestinal, hepatic
and renal toxicity may be seen, depending on the dosage given and the physical
condition of the patient. The management of overdosage is symptomatic and sup
portive and patients should be monitored closely. (See also the sections “ WARN
INGS", "PRECAUTIONS" and "ADVERSE REACTIONS” ).
DOSAGE
Breast Cancer, Lymphoma, Hepatoma
The recommended initial dosage for use as a single agent is 14 mg/m2 of body
surface area, given as a single intravenous dose, which may be repeated at 21-day
intervals. A lower initial dose (12 mg/m2 or less) is recommended in patients with
inadequate marrow reserves due to prior therapy or poor general condition.
Dosage modification and timing of subsequent dosing should be determined by
clinical judgement depending on the degree and duration of myelosuppression. If
21-day white blood cell and platelet counts have returned to adequate levels, prior
doses can usually be repeated. The following Table indicates a guide to dosing based
on myelosuppression.
WBC AND
TIME TO
PLATELET NADIR
RECOVERY
IF WBC NADIR>1 500
RECOVERY
AND
< 21 DAYS
PLATELET N A D IR >50 000
IF WBC NADIR > 1 500
RECOVERY
AND
> 2 1 DAYS
PLATELET NADIR > 5 0 000
IF WBC NADIR < 1 500
ANY DURATION
OR
PLATELET NADIR < 5 0 000
IF WBC NADIR < 1 000
ANY DURATION

OB

SUBSEQUENT DOSING
REPEAT PRIOR DOSE OR
INCREASE BY 2 mg/m2 IF
MYELOSUPPRESSION NOT
CONSIDERED ADEQUATE
WITHHOLD UNTIL RECOVERY
THEN REPEAT PRIOR DOSE
DECREASE BY 2 mg/m2 FROM
PRIOR DOSE AFTER RECOVERY
DECREASE BY 4 mg/m2 FROM
PRIOR DOSE AFTER RECOVERY

PLATELET NADIR < 2 5 000_______________
Combination Therapy for Breast Cancer, Lymphoma
NOVANTRONE* has been given in various combination regimens with the following
cytotoxic agents for the treatment of breast cancer and lymphomas: cyclophos
phamide, fluorouracil, vincristine, vinblastine, bleomycin, METHOTREXATE (stan
dard dose or 200 mg/m2 with LEUCOVORIN rescue) and glucocorticoids.
As a guide, when used in combination chemotherapy with another myelosuppressive agent, the initial dose of NOVANTRONE* should be reduced by 2-4 mg/m2
below the doses recommended above for single agent usage; subsequent dosing,
as outlined above, depends on the degree and duration of myelosuppression.
Dosage for Patients with Acute Leukemia in Relapse
The recommended dosage for induction is 12 mg/m2of body surface area, given as a
single intraveneous dose daily for five consecutive days (total of 60 mg/m2).
In clinical studies, with a dosage of 12 mg/m2 daily for 5 days, patients who
achieved a complete remission did so as a result of the first induction course.

Re-induction upon relapse may be attempted with NOVANTRONE* and again the
recommended dosage is 12 mg/m2 daily x 5.
Combination Therapy for Leukemia
NOVANTRONE *, together with cytosine arabinoside, has been used successfully for
the treatment of both first line and second line patients with acute non-lymphocytic
leukemia.
For induction, the recommended dosage is 10-12 mg/m2 of NOVANTRONE* for 3
days and 100 mg/m2 of cytosine arabinoside for 7 days (the latter given as a continu
ous 24 hour infusion).
If a second course is indicated, then the second course is recommended with the
same combination at the same daily dosage levels but with NOVANTRONE * give for
only 2 days and cytosine arabinoside for only 5 days.
If severe or life-threatening non-hematological toxicity is observed during the first
induction course, the second induction course should be withheld until the toxicity
clears.
Note regarding pediatric usage: Experience in pediatric patients is limited; how
ever, complete remissions have been observed with NOVANTRONE * as single agent
therapy at a dosage of 8 mg/m2 daily for 5 days.
ADMINISTRATION OF SOLUTION
NOVANTRONE* solution should be diluted to at least 50 mL with either Sodium
Chloride for Injection (USP) or 5% Dextrose for Injection (USP). This solution should
be introduced slowly into the tubing of a freely-running intravenous infusion of
Sodium Chloride for Injection (USP) or 5% Dextrose for Injection (USP) administered
over not less than three to five minutes intravenously. If extravasation occurs, the
administration should be stopped immediately and restarted in another vein. The
nonvesicant properties of NOVANTRONE minimize the possibility of severe reactions
following extravasation, however, tissue necrosis has been reported rarely.
NOVANTRONE should be administered by individuals experienced in the use of
antineoplastic therapy.
Caution in the handling and preparation of NOVANTRONE solutions must be
exercised and the use of protective eyeglasses, gloves and other protective clothing
is recommended. (See "GUIDELINES FOR SAFE USE BY HOSPITAL PERSON
NEL" section.)
STORAGE DIRECTIONS
NOVANTRONE should be stored at room tem perature-D O NOT FREEZE. With
recommended storage, NOVANTRONE remains stable for two (2) years.
Following preparation of the infusion, the diluted solution should be stored at room
temperature and used within 24 hours. Any original solution which remains in the vial
should be discarded. NOTE: LIKE THE ORIGINAL SOLUTIONS, THE DILUTIONS
SHOULD ALSO NOT BE FROZEN.
DRUG COMPATIBILITY
NOVANTRONE* should not be administered concommitantly with heparin since a
precipitate may form. Until specific compatibility data are available, it is recom
mended that NOVANTRONE* not be mixed in the same infusion with other drugs.
GUIDELINES FOR SAFE USE BY HOSPITAL PERSONNEL-CONSULT THE
PACKAGE INSERT.
CHEMISTRY
Composition
NOVANTRONE* mitoxantrone hydrochloride, a synthetic anthracenedione, is a
potent antineoplastic agent. Its molecular formula is C222H28N „0 62HCI and its molec
ular weight is 517.4. It is a hygroscopic dark blue solid supplied as a sterile, aqueous
solution containing mitoxantrone hydrochloride equivalent to 2 mg/mL mitoxantrone
free base, with sodium chloride, sodium acetate, and acetic acid as inactive ingredi
ents. The product does not contain antibacterial preservatives. Its structural formula
appears below.
H
H
HO
O
NCH2CH2NCH2CH2OH

Molecular Formula: C22H28N40 6.2 HCI
Molecular Weight: 517.4
Chemical Name: 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)aminol-ethyl]amino]9,10-anthracenedione dihydrochloride
AVAILABILITY
NOVANTRONE mitoxantrone hydrochloride injection is supplied as a sterile aqueous
solution at a concentration equivalent to 2 mg mitoxantrone free base per mL, and is
available in the following vial sizes:
10 mL/vial (20 mg) Product C o d e .....................................................................9393-34
12.5 mL/vial (25 mg) Product C ode...................................................................9393-72
Identification
Glass vials containing 10 and 12.5 mL of a clear, dark blue solution.
REFERENCES:
1. Cowan J D. A randomized trial of doxorubicin, mitoxantrone and bisantrene in
advanced breast cancer (A South West Oncology Group Study). Investigational New
Drugs 3:149-152,1985.
2. Submission: United States Food and Drug Administration, Sept. 1985.
3. Neidhart J A. Comparable efficacy of Novantrone and Adriamycin in breast can
cer. The Current Status of Novantrone (Symposium), Scottsdale, Arizona, March
1985.
4. Posner LE et al. Mitoxantrone: an overview of safety and toxicity. Investigational
New Drugs 3 (2): 133-137,1985.
•Registered User Cyanamid Canada Inc. Product Monograph available upon request.

GED

CYANAMID CANADA INC.
Toronto

IPAABI
ICCPP|

T.

RHEAUME, m d ;*

D.I.

R o b e r t s o n , MD, PH D, f r c p c ;* S.J. U r b a n s k i , m d , f r c p c ;*
G.C.E. Stuart , m d , FReset
1

Inguinal Intranodal Blue Nevus: a Case Report
Inguinal intranodal blue nevus is a rare
lesion, but awareness of the condition
will avoid a mistaken diagnosis of
metastatic melanoma. The authors
describe the case of a 40-year-old
woman in whom an inguinal node blue
nevus was discovered incidentally during
radical vulvectomy for squamous cell
carcinoma. They describe the character
istic light and electron microscopic fea
tures. With increased awareness of this
lesion the authors believe it will be found
in lymph-node chains other than the
inguinal and axillary ones previously
reported.
II est rare qu'on decouvre un naevus
bleu dans un ganglion inguinal. II faut en
garder la possibilite a I'esprit afin d'eviter
un diagnostic errone de melanome
metastatique. Les auteurs decrivent le
cas d'une patiente de 40 ans chez qui
on a decouvert accidentellement un nae
vus bleu dans un ganglion inguinal au
cours d'une vulvectomie radicale pour
epithelioma malpighien. Ils decrivent les
caracteristiques observees aux microsco
pes optique et electronique. Si Ton recher
che davantage cette lesion, les auteurs
croient qu'elle sera identifiee dans des
chaines ganglionnaires autres que les
chatnes inguinale et axillaire ou elles ont
deja ete signalees.

lymph nodes were involved in 8. We
report a further case in which an ingui
nal lymph node was involved.
Case Report
A 40-year-old multiparous Caucasian wom an
com plained of a lesion on the vulva, present

for 1 month. A 1-cm raised ulcerated lesion was
seen on the inner aspect of the left labium
minus and there were several smaller (up to 5
mm), slightly pigmented, macular lesions on
the perineum and right labium. No enlarged
lymph nodes could be palpated in either groin
and no other genital tract lesions were noted.
The uterus and cervix had been removed 4
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HG. 1—Photomicrograph of inguinal lymph node containing intracapsular pigmented bipo
lar nevo-melanocytes (hematoxylin and eosin, original magnification x 200).

Blue nevi are uncommon pigmented
lesions composed of bipolar or dendritic
melanocytes and are usually found in the
skin. Intranodal blue nevus was first
described as a distinct pathologic entity
in 1977 by Azzopardi and associates.1
Since their report of two cases, 10 other
patients with this lesion have been
described.2' 8 Of these 12 patients, 10
were female and 2 male, and the axillary
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FIG. 2—Electron micrograph of nevo-melanocyte characterized by basement membrane
and melanosomes at different stages of maturation (original magnification x 22 000).
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years before because of dysfunctional uterine
bleeding.
Excisional biopsy of the left labial lesion was
performed. Histologic examination of the
specimen revealed a small area of squamous
cell carcinoma with early stromal invasion aris
ing in a background of extensive carcinoma in
situ.
A radical vulvectomy was performed with
en-bloc resection of the superficial inguinal
lymph nodes bilaterally. During the right ingui
nal dissection, a single darkly pigmented lymph
node, measuring 1.8 cm, was noted superficial
to the cribriform fascia.
The pigmented lymph node contained elon
gated bipolar and dendritic cells with numer
ous intracytoplasmic melanin granules and
some pigment-laden melanophages (Fig. 1).
The pigment stained positively with MassonFontana stain but negatively with ZiehlNeelsen (lipofuscin) and Prussian blue (iron)
stains. The lesion involved the capsule of the
lymph node, extending along the fibrous
trabeculae, but it did not involve the subcapsular sinus or the nodal parenchyma. There was
no necrosis or mitoses in this lesion and
metastatic squamous carcinoma was not evi
dent. Electron microscopic examination rev
ealed a dual cell population. Some cells were
elongated with a prominent basement mem
brane, occasional cytoplasmic processes and
cytoplasmic organelles, including melanosomes
at different stages of maturation (Fig. 2). In
addition, prominent melanophages were seen.
No residual invasive carcinoma was present
in the vulva, but there was extensive in-situ car
cinoma at the margins of the previous biopsy.
The smaller pigmented lesions were multifo
cal in-situ squamous carcinomas with features
suggesting an associated condyloma virus infec
tion. None of the other submitted lymph nodes
contained melanocytes or metastatic car
cinoma.

Discussion
Blue nevi are usually found in the skin,
but they have also been described in the
cervix,9-13 prostate,14 palate15 and, more
recently, in the capsule o f lymph
nodes.2-8 The histogenesis is uncertain
but has been discussed by Azzopardi and
colleagues' and Epstein and associates.6
Briefly, the intranodal blue nevus may
develop from a “ benign metastasis” or
passive transfer of melanocytic cells from
a melanocytic lesion in the region drained
by the involved lymph node. Alterna
tively, aberrant migration o f neural crest
cells may explain the intranodal location.
Such aberrant neurocristic cells may
exhibit melanocytic or nerve-sheath
differentiation,6 the latter occurring in
this case.
Although malignant transformation of
a dermal blue nevus is uncommon, such
an event involving an intranodal blue
nevus has been postulated in patients with
metastatic melanoma in whom no pri
mary tumour could be found.2'5,6 In a
recent autopsy study a primary location
could not be found in 4% of patients who
died of melanoma.16
Eight of the 12 previously reported

cases of intranodal blue nevi involved
axillary lymph nodes in mastectomy
specimens of women with breast carci
noma. Only two previous cases involved
inguinal lymph nodes and one each a submental and popliteal lymph node.
The two inguinal intranodal blue nevi
previously reported were found in a
56-year-old man who underwent surgery
for varicose veins7 and a 20-year-old
woman reported to have melanoma o f the
foot.8 Two o f the resected inguinal
lymph nodes in this woman were believed
to contain metastatic melanoma. On
review 10 years later both the lesion in the
foot and inguinal lymph nodes were blue
nevi.
Only two o f the previously reported
cases have involved men. The pre
dominance of women and axillary lymphnode involvement is probably related to
the frequency with which axillary lymph
nodes are removed from women with
breast carcinoma. We decided to report
this case o f a blue nevus in an inguinal
lymph node because we suspect that with
an awareness of this entity, further exam
ples will be found in other lymph-node
chains. Further, an enhanced awareness
o f this relatively rare condition by both
pathologists and surgeons will avoid a
mistaken diagnosis of metastatic mela
noma and a futile investigation for an
occult primary melanoma or even unwar
ranted further surgery.
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BOOK REVIEWS
continued from page 246
Pathologic features that might be encoun
tered are well illustrated by the use of colour
pictures taken through the sigmoidoscope, giv
ing the visual cues of size, colour and shape.
This is the best means of conveying the image
of possible abnormalities of the colorectum.
These pictures will be of greatest value to the
primary care physician who is an occasional
sigmoidoscopist. In general, surgeons will
recognize the pathologic conditions based upon
experience with rigid sigmoidoscopy and
familiarity with surgical specimens.
This book will serve the physicianendoscopist as a reference resource for sig
moidoscopy. The index is reasonably complete,
which is a primary requirement for a good
reference source.
L ee E . S m it h , m d
Department of Surgery,
George Washington University,
2550 Pennsylvania Ave. NW,
Washington, DC,
20037
MANUAL ON CONTROL OF INFECTION
IN SURGICAL PATIENTS. 2nd ed.
American College of Surgeons Committee
on Control of Surgical Infections of the
Committee on Pre- and Postoperative
Care. Edited by William A. Altemeier
(Chmn.), John F. Burke, Basil A. Pruitt,
Jr. and William R. Sandusky. 388 pp.
Illust. J.B. Lippincott Company, Philadel
phia, 1984. S35. (US). ISBN 0-397-50575-2.
The first edition of this book, published in
1976, was a review and summary of four work
shops on the control o f surgical infection,
organized by Dr. Altemeier between 1970 and
1972 and attended by most active investigators
in this field. This edition revises and updates
the first with much of the new material com
ing from the scientific meetings of the Surgi
cal Infection Society, formed in 1980. The
stated aim is to “ provide an up-to-date, read
ily available source of information and guide
that will be useful for the prevention and con
trol of surgical infection in hospital practice” .
This manual provides a broad, authoritative
database, o f value to health professionals
interested in solutions to the problems of infec
tion. The material is well organized into dis
tinct chapters. The commentary and references
are often repetitive, but this has the advantage
of allowing different groups to access areas of
particular interest without having to read the
entire book.
Chapters dealing with definitions and clas
sification of surgical infections, incidence and
cost, epidemiology and surveillance, preoper
ative preparation of the patient, preparation
of the operating team (attire and surgical
scrub), preparation and maintenance of a safe
operating-room environment, hospital design
requirements for safe surgery, housekeeping
techniques, laboratory support, sterilization
and isolation, provide practical, state-of-theart, authoritative information. These chapters
are probably of greatest interest to operatingroom nurses and supervisors, infectious-disease
specialists, infection-control comm ittees,
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Immune Response After Gastric Bypass
and Weight Loss
The immune response of 22 morbidly
obese patients was measured before and
6 months after gastric bypass. In-vivo
skin testing was carried out using five
recall antigens. In-vitro response
assessed the ability of isolated lympho
cytes to take up radioactive thymidine
after culture with the same antigens.
The mean ( ± SD) preoperative weight of
the patients of 122 ± 14 kg declined by
33.5 ± 8 kg after 6 months. The num
ber of positive skin tests increased from
a mean (± SEMI of 1.8 ± 0.17 to 2.1
± 0.17 (p = 0.2). Mean (± SEM) indu
ration of the skin-test response assessed
at 24 hours after antigen injection
increased from 4.7 ± 0.6 mm to 5.5 ±
0 .6 mm (p = 0.35) and at 48 hours
from 5.4 ± 0.7 mm to 6.9 ± 0.9 mm
(p = 0 .0 5 ). One patient who was aner
gic before gastroplasty responded nor
mally 6 months later after substantial
weight loss. In-vitro response, expressed
as a stimulation index (± SEM),
increased from 4.71 ± 0.65 to 7.95 ±
1.56 (p = 0.06) for the average of all
antigens and from 12.85 ± 2.05 to
15.79 ± 2 .84 (p = 0.2) for the largest
response. The authors conclude that the
response to test antigens in vitro and in
vivo is not reduced significantly 6
months after gastric bypass and pro
found weight loss. Patients with severe
vomiting, rapid weight loss or sepsis
may respond differently and require
individual assessment.

poids moyen (± ecart type) preoperatoire des patients Stait de 122 ± 14 kg
a ete r6duit de 33.5 ± 8 kg apres 6
mois. Le nombre d'intradermoreactions
positives a augmente d'une moyenne (±
erreur type) de 1.8 ± 0.17 a 2.1 ±
0.17 (p = 0.2). En ce qui concerne le
diametre d'induration de la reaction cutan£e, la moyenne (± erreur type) apres
24 heures a augmente de 4.7 ± 0.6 mm
a 5.5 ± 0.6 mm (p = 0.35) alors
qu'apres 48 heures elle passait de 5.4 ±
0.7 mm d 6.9 ± 0.9 mm (p = 0.05).
Un patient anergique avant gastroplastie
a presente une reponse normale 6 mois
plus tard apres une perte de poids importante. La reaction in vitro exprimg sous
forme d'indice de stimulation ( ± erreur
type) a augmente de 4.71 ± 0.65 a
7 .95 ± 1.56 (p = 0.06) pour la
moyenne de tous les antigenes, et de
12.85 ± 2.05 a 15.79 ± 2.84
<p = 0.2) pour les reactions les plus
importantes. Les auteurs concluent que
la reponse in vitro et in vivo aux antige
nes de rappel n'est pas reduite significativement 6 mois apr6s derivation gastri
que et perte de poids importante. II est
possible que les patients qui ont des
vomissements importants, une perte de
poids rapide ou une sepsie repondent differemment et necessitent une evaluation
individuelle.

since most weight loss occurs within this
period. We evaluated the skin-test
response by the techniques of Meakins
and an in-vitro test of cellular immunity
that has been useful in monitoring
patients who have undergone transplan
tation.6

<

a

Patients and Methods

Twenty-two morbidly obese patients (2
men, 20 women) ranging in age from 20
to 60 years (mean [±SD] 41 ± 9 years)
were admitted to University Hospital in
London for gastric bypass. All weighed
more than twice the ideal weight. A Rouxen-Y gastric bypass was done in all. At
least 2 days before operation skin testing
was carried out using five recall antigens
(Candida, mumps, purified protein
derivative [PPD], Trichophyton and Varidase); 0.1 ml of antigen was injected
intradermally as described by others.4
The area of induration was measured at
24 and 48 hours and a test considered
positive if the diameter of induration was
greater than 5 mm. The test was repeated
6 months after operation. A mean skintest response was also calculated by meas
uring the diameter of induration for each
antigen, adding the values and dividing
by five. This score was calculated 24 and
48 hours after antigen injection, before
and 6 months after operation.
Gastroplasty and gastric bypass are fre
For in-vitro testing the procedure was
quently performed for the management carried out as described previously for
of morbid obesity. MacLean and cell-mediated lymphocytotoxicity.6
La reponse immunitaire de 22 patients
associates1 found that a substantial Before testing, 40 ml of blood was drawn
souffrant d'obesite pathologique a ete
proportion of these patients have become from each patient. Lymphocyte separa
mesuree avant et 6 mois apres derivation
malnourished postoperatively. In tion was carried out by a Ficoll-Hypaque
gastrique. Une intradermoreaction a ete
developing countries malnourishment is technique. Cells were made up to a con
pratiquee a I'aide de cinq antigenes de
known to be associated with an impaired centration of 2 X 106 ml and suspended
rappel. La reponse in vitro a evalue la
host immune response.2,3 Meakins and in tissue culture medium (RPMI) with
capacite de lymphocytes isol6s a capter
colleagues4,5 have used skin testing to 20% heat-inactivated autologous serum
la thymidine marquee apres culture en
predict postoperative complications. or A serum. Tests were carried out in
presence de ces memes antigenes. Le
Since patients who undergo gastroplasty triplicate on microtitre plates using 0.1
From the *Department o f Surgery and
may
require further operations urgently ml of cells and 0.1 ml of medium con
t Department o f Microbiology and Immu
for problems such as stomal obstruction taining antigen, giving a final cell num
nology, University o f Western Ontario,
or electively for management of hernias, ber of 1 x 105 cells and a serum concen
London, Ont.
gallstones or dependent skin, it seemed tration of 10%. Controls included 1 x
Accepted fo r publication Feb. 11, 1986
105 cells in 0.1 ml of 20% A serum in
Reprint requests to: Dr. D.M. Grace, Divi appropriate to assess the skin-test
sion o f General Surgery, University Hospi response in a group of obese patients after RPMI, 1 x 105 cells in 0.1 ml of 20%
gastroplasty. We chose 6 months as a autologous serum in RPMI and 1 x 105
tal, PO Box 5339, Station A, London,
Ont. N6A 5A5
suitable time for postoperative follow-up, cells in 0.1 ml of RPMI medium only.
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after weight loss. The paired f-test was
used to compare results before and after
operation.
Patients were seen preoperatively and
postoperatively in hospital by a dietician
and given diet sheets to take home. They
were followed up by their family doctor
and seen monthly at our obesity clinic.
High protein intake was encouraged but
exact caloric intake was not assessed.
Multiple vitamins containing iron were
taken by all patients.

Antigen dilutions were Candida (Bencard
Allergy Service, Division of Beecham
Laboratories, Weston, Ont.) 1/100 and
1/200, mumps (Eli Lilly, Co., Scar
borough, Ont.) 1/200 and 1/400, PPD
(Connaught Laboratories, Toronto, Ont.)
0.2 mg and 0.02 mg, Trichophyton 1/100
and 1/200 and Varidase (Bencard Allergy
Service) 0.1 ml (5 units streptokinase and
1.2 units of streptodornase or 0.5 units
streptokinase and 0.12 units streptodor
nase). Cells were incubated for 4 days at
37°C with 5% carbon dioxide and then
pulsed with 1 /rCi of 3H-thymidine for 16
hours. After harvesting, each plate was
counted for 5 minutes in a B counter.
Blastogenic response was recorded as a
stimulation index: the mean count per
minute of stimulated cells divided by the
mean count per minute for control cells.
The test was repeated 6 months later.
Twenty values were obtained for each
patient at each testing since there were
two dilutions of each of the five antigens
and all tests were carried out in autolo
gous and A sera. The mean of all values
was obtained for each patient preoperatively and postoperatively. The changes
in the largest stimulation index were also
calculated for each patient, since this was
assumed to be the antigen to which the
patient was most sensitized preoperatively
and which might show the greatest change

Results
The average weight of the patients
immediately preoperatively was 122 ± 14
(SD) kg. Six months later the average
weight had decreased to 86 ± 11 kg.
Results of skin testing and in-vitro
response are summarized in Table I.
Response tended to increase rather than
decrease postoperatively, but the change
was not significant. Skin testing was con
sidered normal or reactive if there was a
positive response (induration greater than
5 mm) to two or more antigens. Response
to only one antigen indicated relative
anergy and no response indicated anergy.
Table II compares the mean skin-test
score (diameter of induration in mil
limetres per antigen) before and 6 months
after operation. Again the response
tended to improve although only the

Table 1- Immune Response After Gastroplasty in 22 Patients*
Measurement of
immune response
No. positive skin tests
Average stimulation index
Largest stimulation index

Preoperative

Postoperative

p value

1.8 ± 0.17
4.71 ± 0.65
12.85 ± 2.05

2.1 ± 0.17
7.95 ± 1.56
15.79 ± 2.84

0.2
0.06
0.2

'Figures are mean ± standard error.
Table 11-Mean Skin-Test Response per Antigen Before and After
Gastroplasty*
Time of measurement
after antigen injection, h
24
48

Induration diameter, mm
Preoperative

Postoperative

p value

4.7 ± 0.6
5.4 ± 0.7

5.5 ± 0.6
6.9 ± 0.9

0.35
0.05

’ Figures are mean ± standard error.
Table Ill-Skin-Test Response After Gastroplasty in 22 Patients
Response
Normal
Relative anergy
Anergy

Preoperative

Postoperative

17
4
1

17
5
0

Table IV—Change in Immune Response Related to Weight Loss
Change

Preoperative

Postoperative

Improved
response
Same response

Anergy
Relative anergy
Relative anergy
Normal
Normal

Normal
Normal
Relative anergy
Normal
Relative anergy

Worse response

No. of
patients

Weight loss,
%

1
3
1
14
3

25
28
26
29
24

result read after 48 hours was significant
(p = 0.05). Table III indicates the
proportion of patients in each category
before and after operation and Table IV
shows the change in immune response
relative to weight loss.
Review of clinical data revealed no
unusual features except in the patient who
was anergic preoperatively. He underwent
a transverse gastroplasty reinforced with
Marlex around a greater curve channel.
An umbilical hernia was also repaired.
His weight at the time of operation was
180 kg and his height 188 cm. Initial
recovery was uncomplicated and he was
discharged 8 days after operation. Over
the next 2 months excessive vomiting was
a major problem and upper gastrointes
tinal series with barium confirmed that
the stoma was narrow and gastric emp
tying delayed. Within 2 months of oper
ation he had lost 40 kg (22% of body
weight). Because of continued vomiting,
the gastric bypass was revised within 3
months of operation. Skin testing before
reoperation showed that he was anergic.
Postoperative recovery and his subse
quent course were smooth. One year later
his weight was 104.6 kg.
Discussion
Our patients, who recovered from gas
tric bypass without complications and lost
27% of body weight in 6 months, showed
no significant reduction in immune
response. In fact there was a tendency for
the test results to improve although the
changes approached statistical sig
nificance only for the mean skin-test score
48 hours after antigen injection. Studies
in a larger number of patients might show
a significant increase in skin-test and invitro immune response for all tests.
Preoperatively, many obese patients ate
a poorly balanced diet high in fat and car
bohydrate. Postoperatively, the diet is
low in calories but should be high in pro
tein and vitamins. The improved diet
could explain the tendency for immuno
logic test results to improve.
The fact that four of our patients were
relatively anergic before gastroplasty is
surprising and unexplainable. In a group
of 727 patients with a variety o f health
problems preoperatively, including cancer
and sepsis, 18% were relatively anergic
and 12% anergic.5 In the same study, 25
morbidly obese patients all had normal
preoperative skin-test results. It is not
clear whether our results are due to faulty
technique, since skin testing is difficult to
interpret,7 or whether our patients were
abnormal before gastroplasty. Measure
ment of the skin-test response using seven
rather than five antigens in a multitest
may give a more standardized assessment
of cell-mediated immunity,8 but the
small size of the reaction is difficult to
read.
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The one anergic patient should have
been excluded from the study because of
a prior gastroplasty, but he demonstrates
that anergy can occur. We were fortunate
that he did well following a revision gas
troplasty. In retrospect he should have
been placed on parenteral nutrition to
counteract the excessive preoperative
weight loss. The lack of skin-test response
was an even stronger indication for delay
ing operation. Placement of a feeding
tube was not possible because of a
stenotic stoma, but a smaller operation
such as jejunostomy would have allowed
correction of his nutritional deficit before
the major revision. Such procedures have
proven useful after gastroplasty.9
Whether patients are malnourished
after gastric stapling operations is a con
troversial matter. One study,1 using
sophisticated methods to determine the
sodium to potassium ratio, showed that
patients suffered serious malnutrition
after gastroplasty. Another study10 that
determined body-cell mass by whole-body
counting after gastric bypass showed that
lean mass was preserved although tem
porarily reduced early after operation.
Protein malnutrition does not always
affect the immune response.11 Anergy
may be more important than nutritional
status in predicting susceptibility to infec
tio n .12 However, other clinical studies13
suggested that nutritional data can predict
postoperative complications.

In our study immunosuppression was
not detected 6 months after gastric
bypass. Testing early postoperatively
might have demonstrated a change in
skin-test responsiveness.8 Although most
of the weight loss occurs in the first 6
months, the most rapid loss occurs dur
ing the first 3 months, when immunologic
testing might have shown a reduced
response. For patients requiring emer
gency reoperation after gastroplasty or
gastric bypass, there is no time for nutri
tional or immunologic assessment. When
elective operations such as cholecystec
tomy, hernia repair or abdominal lipectomy are performed, nutritional assess
ment is important. For most patients
clinical judgement may be as useful as
immunologic testing in predicting
postoperative complications.14 For the
exceptional case in which the patient has
severe vomiting or excessive weight loss,
skin testing may help to determine the
need for parenteral nutrition and delayed
operation. In some patients sepsis must
be treated and abscesses drained before
anergy can be corrected.15
In conclusion, most patients will have
no detectable change in skin-test response
or in-vitro tests of cellular immunity 6
months after gastric bypass and substan
tial weight loss. Careful dietary advice
and regular follow-up are essential to
maintain nutritional status and allow
early detection of complications.
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SESAP V Critique
ITEM 44
Carcinoma of the pancreas is not amenable to surgical excision of the tumor for most patients. Relief of biliary and
duodenal obstruction and reduction of pain are the goals of palliative operation. Percutaneous intubation of the bile duct
under radiographic control relieves biliary obstruction in many patients, but does not relieve duodenal obstruction and
may be associated with major morbidity related primarily to sepsis and hemorrhage.
Biliary enteric bypass via the gallbladder is possible only if gallstones are absent, the gallbladder is healthy, and the
cystic duct is not obstructed. Distention of the gallbladder, which may be associated with tumor encroachment on the
cystic duct, is not a reliable indication of cystic duct patency. If the gallbladder cannot be used, biliary bypass should
be by choledochojejunostomy.
Obstruction of the duodenum occurs in up 30% of patients with pancreatic carcinoma. Obstruction may occur in
the duodenal sweep and also in the fourth portion of the duodenum. If gastrojejunostomy is performed only for patients
with established duodenal obstruction, 13% of patients not undergoing bypass subsequently develop duodenal obstruc
tion. Whether the duodenum should be bypassed with gastrojejunostomy will require surgical judgement depending on
the operative findings.
Drainage of the obstructed pancreatic duct has been described, but its value has not been demonstrated. U tubes
are contraindicated for patients with pancreatic cancer and obstructive jaundice.
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Needle-Guided Breast Biopsy for Mammographic Abnormalities
in 561 Patients
Between 1977 and 1983, 561 consecu
tive patients underwent 595 surgical
biopsies for suspicious mammographic
lesions with negative clinical correlation.
The procedure consisted of preoperative
needle localization, with or without
immediate radiologic examination of the
biopsy specimen, depending on the
presence or absence of microcalcifica
tions in the mammographic lesion.
Eighty-four carcinomas were found. Of
these, 60 (7 1 % ) were infiltrating carci
noma and 24 (2 9 % ) were noninvasive
carcinoma. The carcinoma yield was
2 4 .2 % in the patients with lesions
involving foci of microcalcifications and
9 % in those lesions without calcifica
tions. Surgical treatment of infiltrating
carcinoma consisted of 39 modified radi
cal mastectomies, 10 (2 5 .6 % ) of which
were associated with positive nodes, 16
partial mastectomies with axillary dissec
tion, 3 (1 8 .7 % ) of which were
associated with positive nodes, and 5
wedge resections. Treatment of noninva
sive carcinoma consisted of 19 partial
mastectomies with axillary dissection
and 5 modified radical mastectomies.
None of these were associated with
positive nodes. Modified radical mastec
tomy was used with decreasing fre
quency. Of the 10 patients with infiltrat
ing carcinoma and positive axillary nodes
treated by modified radical mastectomy,
7 had one to three involved nodes and 3
had four or more; of those with positive
nodes treated by partial mastectomy, 1
had one to three involved nodes and 2
had four or more. These results confirm
the correlation between suspicious mam
mographic non-clinical lesions and breast
carcinoma.
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De 1977 d 1983, 561 patientes cons6cutives ont subi 595 biopsies chirurgicales pour des lesions suspectes a la mammographie, en I'absence de correlation
clinique. L'intervention a consiste en une
localisation de I'aiguille en preop£ratoire,
avec ou sans examen radiologique immediat du materiel de biopsie, selon que
Ton avait deceie ou non des microcalcifi
cations a la mammographie. Quatrevingt-quatre lesions cancereuses ont 6te
trouvees. Parmi celles-ci, 60 (71% )
etaient des cancers infiltrants et 24
(2 9 % ) des tumeurs non envahissantes.
Le rendement de lesions cancereuses
etait 2 4 .2 % chez les patients avec les
calcifications. Dans les cas de tumeurs
infiltrantes, on a procede e 39 mastecto
mies radicales modifiees dont 10
(2 5 .6 % ) ont mis en evidence des gan
glions positifs, 16 mastectomies partielles avec dissection axillaire dont 3
(1 8 .7 % ) ont ete associees e des gan
glions positifs et 5 resections cuneiformes. Le traitement des cancers non
envahissants s'est fait, chez 19 patien
tes, par resection partielle avec dissec
tion axillaire et, chez 5, par mastectomie
radicale modifiee. Dans aucun cas, on
n'a mis en evidence des ganglions posi
tifs. La frequence des mastectomies radi
cales modifiees est aliee en decroissant.
Des 10 patientes porteuses de cancers
infiltrants avec ganglions axillaires posi
tifs et qui ont subi une mastectomie radi
cale modifiee, 7 avaient une atteinte de
un a trois ganglions, alors que 3 avaient
une atteinte de quatre ganglions ou plus;
parmi cedes qui avaient des ganglions
positifs et qui ont ete traitees par mas
tectomie partielle, 1 avait un envahissement de un e trois ganglions et 2 avaient
quatre ganglions positifs ou plus. Ces
resultats confirment la correlation observee entre les lesions suspectes a la
mammographie, sans manifestation clini
que, et le cancer du sein.

Over the last 40 years there has been a
trend toward conservatism in the surgi
cal treatment of breast carcinoma, from

Halsted’s radical mastectomy, then modi
fied radical mastectomy to the presentday controversial wedge resection or par
tial mastectomy with an axillary dissec
tion. Also, the use of mammography by
both the primary physician and in breast
screening programs has increased. This,
combined with the development of finegrain film and dedicated equipment, has
greatly increased the accuracy and iden
tification of clinically nonpalpable
lesions, thus posing the challenge of how
to manage the patient found to have sus
picious changes on mammography. In
1971, Gallagher and Martin1 introduced
the term “ minimal breast carcinoma” ,
defining it as a carcinoma less than 0.5
cm in size. However, the term has come
to represent most clinically occult lesions,
up to and including those 1.0 cm in size,
which for years were considered to have
a more favourable prognosis because of
their small size and earlier detection.

Patients and Methods
Mammograms from 561 women were
evaluated by one radiologist who recom
mended biopsy on the basis of the follow
ing criteria.
• Microcalcifications present: (a)
Clusters of fine, irregular calcifications of
different shapes, sizes and density. The
finer the granules and the greater the
number, the more likelihood there is of
a malignant lesion, (b) Lace-like branch
ing linear groups of microcalcifications
that may or may not be associated with
nodular densities.
• No microcalcifications: (a) Irregular
nodular densities, (b) Asymmetric densi
ties. (c) Focal structural parenchymal
alterations with a fluffy or stellate
appearance.
During the period January 1977 to
December 1983, 595 procedures were car
ried out by one surgeon using a technique
of needle localization as follows. In the
mammography unit, just before surgery,
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the lesion is noted on the preoperative
films in the craniocaudal and mediolateral
projections, and the distance of the lesion
from the middle of the nipple is measured
in both the horizontal and vertical planes
on both projections. The depth of the
lesion is measured on the projection in
which the lesion is closer to the skin. The
appropriate needle size is selected. Nee
dles used were 25 gauge x 5/8 inch and
22 gauge x 1'A inches for more superfi
cial lesions and 22 gauge x 3!4 inches for
deeper lesions. The needle is securely
anchored to the skin with Steristrips and
a two-view mammogram is obtained. If
not sufficiently close, the needle is reposi
tioned without complete removal and
mammography is repeated. Once a satis
factory needle position has been obtained,
the patient is transferred to the operat
ing room and under general anesthesia 1.0
ml o f toluidine blue is injected as the
needle is withdrawn. Incisions are made in
the areola where possible or along natural
skin lines and the suspect, stained tissue
is excised. The amount of tissue removed
is minimal and the cosmetic results are
excellent. Meticulous hemostasis is
obtained, no reconstruction is done and
drainage is not used.
If a clinically obvious carcinoma is
demonstrated, quick-section examination
is performed and a specimen sent for
determination of estrogen and progester
one receptors. All other specimens
undergo routine pathological examina
tion. In biopsies taken because of the
presence of microcalcifications the calcifi
cations are confirmed by tissue radiogra
phy and an additional separate biopsy is
done at the same time if required (as in
approximately 3% of our procedures).
Areas of microcalcification are tagged for
the pathologist, who also has the benefit
of the tissue x-ray films. Mammography
of the biopsied breast is done 3 months
postoperatively to verify that the suspi
cious lesion has been excised. This is
preferably performed in the same insti
tution as the initial procedure. Fewer than
six patients required re-excision for
missed lesions or inadequate excision.
One patient in this group was found to
have noninvasive carcinoma.

Results

The 595 biopsies yielded 84 carcinomas
(14.1% of procedures or 15.0% of
patients). Of these carcinomas, 60
(71.4%) were of the infiltrating type and
24 (28.6%) were noninvasive. Carcinoma
was found in 49 (24.2%) of the 202 biop
sies done for microcalcifications. Biopsies
undertaken for lesions without microcal
cifications yielded a positive result in only
9%.
Further surgical treatment consisted of
288

the following. Of the 60 women with
invasive carcinoma, 39 underwent modi
fied radical mastectomy; 10 (25.6%) had
involved axillary nodes. Sixteen had par
tial mastectomy with axillary dissection
and 3 (18.7%) had axillary node involve
ment. Because they refused further treat
ment or because of referral back to the
original surgeon, five women had wedge
resection only. Thus, 13 of the 55 patients
with infiltrating carcinoma at the time of
detection already had axillary involve
ment with the clinically occult lesion.
Of the 24 patients with noninvasive car
cinoma, 19 underwent partial mastectomy
with axillary dissection and 5 had a modi
fied radical mastectomy. None had axil
lary node involvement.
The frequency of modified radical
mastectomies decreased during the series,
because of a change in philosophy in the
management of breast carcinoma. Now,
patients with focal areas of noninvasive
cancer are treated by wedge resection only
and closely followed up.
Discussion

We emphasize the use of dedicated
equipment, proper compression technique
and dedicated technologists and radiolo
gists. To acquire expertise in this proce
dure, the radiologist should have follow
up data on all patients who have had
breast biopsy recommended as a result of
mammographic findings. This will
increase diagnostic confidence and
decrease mammographic overcall. In our
view, it is necessary to have preoperative
localization of the lesion verified by mam
mography. We see no virtue in inserting
a needle preoperatively and not accurately
localizing the lesion.2 Even when per
formed by radiologists experienced in the
procedure, needle localization on the first
attempt may be inaccurate, requiring a
reinsertion and further mammographic
verification. Without this visual guidance
the surgeon is operating “ blind” .
In their series, Schw artz and
colleagues3 reported a 31.4% incidence
of carcinoma. The largest group had
lesions 1 to 2 cm in diameter, which
would not be considered minimal breast
cancer. Fewer than six patients with
infiltrating cancer in our series did not
fulfil the criteria of minimal breast cancer
in its broader definition. Schwartz and
associates also reported a 37.8% inci
dence of axillary node involvement in
patients with infiltrating cancer. Some of
their patients had disseminated disease at
the time of surgery but we could not
document a single such case by conven
tional testing. The differences may be
explained by different criteria of opera
bility. Powell and colleagues4 looked
only at those patients with microcalcifi

cations and noted a 17% incidence of car
cinoma and a 9% incidence of axillary
involvement.
All these reports confirm the simplic
ity of the procedure and the lack of seri
ous morbidity, indicating that it is an
effective tool in the armamentarium of
the surgeon treating breast disease.

Conclusions

With the increased use of screening,
suggestive changes found on mammogra
phy should be dealt with early and
aggresssively owing to the substantial
correlation with carcinoma. The term
“ aggressive” is not used to denote radi
cal in the surgical sense, but early inter
vention as opposed to a “ wait-and-see”
attitude. Occult lesions can frequently be
managed with conservative surgery.
It is time we discarded the notion that
minimal breast carcinoma is not serious.
In our series, almost 25% of clinically
occult invasive breast cancers were
associated with axillary involvement at
the time of surgery. However, this
represents a 50% decrease in axillary node
involvement over carcinomas that present
clinically and thus should result in
improved survival.

Addendum
We have recently become concerned by the
low cancer yield from mammographic lesions
without calcification that have been described
as either irregular nodular densities or asym
metric densities. Repeat mammography on the
day o f surgery has often failed to confirm a
lesion and the proposed surgery has been can
celled. The discrepancy may be due to techni
cal factors or regression o f an area of benign
breast disease. We now repeat the mammog
raphy before scheduling an operation. This
policy, we believe, will reduce the number o f
unnecessary biopsies.

We thank Miss Morag M. Simpson for typ
ing the manuscript.
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Effect of Total Parenteral Nutrition
on Biliary Lipids in Neonates
To study the effect of total parenteral
nutrition (TPN) on biliary lipids in criti
cally ill neonates, biliary lipid concentra
tions were determined in 13 neonates
before starting TPN, in 8 receiving TPN
for up to 2 weeks and in 9 receiving
TPN for up to 8 weeks. Bile was very
dilute in the 13 neonates not receiving
TPN owing to a low concentration of bile
acids. In many the bile-acid concentra
tion was below the critical micellar con
centration, thus cholesterol in bile was
not dissolved. The neonates receiving
TPN for up to 2 weeks showed a marked
increase in bile-acid content and had
levels above the critical micellar concen
tration. This apparently beneficial effect
of TPN disappeared after 2 weeks and
neonates who received TPN for 3 to 8
weeks again had bile-acid levels below
the critical micellar concentration. Three
conclusions may be drawn from this
study: (a) in the fasting state before TPN
is begun, the cholesterol content of bile
relative to phospholipid and bile acids
increased in linear fashion during the
fasting period; (b) short-term TPN of up
to 2 weeks' duration was associated
with an increased bile-acid content to
levels at which cholesterol could be dis
solved; (c) neonates on long-term TPN
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and no oral intake secrete extremely
dilute bile with an insufficient concentra
tion of bile-acid molecules to form
micelles to dissolve cholesterol. This
finding may explain some of the adverse
hepatobiliary changes associated with
long-term administration of TPN.
Dans le but d'etudier les effets de I'ali
mentation parentgrale complete (APC)
sur les taux de lipides biliaires du
nouveau-ne gravement malade, les con
centrations de lipides biliaires ont ete
mesures chez 13 nouveau-nes sur le
point de recevoir I'APC, chez 8 qui recevaient de I'APC depuis 2 semaines au
maximum et chez 9 qui avaient ete sous
APC pour une periode allant jusqu'd 8
semaines. La bile des 13 nouveau-nes
qui n'avaient pas requ d'A PC etait tr6s
diluee a cause de la faible concentration
en acides biliaires. Chez plusieurs, la
concentration d'acide biliaire etait en
deca de la concentration micellaire criti
que de sorte que le cholesterol n'etait
pas dissous dans la bile. Les nouveaunes qui avaient recu de I'APC pour une
periode allant jusqu'a 2 semaines presentaient une augmentation marquee de la
teneur en acide biliaire, au dessus de la
concentration micellaire critique. Cet
effet benefique apparent de I'APC avait
disparu apres 2 semaines et les nouveaunes qui avaient et6 sous APC pour de 3
a 8 semaines avaient de nouveau des
taux d'acides biliaires sous la concentra
tion micellaire critique. De cette etude,
trois conclusions peuvent etre tirees:
a) avant la mise en route de I'APC, la
teneur en cholesterol de I'acide biliaire
relative aux phospholipides et aux acides
biliaires augmente de fagon lineaire pen
dant la pgriode de jeune; b) a court
terme (jusqu'a 2 semaines) I'APC est
reliee a une augmentation des acides
biliaires jusqu'd des concentrations permettant la dissolution du cholesterol; c)
les nouveau-nes sous APC £ long terme
qui ne sont pas alimentes par la bouche
secretent une bile extremement diluee
dont la teneur en molecules d'acides
biliaires est insuffisante pour former les
micelles necessaires pour dissoudre le

cholesterol. Ces resultats sont capables
d'expliquer quelques uns des changements hepatobiliaires indesirables qui
sont relies e I'APC a long terme.

Disturbances of hepatobiliary function
are common in patients of all ages receiv
ing total parenteral nutrition (TPN) in
place of normal oral alimentation.1 3
Although TPN has been implicated by
association as the cause of these condi
tions, it is difficult to separate the effects
of TPN from those of prolonged fasting,
underlying disease and, in neonates, liver
immaturity. In neonates in an intensive
care unit we studied biliary lipid
(cholesterol, phospholipid and total bile
acid) concentrations during the fasting
state of up to 6 days before the start of
TPN and for up to 8 weeks after.

Patients and Methods
Thirty neonates were divided into three
groups. Group 1 (control) consisted of 13
babies who were fasting for up to 6 days
before the initiation of TPN and were
maintained on dextrose-electrolyte solu
tion administered by peripheral vein.
Group 2 comprised eight neonates on
TPN for up to 2 weeks with no oral
intake. In group 3 were nine patients who
were on TPN for 3 to 8 weeks with no
oral intake. Table I shows the incidence
of neonatal jaundice and gastrointestinal
disorders (predominantly necrotizing
enterocolitis) affecting the enterohepatic
circulation in the three groups. The inci
dence of neonatal jaundice in group 3 was
less than in group 1 (p < 0.05), reflect
ing the older age of the neonates in the
former group. The proportion of infants
with gastrointestinal disorders did not
differ significantly in the three groups.
The groups were also similar in regard to
gestational age, birth weight and weight
at the time of study (Table I). Infants in
group 3 tended to be heavier at the time
of bile sampling, but the differences were
not significant. None of the mothers had
received phenobarbital before delivery.4
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matic colorimetric method using the
Abbott bichromatic analyser — ABA-100
(Abbott Laboratories, South Pasadena,
Calif.).5 Phospholipid concentration was
measured by the method o f Sunderman
and Sunderman6 using the Unicam spec
trophotometer (Pye Unicam Ltd., Cam
bridge, UK) at 675 nm. The enzymatic
determination o f total bile acids was car
ried out using the method o f Engert and
Turner7 and the Beckman DU-8 spec
trophotometer (Beckman Instruments,
Fullerton, Calif.) at 340 nm.
We attempted to portray the biliary
lipid data on triangular coordinates and
to use Carey’s tables8 for cholesterol
solubility in bile; however, the extremely
dilute nature o f bile in the premature
neonate puts most specimens out o f the
range of these devices. The data are
presented as a percentage o f total lipid
millimoles and total lipid concentration
with reference to cholesterol solubility in
bile in only group 1. Tests o f statistical
significance (Student’s /-test for unpaired
data, X2 test and linear regression analy
sis) were done using a Hewlett-Packard
97 programmable calculator (HewlettPackard [Canada] Ltd., Mississauga,
Ont.).
The study was approved by a Univer
sity of Alberta, Faculty of Medicine, Ethi
cal Review Committee. Parental consent
was obtained after a full explanation of
the study as was the consent of a neonatalogist who was not involved in the
study.

The infants in groups 2 and 3 received
TPN through a centrally-placed catheter.
The amount of TPN was increased gradu
ally and stabilized at a daily rate o f 2.0
to 2.5 g/k g protein (Travasol; Travenol
Canada Inc., Mississauga, Ont.), 2.0 to
3.0 g /k g fat (Intralipid; Cutter Labora
tories, Mississauga, Ont.) and 12 to 15
g /k g glucose. Electrolytes, vitamins and
trace elements were added to the TPN
solution.

Collection and Analysis o f Bile Specimens
Duodenal bile was obtained by duo
denal intubation using a no. 5 to 8
French, soft rubber catheter passed with
the patient positioned on the right side.
The duodenal position o f the tube was
determined by pH monitoring (more than
6.5) and colour o f the aspirate (yellow).
Whenever possible tube position was veri
fied by an x-ray film taken for other pur
poses (e .g ., pneum othorax, pneu
moperitoneum) or by palpation at the
time o f laparotomy. Gallbladder contrac
tion was induced 20 minutes before we
collected the bile specimen, by instilling
an amino-acid solution (0.5 to 1.0 m l/kg
o f 10% Travasol) into the duodenum.
Bile-rich duodenal juice was then aspi
rated over 1 to 2 hours to give a 1- to
3-ml specimen. Bile specimens were
taken to the laboratory immediately after
collection where they were extracted and
refrigerated until they were analysed for
lipid content.
The molar concentrations o f choles
terol, phospholipid and total bile acids
were determined for each specimen; from
these data the total biliary lipid concen
tration was calculated. Cholesterol con
centration was determined by an enzy

but particularly in groups 1 and 3. The
total biliary lipid concentrations of only
three specimens, all from group 2, fell
within the lower limits of the normal adult
range.8
When total biliary lipid concentration
is broken down into the three components
(cholesterol, phospholipid and total bile
acids), it is apparent that cholesterol and
phospholipid concentrations in bile
changed little in the three groups (Table
II). Total bile-acid concentration showed
a large increase in group 2 compared with
groups 1 and 3 and accounts for the in
crease in total biliary lipid concentrations
seen in that group (Fig. 2, Table II).
The critical micellar concentration
(CMC) or minimum concentration at
which micelles start to form for bile acids
in bile is 0.9 to 2.2 mmol (mean 1.45
mmol).9'10 Five o f the 13 neonates in
group 1 showed bile-acid concentrations
below the CMC. In group 2 in which bileacid concentration was much higher, all
bile specimens were at or above the CMC.
In group 3 the concentrations of only two
specimens were at the lower range o f the
CMC for bile acids and in the remaining
seven, specimens were clearly below the
CMC (Fig. 3).
In group 1 patients (control group), the
relation between cholesterol in bile
expressed as a percent o f total lipid mil-

Results
The concentration o f lipids in the bile
o f neonates studied was extremely dilute
compared with the generally stated range
for normal adults (Fig. 1, Table II).
Dilute bile was noted in all three groups

Table 1—Infant Data
Feature
Male/female
Duration of total parenteral
nutrition, wk
Neonatal jaundice, no.*
Gastrointestinal disorder, no.
Gestational age, wk (x ± SEM)
Birth weight, g (x ± SEM)
Weight at time of testing, g
(x ± SEM)

Group 1
(n - 13)

Group 2
(n = 8)

Group 3
(n = 9)

8/5

4/4

4/5

0
10
8
33.3 ± 1.2
1892 ± 201

2
5
7
33.8 ± 1.6
1784 ± 213

3-8
3
8
32.8 ± 1.8
1858 + 297

1938 ± 192

2070 ± 223

2651 ± 357

FIG. 1—Total biliary lipid concentration
(g/L) in groups 1, 2 and 3 (mean ± SEM).
Shaded area indicates normal range for total
biliary lipid concentration.

B ile A c id
C o n c e n t r a t io n
in B ile

'Group 1 vs group 3 p < 0.05.
P h o s p h o lip id
C o n c e n t r a t io n
in B ile

Table II—Lipid Concentrations for the Three Groups of Neonates*
Lipid values
Total bile, g/L
Cholesterol, mmol/L
Phospholipid, mmol/L
Total bile acids, mmol/L

Group 1
1.17
0.30
0.70
1.04

±
±
±
±

0.19
0.05
0.16
0.18

Group 2
2.49
0.40
0.67
3.67

±
±
±
±

0.49
0.05
0.10
0.88

'Normal adult range of total biliary lipid concentration is 3 to 300 g/L.
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Group 3
0.77
0.23
0.56
0.50

±
+
±
±

0.10
0.04
0.08
0.12

C h o le s t e r o l
C o n c e n t r a t io n
in B ile

2.0

-

1.0 o*—G r o u p

1

E%2P

G ro u p 2

G ro u p 3

FIG. 2—Concentrations of cholesterol,
phospholipid and bile acids (mmol/L) in bile
(mean ± SEM).

VOLUME 29, NO. 4, JULY 1986 / THE CANADIAN JOURNAL OF SURGERY

limoles and duration of the fasting period
in days was linear (y = - 18.72 + 7.37x)
with a correlation coefficient of 0.90 (Fig.
4). This temporal relation did not apply
in groups 2 and 3 and or to phospholipid
or bile acids in any group. This relation
between biliary cholesterol and fasting is
also seen in normal adults in whom bile
tends to become supersaturated with
cholesterol during fasting. In Fig. 4 we
have indicated the cholesterol solubility
line of A dm irand and Sm all11 (at
approximately 10% cholesterol-percent of
total millimoles) as a reference point.
Discussion
A notable finding in this study was that
the infants in groups 1 and 3 had ex
tremely dilute bile compared with that
of adults8 and full-term infants.4 This
was owing mainly to the small amount of
bile acid present in the bile obtained from
the duodenum. This observation is con
sistent with the finding that the functional

C ritic a l M icellar
C o n c e n tra tio n
o f B ile A cids
in Bile

FIG. 3—Total bile-acid concentrations
(mmol/L). Shaded area indicates critical micel
lar concentration of bile acids in bile.

FIG. 4—Percent cholesterol in bile plotted
against duration of fasting period for group
1 (control group receiving no TPN). Broken
horizontal line indicates approximate limit of
cholesterol solubility in bile.

maturity of the liver is reduced in prema
ture infants, whose livers cannot carry out
the complex functions of synthesizing bile
acid from cholesterol, conjugating the
bile acid with glycine or taurine and
secreting the conjugates into bile. The
most important finding was that bile
became more concentrated in the
neonates in group 2 who received TPN
for up to 2 weeks due to a large increase
in bile-acid content. Short-term TPN
appeared to provide substrate for bileacid synthesis or in some way “ turned on
a switch” for bile-acid conjugation and
secretion. Unfortunately this beneficial
effect was short lived as infants receiving
TPN for longer than 3 weeks again had
very dilute bile. It is noteworthy that
Postuma and Trevenen12 and Cohen and
Olsen13 noted a deterioration in liver
function and histologic changes in the
livers of neonates receiving TPN for lon
ger than 14 days.
A consequence of the dilute bile and
low bile-acid content seen in groups 1 and
3 infants is that their bile-acid level was
below the critical micellar concentration
for bile acids; this is the level below which
there are insufficient bile-acid molecules
present to form micelles to dissolve
cholesterol. Although the bile sludge and
stones formed in the gallbladders of
patients on TPN has largely been at
tributed to gallbladder stasis,14'15 the bile
of many infants in this study was also
incapable of solubilizing cholesterol.
The neonates in group 1 (fasting
without TPN) showed the same type of
relation between cholesterol content of
bile (as a percent of total millimoles) and
fasting as is seen in normal adults;
namely, that bile becomes supersaturated
with cholesterol in the fasting state.16-18
The bile content of cholesterol relative to
bile acids and phospholipids increased
during the fasting period of up to 6 days.
In Fig. 4 we have indicated the cholesterol
solubility line of Admirand and Small as
a reference point only because some bile
samples in this group were below the crit
ical micellar concentration for bile acids
and were incapable of solubilizing even
relatively small amounts of cholesterol.
In summary, it appears that bile be
comes increasingly saturated with
cholesterol in fasting neonates. However,
short-term TPN (up to 2 weeks) is asso
ciated with an increase in bile-acid con
tent and hence decreased cholesterol satu
ration of bile. These effects disappear on
continued TPN without oral intake. The
reasons for the apparent beneficial effect
of short-term TPN need further investi
gation.
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Index Reminder
The 1983 index to the Canadian Jour
nal o f Surgery, volume 26, is still avai
lable. If you would like to receive a
copy, please return the request card
that was included in the November
1985 issue or notify the Library, Cana
dian Journal o f Surgery, PO Box
8650, Ottawa, ON K1G 0G8; (613)
731-9331.

1. M essing B, Bories C, Kun stlin ger F, et al: Does
total parenteral nutrition induce gallbladder sludge for
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microbiologists, hospital administrators and
chiefs of service, and should probably be
required reading. The busy clinical surgeon and
surgical resident are more concerned with the
30% to 40% of surgical patients who are
admitted with home-based spontaneous infec
tion from acute inflammation or viscus perfo
ration, the proper choice and use of antibiotics
(both prophylactic and therapeutic) and sur
gical techniques. They will be more attracted
to the chapters concerning influence of oper
ating technique on rate of wound infection;
inhospital (nosocomial) infections other than
surgical wound infection; use o f antimicrobial
agents and infection in the immunocom
promised host.
The chapter on operating technique is dis
appointingly elementary and dated. The princ
iples enunciated—careful technique to
minimize tissue injury, protection of wound
edges, debridement of dead tissue, hemosta
sis and avoidance of seroma and dead space—
are basic. O f the 20 references, 13 are earlier
than 1971 and only 2 are from reports of the
1980s. Equally disappointing is the chapter on
pathophysiology of infection that reviews the
inflammatory and immunologic responses of
the invaded body and the energy metabolism
and synthesis of proteins essential to maintain
immunocompetence, to heal wounds, and to
preserve the structure of vital organs. Although
it introduces the average practitioner to a daz
zling array of new terms (e.g., leukocidin, bac
terial L-forms, erythrogenic toxin, lipid A,
kallikrein, opsonic proteins, peptidases, throm
boxane, prostacyclin, interleukin and fibronectin), this kaleidoscopic review is overwhelm
ing. In attempting to touch all bases, it fails
to develop a comprehensive picture. This is
probably more a reflection of the state of the
art than a failure of the editors. The defects

in these two chapters are compensated for by
the outstanding in-depth tabulated review of
the classes of antimicrobial agents, their mode
of action and side effects, and a guide to the
selection of the most appropriate agent or an
alternative. This is complemented by an excel
lent review o f the causes and prevention of
nosocomial infection, especially of the catheterized urinary tract, and the diagnostic and spe
cial preventive and therapeutic considerations
in infections in immunodepressed patients (the
aged, malnourished and critically ill) that are
being encountered with increasing frequency.
These two chapters alone make this a worth
while reference text.
It is noteworthy that there has been a shift
o f the bacteria in secondary infections occur
ring during hospitalization (hospital acquired
or nosocomial) from gram-positive Staphy
lococcus, the major offender, to predominantly
aerobic gram-negative bacilli. There has also
been a sharp increase in the number of infec
tions caused by invasive gram-negative bacteria
previously considered to have little or no viru
lence, and infections by fungi and viruses.
Approximately 80% of serious infections by
these organisms developed while patients were
on antibiotic prophylaxis or therapy for other
infections. It.is incumbent upon the operating
surgeon to be familiar with their control.
The organization, headings, layout and print
make this manual easy to read and subjects
easy to locate. There is liberal use of drawings
and photographs, most of which add little to
the text and are redundant but serve well to
break the monotony of the written page. The
multiple tables and lists are exhaustive but
useful.
M arvin J. W exler , m d , frcsc

When many urology texts seem to be wordprocessor-generated variations o f each other,
it is refreshing to read this book.
Urologists and pathologists will find
the book both enjoyable and beneficial.
Its emphasis is on histologic features and
ultrastructure. The full colour micrographs are
of the highest quality and clearly illustrate the
text. They are particularly good in the con
troversial sections such as those on urothelial
atypia, renal cell adenoma and carcinoma.
The book begins with a clear and logical dis
cussion o f the problems of definition and ter
minology of renal cell adenoma and carci
noma. The author does not draw a definite line
between adenoma and carcinoma, but he nar
rows the grey area and highlights the dilemma
facing the histopathologist trying to distinguish
between the two.
Lesions mistaken for tumours, such as cys
titis cystica and malakoplakia, are discussed,
and the diagnostic features are well illustrated;
prostatic hyperplasia is discussed briefly and
only to allow a comparison with carcinoma.
The different staging and grading systems
of urologic malignant disease are discussed
and compared, and as an appendix the book
contains the complete UICC (TNM system)
classification. The references are numerous and
up to date.
This book can be recommended to urologists
and pathologists. It should be available as a
reference in all teaching units.
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N orm an G. F utter , m b , frcsc

Associate professor of surgery,
Royal Victoria Hospital,
McGill University,
Montreal, PQ,
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PLASTIC SURGEON: ON - FRCSC required for
very active Metropolitan Toronto Community
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Department of Plastic Surgery, Northwestern

CLINICAL BURN FELLOWSHIP: - Six months or
twelve months, regional adult burn centre, Welles
ley Hospital, beginning January 1, 1987. New
10-bed, ultra modern burn centre, 100 burns per
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ANUSOL-HC AND TUCKS
TEAM UP FOR RELIEF
Anusol-HC and Tucks team up to effec
tively relieve the discomfort associated
with hemorrhoids and other anorectal
disorders.

ANUSOL*-HC
• Relieves pain and itch caused by
inflammation.
• Lubricating petrolatum base m ini
mizes friction.
• Colorless ointment and suppositories
protects against personal embarrass
ment.
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• Soothes inflam ed hem orrhoidal tissue.
• Eliminates mechanical irritation from
toilet tissue.
• Helps maintain proper hygiene.
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